Form FR Y-14A FR Y-14A Capital Assessments and Stress Testing (Annual)

Capital Assessments and Stress Testing Reports

FRY14A_20200331_f

FR Y-14A

OMB: 7100-0341

Document [pdf]
Download: pdf | pdf
FR Y‐14A Schedule A ‐ Summary
Summary Submission Cover Sheet
All BHCs and IHCs are expected to complete a version of the Summary template for each required scenario ‐ BHC Baseline, BHC Stress, Supervisory Baseline, and Supervisory Severely Adverse ‐  and additional scenarios that are 
named accordingly. 
BHCs, SLHCs, and IHCs should complete all relevant cells in the corresponding worksheets, including this cover page.  BHCs, SLHCs, and IHCs should not complete any shaded cells.
Please ensure that the data submitted in this Summary Template match what was submitted in other data templates.
Please do not change the structure of this workbook.
Please note that unlike FR Y‐9C reporting, all actual and projected income statement figures should be reported on a quarterly basis, and not on a cumulative basis

Institution Name:
RSSD ID: 
Source:
Submission Date (MM/DD/YYYY):
When Received:

BHC, SLHC, or IHC

Please indicate the scenario associated with this submission using the following drop‐down menu:
Briefly describe the scenario below:

FR Y‐14A Schedule A.1.a ‐ Income Statement
Actual in 
$Millions
Item

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43

Projected in $Millions

as of date
LOSSES ASSOCIATED WITH LOANS HELD FOR INVESTMENT AT AMORTIZED COST
Real Estate Loans (in Domestic Offices)
First Lien Mortgages
First Lien Mortgages
First Lien HELOAN
Second / Junior Lien Mortgages
Closed‐End Junior Liens
HELOCs
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential
Owner‐Occupied
Non‐Owner‐Occupied
Loans Secured by Farmland
Real Estate Loans (Not in Domestic Offices)
First Lien Mortgages
Second / Junior Lien Mortgages
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential
Owner‐Occupied
Non‐Owner‐Occupied
Loans Secured by Farmland
C&I Loans
C&I Graded
Small Business (Scored/Delinquency Managed)
Business and Corporate Card
Credit Cards
Other Consumer
Auto Loans
Student Loans
Other loans backed by securities (non‐purpose lending)
Other 
Other Loans
Loans to Foreign Governments
Agricultural Loans
Loans for purchasing or carrying securities (secured or unsecured)
Loans to Depositories and Other Financial Institutions
All Other Loans and Leases
All Other Loans (exclude consumer loans)
All Other Leases
Total Loans and Leases

CASIP521
CASIP522
CASIP386
CASIP394
CASIP523
CASIP402
CASIP412
CASIP524
CASIP525
CASIP526
CASIP527
CASIP528
CASIP529
CASIP530
CASIP531
CASIP420
CASIP428
CASIP532
CASIP533
CASIP534
CASIP535
CASIP536
CASIP537
CASIP538
CASIP539
CASIP540
CASIP541
CASIP542
CASIP543
CASIP544
CASIP545
CASIP496
CASIP546
CASIP547
CASIP548
CASIP549
CASIP550
CASIP551
CASIP552
CASIP553
CASIP554
CASIP555
CASIP556

                       ‐
                       ‐

                       ‐

                       ‐

                       ‐

                       ‐

                       ‐

                       ‐

                       ‐

                       ‐

                       ‐

                       ‐

CPSIP521
CPSIP522
CPSIP386
CPSIP394
CPSIP523
CPSIP402
CPSIP412
CPSIP524
CPSIP525
CPSIP526
CPSIP527
CPSIP528
CPSIP529
CPSIP530
CPSIP531
CPSIP420
CPSIP428
CPSIP532
CPSIP533
CPSIP534
CPSIP535
CPSIP536
CPSIP537
CPSIP538
CPSIP539
CPSIP540
CPSIP541
CPSIP542
CPSIP543
CPSIP544
CPSIP545
CPSIP496
CPSIP546
CPSIP547
CPSIP548
CPSIP549
CPSIP550
CPSIP551
CPSIP552
CPSIP553
CPSIP554
CPSIP555
CPSIP556

PQ 1

PQ 2

PQ 3

PQ 4

PQ 5

PQ 6

PQ 7

PQ 8

PQ 9

             ‐
             ‐
             ‐
             ‐
             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐
             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐
             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐
             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐
             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐
             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐
             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐
             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐
             ‐
             ‐
             ‐
             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐
             ‐
             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐
             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

FR Y‐14A Schedule A.1.a ‐ Income Statement

Sums in $Millions
Item

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43

PQ 2 ‐ PQ 5
LOSSES ASSOCIATED WITH LOANS HELD FOR INVESTMENT AT AMORTIZED COST
Real Estate Loans (in Domestic Offices)
First Lien Mortgages
First Lien Mortgages
First Lien HELOAN
Second / Junior Lien Mortgages
Closed‐End Junior Liens
HELOCs
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential
Owner‐Occupied
Non‐Owner‐Occupied
Loans Secured by Farmland
Real Estate Loans (Not in Domestic Offices)
First Lien Mortgages
Second / Junior Lien Mortgages
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential
Owner‐Occupied
Non‐Owner‐Occupied
Loans Secured by Farmland
C&I Loans
C&I Graded
Small Business (Scored/Delinquency Managed)
Business and Corporate Card
Credit Cards
Other Consumer
Auto Loans
Student Loans
Other loans backed by securities (non‐purpose lending)
Other 
Other Loans
Loans to Foreign Governments
Agricultural Loans
Loans for purchasing or carrying securities (secured or unsecured)
Loans to Depositories and Other Financial Institutions
All Other Loans and Leases
All Other Loans (exclude consumer loans)
All Other Leases
Total Loans and Leases

                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐

PQ 6 ‐ PQ 9

                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐

9‐Quarter

                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐

FR Y‐14A Schedule A.1.a ‐ Income Statement

Item

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43

LOSSES ASSOCIATED WITH LOANS HELD FOR INVESTMENT AT AMORTIZED COST
Real Estate Loans (in Domestic Offices)
First Lien Mortgages
First Lien Mortgages
First Lien HELOAN
Second / Junior Lien Mortgages
Closed‐End Junior Liens
HELOCs
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential
Owner‐Occupied
Non‐Owner‐Occupied
Loans Secured by Farmland
Real Estate Loans (Not in Domestic Offices)
First Lien Mortgages
Second / Junior Lien Mortgages
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential
Owner‐Occupied
Non‐Owner‐Occupied
Loans Secured by Farmland
C&I Loans
C&I Graded
Small Business (Scored/Delinquency Managed)
Business and Corporate Card
Credit Cards
Other Consumer
Auto Loans
Student Loans
Other loans backed by securities (non‐purpose lending)
Other 
Other Loans
Loans to Foreign Governments
Agricultural Loans
Loans for purchasing or carrying securities (secured or unsecured)
Loans to Depositories and Other Financial Institutions
All Other Loans and Leases
All Other Loans (exclude consumer loans)
All Other Leases
Total Loans and Leases

FR Y‐14A Schedule A.1.a ‐ Income Statement

Item

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43

LOSSES ASSOCIATED WITH LOANS HELD FOR INVESTMENT AT AMORTIZED COST
Real Estate Loans (in Domestic Offices)
First Lien Mortgages
First Lien Mortgages
First Lien HELOAN
Second / Junior Lien Mortgages
Closed‐End Junior Liens
HELOCs
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential
Owner‐Occupied
Non‐Owner‐Occupied
Loans Secured by Farmland
Real Estate Loans (Not in Domestic Offices)
First Lien Mortgages
Second / Junior Lien Mortgages
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential
Owner‐Occupied
Non‐Owner‐Occupied
Loans Secured by Farmland
C&I Loans
C&I Graded
Small Business (Scored/Delinquency Managed)
Business and Corporate Card
Credit Cards
Other Consumer
Auto Loans
Student Loans
Other loans backed by securities (non‐purpose lending)
Other 
Other Loans
Loans to Foreign Governments
Agricultural Loans
Loans for purchasing or carrying securities (secured or unsecured)
Loans to Depositories and Other Financial Institutions
All Other Loans and Leases
All Other Loans (exclude consumer loans)
All Other Leases
Total Loans and Leases

FR Y‐14A Schedule A.1.a ‐ Income Statement
Actual in 
$Millions
Item
44
45
46
47
48
49
50
51
52
53
54
55
56
57

Projected in $Millions

as of date
LOSSES ASSOCIATED WITH HELD FOR SALE LOANS AND LOANS ACCOUNTED FOR UNDER THE FAIR VALUE OPTION
                       ‐
Real Estate Loans (in Domestic Offices)
CASIP557
First Lien Mortgages
CASIP558
Second / Junior Lien Mortgages
CASIP559
CRE Loans
CASIP560
Loans Secured by Farmland
CASIP561
                       ‐
Real Estate Loans (Not in Domestic Offices)
CASIP562
Residential Mortgages
CASIP563
CRE Loans
CASIP564
Loans Secured by Farmland
CASIP565
C&I Loans
CASIP566
Credit Cards
CASIP567
Other Consumer
CASIP568
All Other Loans and Leases
CASIP569
CASIP570
Total Loans Held for Sale and Loans Accounted for under the Fair Value Option
                       ‐

CPSIP557
CPSIP558
CPSIP559
CPSIP560
CPSIP561
CPSIP562
CPSIP563
CPSIP564
CPSIP565
CPSIP566
CPSIP567
CPSIP568
CPSIP569
CPSIP570

PQ 1

PQ 2

PQ 3

PQ 4

PQ 5

PQ 6

PQ 7

PQ 8

PQ 9

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

58
59
60
61
62

TRADING ACCOUNT
Trading MTM Losses
Trading Issuer Default Losses
Counterparty Credit MTM Losses (CVA losses)
Counterparty Default losses
Total Trading and Counterparty

63
64
65
66

OTHER LOSSES
Goodwill impairment
Valuation Adjustment for firm's own debt under fair value option (FVO)
Other losses (describe in supporting documentation)
Total Other Losses

CASIC216
CASIP577
CASIP578
CASIP579

CPSIC216
CPSIP577
CPSIP578
CPSIP579

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

67

Total Losses

CASIP580

CPSIP580

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

CASIKU69
CASIP581

CPSIKU69
CPSIP581

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

CASIKU70

CPSIKU70

CASIKU71

CPSIKU71

CASIKU72
CASIP582
CASIP583
CASIP584
CASIP585
CASIP586
CASIP587
CASIP588
CASIP589
CASIP590

CPSIKU72
CPSIP582
CPSIP583
CPSIP584
CPSIP585
CPSIP586
CPSIP587
CPSIP588
CPSIP589
CPSIP590

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

ALLOWANCE FOR LOAN and LEASE LOSSES (1)
68 Total allowance for loan and lease losses, prior quarter
68a ALLL, prior quarter
68b Allowance for credit losses on held‐to‐maturity debt securities, prior quarter (2)
68c Allowance for credit losses on available‐for‐sale debt securities, prior quarter (2)
68d Allowance for credit losses on all other financial assets, prior quarter (2)
69
70
71
72
73
74
75
76
77

Real Estate Loans (in Domestic Offices)
Residential Mortgages
First Lien Mortgages
Closed‐End Junior Liens
HELOCs
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential

CPSIP571
CPSIP572
CPSIP573
CPSIP574
CPSIP576

FR Y‐14A Schedule A.1.a ‐ Income Statement

Sums in $Millions
PQ 2 ‐ PQ 5

Item
44
45
46
47
48
49
50
51
52
53
54
55
56

LOSSES ASSOCIATED WITH HELD FOR SALE LOANS AND LOANS ACCOUNTED FOR U
Real Estate Loans (in Domestic Offices)
First Lien Mortgages
Second / Junior Lien Mortgages
CRE Loans
Loans Secured by Farmland
Real Estate Loans (Not in Domestic Offices)
Residential Mortgages
CRE Loans
Loans Secured by Farmland
C&I Loans
Credit Cards
Other Consumer
All Other Loans and Leases

57

Total Loans Held for Sale and Loans Accounted for under the Fair Value Option

58
59
60
61
62

PQ 6 ‐ PQ 9

9‐Quarter

                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐

                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐

                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐

                      ‐

                      ‐

                      ‐

TRADING ACCOUNT
Trading MTM Losses
Trading Issuer Default Losses
Counterparty Credit MTM Losses (CVA losses)
Counterparty Default losses
Total Trading and Counterparty

                      ‐
                      ‐
                      ‐
                      ‐
                      ‐

                      ‐
                      ‐
                      ‐
                      ‐
                      ‐

                      ‐
                      ‐
                      ‐
                      ‐
                      ‐

63
64
65
66

OTHER LOSSES
Goodwill impairment
Valuation Adjustment for firm's own debt under fair value option (FVO)
Other losses (describe in supporting documentation)
Total Other Losses

                      ‐
                      ‐
                      ‐
                      ‐

                      ‐
                      ‐
                      ‐
                      ‐

                      ‐
                      ‐
                      ‐
                      ‐

67

Total Losses

                      ‐

                      ‐

                      ‐

ALLOWANCE FOR LOAN and LEASE LOSSES (1)
68 Total allowance for loan and lease losses, prior quarter
68a ALLL, prior quarter
68b Allowance for credit losses on held‐to‐maturity debt securities, prior quarter (2)
68c Allowance for credit losses on available‐for‐sale debt securities, prior quarter (2)
68d Allowance for credit losses on all other financial assets, prior quarter (2)
69
70
71
72
73
74
75
76
77

Real Estate Loans (in Domestic Offices)
Residential Mortgages
First Lien Mortgages
Closed‐End Junior Liens
HELOCs
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential

FR Y‐14A Schedule A.1.a ‐ Income Statement

Item
44
45
46
47
48
49
50
51
52
53
54
55
56

LOSSES ASSOCIATED WITH HELD FOR SALE LOANS AND LOANS ACCOUNTED FOR U
Real Estate Loans (in Domestic Offices)
First Lien Mortgages
Second / Junior Lien Mortgages
CRE Loans
Loans Secured by Farmland
Real Estate Loans (Not in Domestic Offices)
Residential Mortgages
CRE Loans
Loans Secured by Farmland
C&I Loans
Credit Cards
Other Consumer
All Other Loans and Leases

57

Total Loans Held for Sale and Loans Accounted for under the Fair Value Option

58
59
60
61
62

TRADING ACCOUNT
Trading MTM Losses
Trading Issuer Default Losses
Counterparty Credit MTM Losses (CVA losses)
Counterparty Default losses
Total Trading and Counterparty

63
64
65
66

OTHER LOSSES
Goodwill impairment
Valuation Adjustment for firm's own debt under fair value option (FVO)
Other losses (describe in supporting documentation)
Total Other Losses

67

Total Losses

ALLOWANCE FOR LOAN and LEASE LOSSES (1)
68 Total allowance for loan and lease losses, prior quarter
68a ALLL, prior quarter
68b Allowance for credit losses on held‐to‐maturity debt securities, prior quarter (2)
68c Allowance for credit losses on available‐for‐sale debt securities, prior quarter (2)
68d Allowance for credit losses on all other financial assets, prior quarter (2)
69
70
71
72
73
74
75
76
77

Real Estate Loans (in Domestic Offices)
Residential Mortgages
First Lien Mortgages
Closed‐End Junior Liens
HELOCs
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential

FR Y‐14A Schedule A.1.a ‐ Income Statement

Item
44
45
46
47
48
49
50
51
52
53
54
55
56

LOSSES ASSOCIATED WITH HELD FOR SALE LOANS AND LOANS ACCOUNTED FOR U
Real Estate Loans (in Domestic Offices)
First Lien Mortgages
Second / Junior Lien Mortgages
CRE Loans
Loans Secured by Farmland
Real Estate Loans (Not in Domestic Offices)
Residential Mortgages
CRE Loans
Loans Secured by Farmland
C&I Loans
Credit Cards
Other Consumer
All Other Loans and Leases

57

Total Loans Held for Sale and Loans Accounted for under the Fair Value Option

58
59
60
61
62

TRADING ACCOUNT
Trading MTM Losses
Trading Issuer Default Losses
Counterparty Credit MTM Losses (CVA losses)
Counterparty Default losses
Total Trading and Counterparty

63
64
65
66

OTHER LOSSES
Goodwill impairment
Valuation Adjustment for firm's own debt under fair value option (FVO)
Other losses (describe in supporting documentation)
Total Other Losses

67

Total Losses

ALLOWANCE FOR LOAN and LEASE LOSSES (1)
68 Total allowance for loan and lease losses, prior quarter
68a ALLL, prior quarter
68b Allowance for credit losses on held‐to‐maturity debt securities, prior quarter (2)
68c Allowance for credit losses on available‐for‐sale debt securities, prior quarter (2)
68d Allowance for credit losses on all other financial assets, prior quarter (2)
69
70
71
72
73
74
75
76
77

Real Estate Loans (in Domestic Offices)
Residential Mortgages
First Lien Mortgages
Closed‐End Junior Liens
HELOCs
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential

FR Y‐14A Schedule A.1.a ‐ Income Statement
Actual in 
$Millions
Item
78
79
80
81
82
83
84
85
86
87
88
89
90

Loans Secured by Farmland
Real Estate Loans (Not in Domestic Offices)
Residential Mortgages
CRE Loans
Farmland
C&I Loans
C&I Graded
Small Business (Scored/Delinquency Managed)
Corporate and Business Cards
Credit Cards
Other Consumer
All Other Loans and Leases
Unallocated

91 Total Provisions during the quarter
91a Provisions for loan and lease losses during the quarter (3)
Provisions for credit losses on held‐to‐maturity debt securities during the quarter 
91b
(4)
Provisions for credit losses on available‐for‐sale debt securities during the quarter 
91c
(4)
91d Provisions for credit losses on all other financial assets during the quarter (4)
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
114a

Projected in $Millions

as of date

Real Estate Loans (in Domestic Offices)
Residential Mortgages
First Lien Mortgages
Closed‐End Junior Liens
HELOCs
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential
Loans Secured by Farmland
Real Estate Loans (Not in Domestic Offices)
Residential Mortgages
CRE Loans
Farmland
C&I Loans
C&I Graded
Small Business (Scored/Delinquency Managed)
Corporate and Business Cards
Credit Cards
Other Consumer
All Other Loans and Leases
Unallocated
Total Net charge‐offs during the quarter
Net charge‐offs during the quarter on loans and leases (5)

114b Net charge‐offs during the quarter on held‐to‐maturity debt securities (6)
114c Net charge‐offs during the quarter on available‐for‐sale debt securities (6)
114d Net charge‐offs during the quarter on all other financial assets (6)
115 Total Other ALLL Changes
115a Other ALLL Changes (7)
115b Other allowances for credit losses changes on held‐to‐maturity debt securities (8)
115c Other allowances for credit losses changes on available‐for‐sale debt securities (8)
115d Other allowances for credit losses changes on all other financial assets(8)
116 Total Allowances, current quarter
116a ALLL, current quarter (9)
Allowances for credit losses on held‐to‐maturity debt securities, current quarter 
116b
(10)
Allowances for credit losses on available‐for‐sale debt securities, current quarter 
116c
(10)
116d Allowances for credit losses on all other financial assets, current quarter (10)

CASIP591
CASIP592
CASIP593
CASIP594
CASIP595
CASIP596
CASIP597
CASIP598
CASIP599
CASIP600
CASIP601
CASIP602
CASIP603

CPSIP591
CPSIP592
CPSIP593
CPSIP594
CPSIP595
CPSIP596
CPSIP597
CPSIP598
CPSIP599
CPSIP600
CPSIP601
CPSIP602
CPSIP603

CASIKU79
CASI4230

CPSIKU79
CPSI4230

CASIKU80

CPSIKU80

CASIKU81

CPSIKU81

CASIKU82
CASIP604
CASIP605
CASIP606
CASIP607
CASIP608
CASIP609
CASIP610
CASIP611
CASIP612
CASIP613
CASIP614
CASIP615
CASIP616
CASIP617
CASIP618
CASIP619
CASIP620
CASIP621
CASIP622
CASIP623
CASIP624
CASIP625
CASIKU83
CASIP626

CPSIKU82
CPSIP604
CPSIP605
CPSIP606
CPSIP607
CPSIP608
CPSIP609
CPSIP610
CPSIP611
CPSIP612
CPSIP613
CPSIP614
CPSIP615
CPSIP616
CPSIP617
CPSIP618
CPSIP619
CPSIP620
CPSIP621
CPSIP622
CPSIP623
CPSIP624
CPSIP625
CPSIKU83
CPSIP626

CASIKU84

CPSIKU84

CASIKU85
CASIKU86
CASIKU87
CASIP627

CPSIKU85
CPSIKU86
CPSIKU87
CPSIP627

CASIKU88

CPSIKU88

PQ 1

PQ 2

PQ 3

PQ 4

PQ 5

PQ 6

PQ 7

PQ 8

PQ 9

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

CASIKU89

CPSIKU89

CASIKU90
CASIKU91
CASI3123

CPSIKU90
CPSIKU91
CPSI3123

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

CASIKU92

CPSIKU92

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

CASIKU93

CPSIKU93

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

CASIKU94

CPSIKU94

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

FR Y‐14A Schedule A.1.a ‐ Income Statement

Sums in $Millions
PQ 2 ‐ PQ 5

Item
78
79
80
81
82
83
84
85
86
87
88
89
90

PQ 6 ‐ PQ 9

9‐Quarter

Loans Secured by Farmland
Real Estate Loans (Not in Domestic Offices)
Residential Mortgages
CRE Loans
Farmland
C&I Loans
C&I Graded
Small Business (Scored/Delinquency Managed)
Corporate and Business Cards
Credit Cards
Other Consumer
All Other Loans and Leases
Unallocated

91 Total Provisions during the quarter
91a Provisions for loan and lease losses during the quarter (3)
Provisions for credit losses on held‐to‐maturity debt securities during the quarter 
91b
(4)
Provisions for credit losses on available‐for‐sale debt securities during the quarter 
91c
(4)

                      ‐

                      ‐

                      ‐

                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐

                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐

                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐
                      ‐

                      ‐

                      ‐

                      ‐

91d Provisions for credit losses on all other financial assets during the quarter (4)
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
114a

Real Estate Loans (in Domestic Offices)
Residential Mortgages
First Lien Mortgages
Closed‐End Junior Liens
HELOCs
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential
Loans Secured by Farmland
Real Estate Loans (Not in Domestic Offices)
Residential Mortgages
CRE Loans
Farmland
C&I Loans
C&I Graded
Small Business (Scored/Delinquency Managed)
Corporate and Business Cards
Credit Cards
Other Consumer
All Other Loans and Leases
Unallocated
Total Net charge‐offs during the quarter
Net charge‐offs during the quarter on loans and leases (5)

114b Net charge‐offs during the quarter on held‐to‐maturity debt securities (6)
114c Net charge‐offs during the quarter on available‐for‐sale debt securities (6)
114d Net charge‐offs during the quarter on all other financial assets (6)
115 Total Other ALLL Changes
115a Other ALLL Changes (7)
115b Other allowances for credit losses changes on held‐to‐maturity debt securities (8)
115c Other allowances for credit losses changes on available‐for‐sale debt securities (8)
115d Other allowances for credit losses changes on all other financial assets(8)
116 Total Allowances, current quarter
116a ALLL, current quarter (9)
Allowances for credit losses on held‐to‐maturity debt securities, current quarter 
116b
(10)
Allowances for credit losses on available‐for‐sale debt securities, current quarter 
116c
(10)
116d Allowances for credit losses on all other financial assets, current quarter (10)

FR Y‐14A Schedule A.1.a ‐ Income Statement

Item
78
79
80
81
82
83
84
85
86
87
88
89
90

Loans Secured by Farmland
Real Estate Loans (Not in Domestic Offices)
Residential Mortgages
CRE Loans
Farmland
C&I Loans
C&I Graded
Small Business (Scored/Delinquency Managed)
Corporate and Business Cards
Credit Cards
Other Consumer
All Other Loans and Leases
Unallocated

91 Total Provisions during the quarter
91a Provisions for loan and lease losses during the quarter (3)
Provisions for credit losses on held‐to‐maturity debt securities during the quarter 
91b
(4)
Provisions for credit losses on available‐for‐sale debt securities during the quarter 
91c
(4)
91d Provisions for credit losses on all other financial assets during the quarter (4)
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
114a

Real Estate Loans (in Domestic Offices)
Residential Mortgages
First Lien Mortgages
Closed‐End Junior Liens
HELOCs
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential
Loans Secured by Farmland
Real Estate Loans (Not in Domestic Offices)
Residential Mortgages
CRE Loans
Farmland
C&I Loans
C&I Graded
Small Business (Scored/Delinquency Managed)
Corporate and Business Cards
Credit Cards
Other Consumer
All Other Loans and Leases
Unallocated
Total Net charge‐offs during the quarter
Net charge‐offs during the quarter on loans and leases (5)

114b Net charge‐offs during the quarter on held‐to‐maturity debt securities (6)
114c Net charge‐offs during the quarter on available‐for‐sale debt securities (6)
114d Net charge‐offs during the quarter on all other financial assets (6)
115 Total Other ALLL Changes
115a Other ALLL Changes (7)
115b Other allowances for credit losses changes on held‐to‐maturity debt securities (8)
115c Other allowances for credit losses changes on available‐for‐sale debt securities (8)
115d Other allowances for credit losses changes on all other financial assets(8)
116 Total Allowances, current quarter
116a ALLL, current quarter (9)
Allowances for credit losses on held‐to‐maturity debt securities, current quarter 
116b
(10)
Allowances for credit losses on available‐for‐sale debt securities, current quarter 
116c
(10)
116d Allowances for credit losses on all other financial assets, current quarter (10)

FR Y‐14A Schedule A.1.a ‐ Income Statement

Item
78
79
80
81
82
83
84
85
86
87
88
89
90

Loans Secured by Farmland
Real Estate Loans (Not in Domestic Offices)
Residential Mortgages
CRE Loans
Farmland
C&I Loans
C&I Graded
Small Business (Scored/Delinquency Managed)
Corporate and Business Cards
Credit Cards
Other Consumer
All Other Loans and Leases
Unallocated

91 Total Provisions during the quarter
91a Provisions for loan and lease losses during the quarter (3)
Provisions for credit losses on held‐to‐maturity debt securities during the quarter 
91b
(4)
Provisions for credit losses on available‐for‐sale debt securities during the quarter 
91c
(4)
91d Provisions for credit losses on all other financial assets during the quarter (4)
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
114a

Real Estate Loans (in Domestic Offices)
Residential Mortgages
First Lien Mortgages
Closed‐End Junior Liens
HELOCs
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential
Loans Secured by Farmland
Real Estate Loans (Not in Domestic Offices)
Residential Mortgages
CRE Loans
Farmland
C&I Loans
C&I Graded
Small Business (Scored/Delinquency Managed)
Corporate and Business Cards
Credit Cards
Other Consumer
All Other Loans and Leases
Unallocated
Total Net charge‐offs during the quarter
Net charge‐offs during the quarter on loans and leases (5)

114b Net charge‐offs during the quarter on held‐to‐maturity debt securities (6)
114c Net charge‐offs during the quarter on available‐for‐sale debt securities (6)
114d Net charge‐offs during the quarter on all other financial assets (6)
115 Total Other ALLL Changes
115a Other ALLL Changes (7)
115b Other allowances for credit losses changes on held‐to‐maturity debt securities (8)
115c Other allowances for credit losses changes on available‐for‐sale debt securities (8)
115d Other allowances for credit losses changes on all other financial assets(8)
116 Total Allowances, current quarter
116a ALLL, current quarter (9)
Allowances for credit losses on held‐to‐maturity debt securities, current quarter 
116b
(10)
Allowances for credit losses on available‐for‐sale debt securities, current quarter 
116c
(10)
116d Allowances for credit losses on all other financial assets, current quarter (10)

FR Y‐14A Schedule A.1.a ‐ Income Statement
Actual in 
$Millions
Item

Projected in $Millions

as of date

117
118
119
120

PRE‐PROVISION NET REVENUE
Net interest income
Noninterest income
Noninterest expense
Pre‐Provision Net Revenue

121
122
123
124
125

CONDENSED INCOME STATEMENT
Pre‐Provision Net Revenue
Provisions during the quarter
Total Trading and Counterparty Losses
Total Other Losses
Other I/S items ‐ describe in supporting documentation

PQ 1

PQ 2

PQ 3

PQ 4

PQ 5

PQ 6

PQ 7

PQ 8

PQ 9

CASI4074
CASI4079
CASIP630
CASIP631

CPSI4074
CPSI4079
CPSIP630
CPSIP631

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

CASIP632
CASI4230
CASIP633
CASIP634
CASIP635
CASI3196

CPSIP632
CPSI4230
CPSIP633
CPSIP634
CPSIP635
CPSI3196

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

CASI3521

CPSI3521

CASI4310

CPSI4310
             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

129 Applicable income taxes (foreign and domestic)
130 Income (loss) before discontinued operations and other adjustments

CASI4302
CASI4300

CPSI4302
CPSI4300

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

131 Discontinued operations, net of applicable income taxes
132 Net income (loss) attributable to BHC and minority interests

CASI4320
CASIG104

CPSI4320
CPSIG104

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

133 Net income (loss) attributable to minority interests
134 Net income (loss) attributable to BHC

CASIG103
CASI4340

CPSIG103
CPSI4340

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

135 Effective Tax Rate (%)

CASIP636

CPSIP636

CASIP637
CASIP638
CASIP195
CASIP639

CPSIP637
CPSIP638
CPSIP195
CPSIP639

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐

126 Realized Gains (Losses) on available‐for‐sale securities, including OTTI (11)
127 Realized Gains (Losses) on held‐to‐maturity securities, including OTTI (11)
128 Income (loss) before applicable income taxes and discontinued operations

136
137
138
139

REPURCHASE RESERVE/LIABILITY FOR MORTGAGE REPS AND WARRANTIES
Reserve, prior quarter
Provisions during the quarter
Net charges during the quarter
Reserve, current quarter

FR Y‐14A Schedule A.1.a ‐ Income Statement

Sums in $Millions
Item

PQ 2 ‐ PQ 5

PQ 6 ‐ PQ 9

9‐Quarter

117
118
119
120

PRE‐PROVISION NET REVENUE
Net interest income
Noninterest income
Noninterest expense
Pre‐Provision Net Revenue

                      ‐
                      ‐
                      ‐
                      ‐

                      ‐
                      ‐
                      ‐
                      ‐

                      ‐
                      ‐
                      ‐
                      ‐

121
122
123
124
125

CONDENSED INCOME STATEMENT
Pre‐Provision Net Revenue
Provisions during the quarter
Total Trading and Counterparty Losses
Total Other Losses
Other I/S items ‐ describe in supporting documentation

                      ‐
                      ‐
                      ‐
                      ‐
                      ‐

                      ‐
                      ‐
                      ‐
                      ‐
                      ‐

                      ‐
                      ‐
                      ‐
                      ‐
                      ‐

126 Realized Gains (Losses) on available‐for‐sale securities, including OTTI (11)
127 Realized Gains (Losses) on held‐to‐maturity securities, including OTTI (11)
128 Income (loss) before applicable income taxes and discontinued operations

                      ‐

                      ‐

                      ‐

129 Applicable income taxes (foreign and domestic)
130 Income (loss) before discontinued operations and other adjustments

                      ‐
                      ‐

                      ‐
                      ‐

                      ‐
                      ‐

131 Discontinued operations, net of applicable income taxes
132 Net income (loss) attributable to BHC and minority interests

                      ‐
                      ‐

                      ‐
                      ‐

                      ‐
                      ‐

133 Net income (loss) attributable to minority interests
134 Net income (loss) attributable to BHC

                      ‐
                      ‐

                      ‐
                      ‐

                      ‐
                      ‐

                      ‐
                      ‐

                      ‐
                      ‐

                      ‐
                      ‐

135 Effective Tax Rate (%)

136
137
138
139

REPURCHASE RESERVE/LIABILITY FOR MORTGAGE REPS AND WARRANTIES
Reserve, prior quarter
Provisions during the quarter
Net charges during the quarter
Reserve, current quarter

FR Y‐14A Schedule A.1.a ‐ Income Statement

Item
117
118
119
120

PRE‐PROVISION NET REVENUE
Net interest income
Noninterest income
Noninterest expense
Pre‐Provision Net Revenue

121
122
123
124
125

CONDENSED INCOME STATEMENT
Pre‐Provision Net Revenue
Provisions during the quarter
Total Trading and Counterparty Losses
Total Other Losses
Other I/S items ‐ describe in supporting documentation

126 Realized Gains (Losses) on available‐for‐sale securities, including OTTI (11)
127 Realized Gains (Losses) on held‐to‐maturity securities, including OTTI (11)
128 Income (loss) before applicable income taxes and discontinued operations
129 Applicable income taxes (foreign and domestic)
130 Income (loss) before discontinued operations and other adjustments
131 Discontinued operations, net of applicable income taxes
132 Net income (loss) attributable to BHC and minority interests
133 Net income (loss) attributable to minority interests
134 Net income (loss) attributable to BHC
135 Effective Tax Rate (%)

136
137
138
139

REPURCHASE RESERVE/LIABILITY FOR MORTGAGE REPS AND WARRANTIES
Reserve, prior quarter
Provisions during the quarter
Net charges during the quarter
Reserve, current quarter

FR Y‐14A Schedule A.1.a ‐ Income Statement

Item
117
118
119
120

PRE‐PROVISION NET REVENUE
Net interest income
Noninterest income
Noninterest expense
Pre‐Provision Net Revenue

121
122
123
124
125

CONDENSED INCOME STATEMENT
Pre‐Provision Net Revenue
Provisions during the quarter
Total Trading and Counterparty Losses
Total Other Losses
Other I/S items ‐ describe in supporting documentation

126 Realized Gains (Losses) on available‐for‐sale securities, including OTTI (11)
127 Realized Gains (Losses) on held‐to‐maturity securities, including OTTI (11)
128 Income (loss) before applicable income taxes and discontinued operations
129 Applicable income taxes (foreign and domestic)
130 Income (loss) before discontinued operations and other adjustments
131 Discontinued operations, net of applicable income taxes
132 Net income (loss) attributable to BHC and minority interests
133 Net income (loss) attributable to minority interests
134 Net income (loss) attributable to BHC
135 Effective Tax Rate (%)

136
137
138
139

REPURCHASE RESERVE/LIABILITY FOR MORTGAGE REPS AND WARRANTIES
Reserve, prior quarter
Provisions during the quarter
Net charges during the quarter
Reserve, current quarter

FR Y‐14A Schedule A.1.a ‐ Income Statement
Actual in 
$Millions
Item

(1)
(2)
(3)
(4)
(5)
(6)
(7)

as of date

Footnotes to the Income Statement Worksheet
Institutions that have adopted ASU 2016‐13 should report the allowance and 
provision for credit losses in items 68 through 116.
Items 68b and 68c are only reported by institutions that have adopted ASU 2016‐
13.
Institutions that have adopted ASU 2016‐13 should report the provision for credit 
losses on loans and leases.
Items 91b and 91c are only reported by institutions that have adopted ASU 2016‐
13.
Institutions that have adopted ASU 2016‐13 should report net charge‐offs during 
the quarter on loans and leases in item 114a.
Items 114b and 114c are only reported by institutions that have adopted ASU 
2016‐13.
Institutions that have adopted ASU 2016‐13 should report other changes to the 
allowances for credit losses on loans and leases in item 115a.

Items 115b and 115c are only reported by institutions that have adopted ASU 
2016‐13.
Institutions that have adopted ASU 2016‐13 should report the allowance for credit 
(9)
losses on loans and leases in item 116a.
Items 116b and 116c are only reported by institutions that have adopted ASU 
(10)
2016‐13.
Institutions that have adopted ASU 2016‐13 should not include OTTI in items 126 
(11)
and 127. 
(8)

Projected in $Millions
PQ 1

PQ 2

PQ 3

PQ 4

PQ 5

PQ 6

PQ 7

PQ 8

PQ 9

FR Y‐14A Schedule A.1.a ‐ Income Statement

Sums in $Millions
Item

(1)
(2)
(3)
(4)
(5)
(6)
(7)

PQ 2 ‐ PQ 5

Footnotes to the Income Statement Worksheet
Institutions that have adopted ASU 2016‐13 should report the allowance and 
provision for credit losses in items 68 through 116.
Items 68b and 68c are only reported by institutions that have adopted ASU 2016‐
13.
Institutions that have adopted ASU 2016‐13 should report the provision for credit 
losses on loans and leases.
Items 91b and 91c are only reported by institutions that have adopted ASU 2016‐
13.
Institutions that have adopted ASU 2016‐13 should report net charge‐offs during 
the quarter on loans and leases in item 114a.
Items 114b and 114c are only reported by institutions that have adopted ASU 
2016‐13.
Institutions that have adopted ASU 2016‐13 should report other changes to the 
allowances for credit losses on loans and leases in item 115a.

Items 115b and 115c are only reported by institutions that have adopted ASU 
2016‐13.
Institutions that have adopted ASU 2016‐13 should report the allowance for credit 
(9)
losses on loans and leases in item 116a.
Items 116b and 116c are only reported by institutions that have adopted ASU 
(10)
2016‐13.
Institutions that have adopted ASU 2016‐13 should not include OTTI in items 126 
(11)
and 127. 
(8)

PQ 6 ‐ PQ 9

9‐Quarter

FR Y‐14A Schedule A.1.a ‐ Income Statement

Item

(1)
(2)
(3)
(4)
(5)
(6)
(7)

Footnotes to the Income Statement Worksheet
Institutions that have adopted ASU 2016‐13 should report the allowance and 
provision for credit losses in items 68 through 116.
Items 68b and 68c are only reported by institutions that have adopted ASU 2016‐
13.
Institutions that have adopted ASU 2016‐13 should report the provision for credit 
losses on loans and leases.
Items 91b and 91c are only reported by institutions that have adopted ASU 2016‐
13.
Institutions that have adopted ASU 2016‐13 should report net charge‐offs during 
the quarter on loans and leases in item 114a.
Items 114b and 114c are only reported by institutions that have adopted ASU 
2016‐13.
Institutions that have adopted ASU 2016‐13 should report other changes to the 
allowances for credit losses on loans and leases in item 115a.

Items 115b and 115c are only reported by institutions that have adopted ASU 
2016‐13.
Institutions that have adopted ASU 2016‐13 should report the allowance for credit 
(9)
losses on loans and leases in item 116a.
Items 116b and 116c are only reported by institutions that have adopted ASU 
(10)
2016‐13.
Institutions that have adopted ASU 2016‐13 should not include OTTI in items 126 
(11)
and 127. 
(8)

FR Y‐14A Schedule A.1.a ‐ Income Statement

Item

(1)
(2)
(3)
(4)
(5)
(6)
(7)

Footnotes to the Income Statement Worksheet
Institutions that have adopted ASU 2016‐13 should report the allowance and 
provision for credit losses in items 68 through 116.
Items 68b and 68c are only reported by institutions that have adopted ASU 2016‐
13.
Institutions that have adopted ASU 2016‐13 should report the provision for credit 
losses on loans and leases.
Items 91b and 91c are only reported by institutions that have adopted ASU 2016‐
13.
Institutions that have adopted ASU 2016‐13 should report net charge‐offs during 
the quarter on loans and leases in item 114a.
Items 114b and 114c are only reported by institutions that have adopted ASU 
2016‐13.
Institutions that have adopted ASU 2016‐13 should report other changes to the 
allowances for credit losses on loans and leases in item 115a.

Items 115b and 115c are only reported by institutions that have adopted ASU 
2016‐13.
Institutions that have adopted ASU 2016‐13 should report the allowance for credit 
(9)
losses on loans and leases in item 116a.
Items 116b and 116c are only reported by institutions that have adopted ASU 
(10)
2016‐13.
Institutions that have adopted ASU 2016‐13 should not include OTTI in items 126 
(11)
and 127. 
(8)

FR Y‐14A Schedule A.1.b ‐ Balance Sheet

PQ 1

Item

PQ 2

PQ 3

PQ 4

Projected in $Millions
PQ 5
PQ 6

PQ 7

PQ 8

PQ 9

Assets

4
5

SECURITIES
Held to Maturity (HTM) (1)
Available for Sale (AFS)
Total Securities
Of which:
Securitizations (investment grade)
Securitizations (non‐investment grade)

6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29

Total Loans and Leases
Real Estate Loans (in Domestic Offices)
First Lien Mortgages
First Lien Mortgages
First Lien HELOAN
Second / Junior Lien Mortgages
Closed‐End Junior Liens
HELOCs
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential
Owner‐Occupied
Non‐Owner‐Occupied
Loans Secured by Farmland
Real Estate Loans (Not in Domestic Offices)
First Lien Mortgages
Second / Junior Lien Mortgages
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential
Owner‐Occupied
Non‐Owner‐Occupied
Loans Secured by Farmland

1
2
3

CPSB1754
CPSB1773
CPSBP640

                ‐

                 ‐

                 ‐

                ‐

                ‐

                ‐

                ‐

                ‐

               ‐

                ‐
                ‐

                 ‐
                 ‐

                 ‐
                 ‐

                ‐
                ‐

                ‐
                ‐

                ‐
                ‐

                ‐
                ‐

                ‐
                ‐

               ‐
               ‐

                ‐

                 ‐

                 ‐

                ‐

                ‐

                ‐

                ‐

                ‐

               ‐

                ‐

                 ‐

                 ‐

                ‐

                ‐

                ‐

                ‐

                ‐

               ‐

                ‐

                 ‐

                 ‐

                ‐

                ‐

                ‐

                ‐

                ‐

               ‐

                ‐

                 ‐

                 ‐

                ‐

                ‐

                ‐

                ‐

                ‐

               ‐

                ‐

                 ‐

                 ‐

                ‐

                ‐

                ‐

                ‐

                ‐

               ‐

                ‐

                 ‐

                 ‐

                ‐

                ‐

                ‐

                ‐

                ‐

               ‐

CPSBP641
CPSBP642

CPSBP643
CPSB5367
CPSBP644
CPSBP645
CPSBP646
CPSB5368
CPSB1797
CPSBP647
CPSBP648
CPSB1460
CPSBP649
CPSBF160
CPSBF161
CPSB1420
CPSBP650
CPSBP651
CPSBP652
CPSBP653
CPSBP654
CPSBP655
CPSBP656
CPSBP657
CPSBP658
CPSBP659

FR Y‐14A Schedule A.1.b ‐ Balance Sheet

Item
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45

PQ 1
C&I Loans
C&I Graded
Small Business (Scored/Delinquency Managed)
Corporate Card
Business Card
Credit Cards
Charge Card
Bank Card
Other Consumer
Auto Loans
Student Loans
Other loans backed by securities (non‐purpose lending)
Other 
Other Loans and Leases
Loans to Foreign Governments
Agricultural Loans

46 Loans for purchasing or carrying securities (secured or unsecured)
47
48
49
50
51

Loans to Depositories and Other Financial Institutions
All Other Loans and Leases
All Other Loans (exclude consumer loans)
All Other Leases
Total Loans and Leases

CPSBP660
CPSBP661
CPSBP662
CPSBP663
CPSBP664
CPSBP665
CPSBP666
CPSBP667
CPSBP668
CPSBK137
CPSBP669
CPSBP670
CPSBP671
CPSBP672
CPSB2081
CPSB1590
CPSB1545
CPSBP673
CPSBP674
CPSBJ451
CPSBF163
CPSBP675

PQ 2

PQ 3

PQ 4

Projected in $Millions
PQ 5
PQ 6

PQ 7

PQ 8

PQ 9

                ‐

                 ‐

                 ‐

                ‐

                ‐

                ‐

                ‐

                ‐

               ‐

                ‐

                 ‐

                 ‐

                ‐

                ‐

                ‐

                ‐

                ‐

               ‐

                ‐

                 ‐

                 ‐

                ‐

                ‐

                ‐

                ‐

                ‐

               ‐

                ‐

                 ‐

                 ‐

                ‐

                ‐

                ‐

                ‐

                ‐

               ‐

                ‐

                 ‐

                 ‐

                ‐

                ‐

                ‐

                ‐

                ‐

               ‐

                ‐

                 ‐

                 ‐

                ‐

                ‐

                ‐

                ‐

                ‐

               ‐

FR Y‐14A Schedule A.1.b ‐ Balance Sheet

PQ 1

Item
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80

LOANS HELD FOR INVESTMENT AT AMORTIZED COST
Real Estate Loans (in Domestic Offices)
First Lien Mortgages
First Lien Mortgages
First Lien HELOAN
Second / Junior Lien Mortgages
Closed‐End Junior Liens
HELOCs
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential
Owner‐Occupied
Non‐Owner‐Occupied
Loans Secured by Farmland
Real Estate Loans (Not in Domestic Offices)
First Lien Mortgages
Second / Junior Lien Mortgages
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential
Owner‐Occupied
Non‐Owner‐Occupied
Loans Secured by Farmland
C&I Loans
C&I Graded
Small Business (Scored/Delinquency Managed)
Business and Corporate Card
Credit Cards

CPSBP676
CPSBP677
CPSBP381
CPSBP389
CPSBP678
CPSBP397
CPSBP405
CPSBP679
CPSBP680
CPSBP681
CPSBP682
CPSBP683
CPSBP684
CPSBP685
CPSBP686
CPSBP415
CPSBP423
CPSBP687
CPSBP688
CPSBP689
CPSBP690
CPSBP691
CPSBP692
CPSBP693
CPSBP694
CPSBP695
CPSBP696
CPSBP697
CPSBP698

PQ 2

PQ 3

PQ 4

Projected in $Millions
PQ 5
PQ 6

PQ 7

PQ 8

PQ 9

                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐

                 ‐
                 ‐
                 ‐
                 ‐
                 ‐
                 ‐
                 ‐
                 ‐

                 ‐
                 ‐
                 ‐
                 ‐
                 ‐
                 ‐
                 ‐
                 ‐

                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐

                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐

                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐

                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐

                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐

               ‐
               ‐
               ‐
               ‐
               ‐
               ‐
               ‐
               ‐

                ‐

                 ‐

                 ‐

                ‐

                ‐

                ‐

                ‐

                ‐

               ‐

                ‐
                ‐
                ‐
                ‐

                 ‐
                 ‐
                 ‐
                 ‐

                 ‐
                 ‐
                 ‐
                 ‐

                ‐
                ‐
                ‐
                ‐

                ‐
                ‐
                ‐
                ‐

                ‐
                ‐
                ‐
                ‐

                ‐
                ‐
                ‐
                ‐

                ‐
                ‐
                ‐
                ‐

               ‐
               ‐
               ‐
               ‐

                ‐

                 ‐

                 ‐

                ‐

                ‐

                ‐

                ‐

                ‐

               ‐

                ‐

                 ‐

                 ‐

                ‐

                ‐

                ‐

                ‐

                ‐

               ‐

                ‐
                ‐
                ‐

                 ‐
                 ‐
                 ‐

                 ‐
                 ‐
                 ‐

                ‐
                ‐
                ‐

                ‐
                ‐
                ‐

                ‐
                ‐
                ‐

                ‐
                ‐
                ‐

                ‐
                ‐
                ‐

               ‐
               ‐
               ‐

FR Y‐14A Schedule A.1.b ‐ Balance Sheet

Item
81
82
83
84
85
86
87
88

PQ 1
Other Consumer
Auto Loans
Student Loans
Other loans backed by securities (non‐purpose lending)
Other 
Other Loans and Leases
Loans to Foreign Governments
Agricultural Loans

89 Loans for purchasing or carrying securities (secured or unsecured)
90
91
92
93
94

Loans to Depositories and Other Financial Institutions
All Other Loans and Leases
All Other Loans (exclude consumer loans)
All Other Leases
Total Loans and Leases

95
96
97
98
99
100
101
102
103
104
105
106
107

Loans Held for Sale and Loans Accounted for under the Fair Value 
Option
Real Estate Loans (in Domestic Offices)
First Lien Mortgages
Second / Junior Lien Mortgages
CRE Loans
Loans Secured by Farmland
Real Estate Loans (Not in Domestic Offices)
Residential Mortgages
CRE Loans
Loans Secured by Farmland
C&I Loans
Credit Cards
Other Consumer
Other Loans and Leases
Total Loans Held for Sale and Loans Accounted for under the Fair 
Value Option

108

CPSBP699
CPSBP700
CPSBP491
CPSBP701
CPSBP702
CPSBP703
CPSBP704
CPSBP705

PQ 2

PQ 3

PQ 4

Projected in $Millions
PQ 5
PQ 6

PQ 7

PQ 8

PQ 9

                ‐
                ‐
                ‐

                 ‐
                 ‐
                 ‐

                 ‐
                 ‐
                 ‐

                ‐
                ‐
                ‐

                ‐
                ‐
                ‐

                ‐
                ‐
                ‐

                ‐
                ‐
                ‐

                ‐
                ‐
                ‐

               ‐
               ‐
               ‐

                ‐
                ‐

                 ‐
                 ‐

                 ‐
                 ‐

                ‐
                ‐

                ‐
                ‐

                ‐
                ‐

                ‐
                ‐

                ‐
                ‐

               ‐
               ‐

                ‐

                 ‐

                 ‐

                ‐

                ‐

                ‐

                ‐

                ‐

               ‐

                ‐

                 ‐

                 ‐

                ‐

                ‐

                ‐

                ‐

                ‐

               ‐

CPSBP712
CPSBP713
CPSBP714
CPSBP715
CPSBP716
CPSBP717
CPSBP718
CPSBP719
CPSBP720
CPSBP721
CPSBP722
CPSBP723
CPSBP724

                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐

                 ‐
                 ‐
                 ‐
                 ‐
                 ‐
                 ‐
                 ‐
                 ‐
                 ‐
                 ‐
                 ‐
                 ‐
                 ‐

                 ‐
                 ‐
                 ‐
                 ‐
                 ‐
                 ‐
                 ‐
                 ‐
                 ‐
                 ‐
                 ‐
                 ‐
                 ‐

                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐

                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐

                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐

                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐

                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐
                ‐

               ‐
               ‐
               ‐
               ‐
               ‐
               ‐
               ‐
               ‐
               ‐
               ‐
               ‐
               ‐
               ‐

CPSBP725

                ‐

                 ‐

                 ‐

                ‐

                ‐

                ‐

                ‐

                ‐

               ‐

CPSBP706
CPSBP707
CPSBP708
CPSBP709
CPSBP710
CPSBP711

FR Y‐14A Schedule A.1.b ‐ Balance Sheet

PQ 1

Item
109 Unearned Income on Loans
110 Allowance for Loan and Lease Losses (2)
Loans and Leases (Held for Investment and Held for Sale), Net of 
111
Unearned Income and Allowance for Loan and Lease Losses (3)
TRADING
112 Trading Assets

113
114
115
116
117

INTANGIBLES
Goodwill
Mortgage Servicing Rights
Not applicable
All Other Identifiable Intangible Assets
Total Intangible Assets

OTHER
118 Cash and cash equivalent
119 Federal funds sold
120 Securities purchased under agreements to resell (4)
121
122
123
124
125
126
127
128
129
130

Premises and Fixed Assets
OREO
Commercial
Residential
Farmland
Collateral Underlying Operating Leases for Which the Bank is the 
Lessor (5)
Autos
Other
Other Assets (6)
Total Other

131 TOTAL ASSETS

PQ 2

PQ 3

PQ 4

Projected in $Millions
PQ 5
PQ 6

PQ 7

PQ 8

PQ 9

CPSB2123
CPSB3123

                ‐

                 ‐

                 ‐

                ‐

                ‐

                ‐

                ‐

                ‐

               ‐

CPSBP726

                ‐

                 ‐

                 ‐

                ‐

                ‐

                ‐

                ‐

                ‐

               ‐

                ‐

                 ‐

                 ‐

                ‐

                ‐

                ‐

                ‐

                ‐

               ‐

                ‐

                 ‐

                 ‐

                ‐

                ‐

                ‐

                ‐

                ‐

               ‐

CPSBP732
CPSBP733
CPSBP734
CPSBP735
CPSBP736

                ‐

                 ‐

                 ‐

                ‐

                ‐

                ‐

                ‐

                ‐

               ‐

                ‐

                 ‐

                 ‐

                ‐

                ‐

                ‐

                ‐

                ‐

               ‐

CPSB2170

                ‐

                 ‐

                 ‐

                ‐

                ‐

                ‐

                ‐

                ‐

               ‐

CPSB3545

CPSB3163
CPSB3164
CPSB5507
CPSBP727

CPSBP728
CPSBB987
CPSBB989
CPSB2145
CPSB2150
CPSBP729
CPSBP730
CPSBP731

FR Y‐14A Schedule A.1.b ‐ Balance Sheet

PQ 1

Item

PQ 2

PQ 3

PQ 4

Projected in $Millions
PQ 5
PQ 6

PQ 7

PQ 8

PQ 9

Liabilities
132 Deposits in domestic offices
Deposits in foreign offices, Edge and Agreement subsidiaries, and 
133
IBFs
134 Deposits
Federal funds purchased and securities sold under agreements to 
135
repurchase
136 Trading Liabilities
137 Other Borrowed Money
138 Subordinated Notes and Debentures
139

Subordinated Notes Payable to Unconsolidated Trusts Issuing 
TruPS and TruPS Issued by Consolidated Special Purpose Entities

140 Other Liabilities
141 Memo: Allowance for off‐balance sheet credit exposures
142 Total Liabilities

CPSBP737
CPSBP738
CPSBP739

             ‐

              ‐

              ‐

             ‐

             ‐

             ‐

             ‐

             ‐

            ‐

                ‐

                 ‐

                 ‐

                ‐

                ‐

                ‐

                ‐

                ‐

               ‐

CPSBP740
CPSB3548
CPSB3190
CPSB4062

CPSBC699
CPSB2750
CPSBB557
CPSB2948

Equity Capital
143
144
145
146
147
148
149

Perpetual Preferred Stock and Related Surplus
Common Stock (Par Value)
Surplus (Exclude All Surplus Related to Preferred Stock)
Retained Earnings
Accumulated Other Comprehensive Income (AOCI)
Other Equity Capital Components
Total BHC Equity Capital

150 Noncontrolling (Minority) Interests in Consolidated Subsidiaries
151 Total Equity Capital

CPSB3283
CPSB3230
CPSB3240
CPSB3247
CPSBB530
CPSBA130
CPSB3210

                ‐

                 ‐

                 ‐

                ‐

                ‐

                ‐

                ‐

                ‐

               ‐

CPSB3000
CPSBG105

                ‐

                 ‐

                 ‐

                ‐

                ‐

                ‐

                ‐

                ‐

               ‐

Other
152 Unused Commercial Lending Commitments and Letters of Credit

(1)
(2)
(3)
(4)

CPSBP741

Footnotes to the Balance Sheet Worksheet
Institutions that have adopted ASU 2016‐13 should report item 1 net of any applicable allowance for credit losses.
For institutions that adopted ASU 2016‐13, this item will represent the allowance for credit losses on loans and leases.
For institutions that adopted ASU 2016‐13, this item will be net of unearned income and allowance for credit losses on loans and leases.
Institutions that adopted ASU 2016‐13 should report item 120 net of any applicable allowance for credit losses.

Refers to the balance sheet carrying amount of any equipment or other asset rented to others under operating leases, net of accumulated 
(5) depreciation.  The total should correspond to the amount provided in Y‐9C Schedule HC‐F Line 6, item 13 in the instructions. The amount 
included should only reflect collateral rented under operating leases and not include collateral subject to capital/ financing type leases.
(6) Institutions that adopted ASU 2016‐13, should report item 129 net of any applicable allowance for credit losses.

FR Y‐14A Schedule A.1.c.1 Standardized RWA

Actual in 
$Millions
as of date

PQ 1

PQ 2

PQ 3

             ‐

             ‐

             ‐

Projected in $Millions
PQ 4
PQ 5
PQ 6

PQ 7

PQ 8

PQ 9

             ‐

             ‐

             ‐

Standardized Approach (Revised regulatory capital rule, July 2013)
Balance Sheet Asset Categories
1 Cash and balances due from depository institutions
2a Securities (excluding securitizations): Held‐to‐maturity
2b Securities (excluding securitizations): Available‐for‐sale debt securities 
3 Federal funds sold

CASS0010
CASS1754
CASS1773
CASSB987

CPSS0010
CPSS1754
CPSS1773
CPSSB987

4a
4b
4c
4d

Loans and leases on held for sale
Residential Mortgage exposures
High Volatility Commercial Real Estate (HVCRE) exposures
Exposures past due 90 days or more or on nonaccrual
All other exposures

CASSS413
CASSS419
CASSS423
CASSS431

CPSSS413
CPSSS419
CPSSS423
CPSSS431

5a
5b
5c
5d

Loans and leases, net of unearned income
Residential mortgage exposures
High Volatility Commercial Real Estate (HVCRE) exposures
Exposures past due 90 days or more or on nonaccrual
All other exposures

CASSS439
CASSS445
CASSS449
CASSS457

CPSSS439
CPSSS445
CPSSS449
CPSSS457

6
7a
7b
7c

Trading assets (excluding securitizations that receive standardized charges)
All Other assets
Separate account bank‐owned life insurance
Default fund contributions to central counterparties

CASS3545
CASSB639
CASSR644
CASSR645

CPSS3545
CPSSB639
CPSSR644
CPSSR645

8a
8b
8c
8d

On‐balance sheet securitization exposures
Held‐to‐maturity securities
Available‐for‐sale securities
Trading assets that receive standardized charges
All other on‐balance sheet securitization exposures

CASSS475
CASSS480
CASSS485
CASSS490

CPSSS475
CPSSS480
CPSSS485
CPSSS490

CASSS495

CPSSS495

9 Off‐balance sheet securitization exposures
10 RWA for Balance Sheet Asset Categories (sum of items 1 though 8d)

CASSS625

               ‐

CPSSS625

Derivatives and Off‐Balance‐Sheet Asset Categories (Excluding Securitization Exposures)
11 Financial standby letters of credit
12 Performance standby letters of credit and transaction related contingent items

CASSB546
CASS6570

CPSSB546
CPSS6570

13
14
15
16

Commercial and similar letters of credit with an original maturity of one year or less
Retained recourse on small business obligations sold with recourse
Repo‐style transactions
All other off‐balance sheet liabilities

CASS3411
CASSA250
CASSS515
CASSB681

CPSS3411
CPSSA250
CPSSS515
CPSSB681

17a
17b
17c
18
19
20
21

Unused commitments: Original maturity of one year or less, excluding ABCP conduits
Unused commitments: Original maturity of one year or less to ABCP conduits
Unused commitments: Original maturity exceeding one year
Unconditionally cancelable commitments
Over‐the‐counter derivatives
Centrally cleared derivatives
Unsettled transactions (failed trades)

CASSS525
CASSG591
CASS6572
CASSS540
CASSS626
CASSS627
CASSH191

CPSSS525
CPSSG591
CPSS6572
CPSSS540
CPSSS626
CPSSS627
CPSSH191

             ‐

             ‐

             ‐

FR Y‐14A Schedule A.1.c.1 Standardized RWA

RWA for Assets, Derivatives and Off‐Balance‐Sheet Asset Categories (sum of items 9 
22 through 21)

CASSS628

RWA for purposes of calculating the allowance for loan and lease losses 1.25 percent 
23 threshold

CASSS580

CPSSS580

CASSN811
CASSN812

CPSSN811
CPSSN812

CASSS305
CASSS306

CPSSS305
CPSSS306

CPSSS307

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

Items 31 through 36 are not applicable to an institution that does not have a comprehensive risk model; such an institution should go to item 37.
Comprehensive risk capital requirement
Modeled comprehensive risk measure
CPSSS316
CASSS316
Standardized specific risk add‐ons for net long  correlation trading positions
CPSSS325
CASSS325
Standardized specific risk add‐on for net short  correlation trading positions
CASSS333
CPSSS333
CASSS335
               ‐
CPSSS335              ‐
Standardized measure of specific risk add‐ons (greater of item 32 or 33)

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

Market Risk 
24 Value‐at‐risk (VaR) with Multiplier
25 Stressed VaR with Multiplier

26
27

Specific risk add‐on
Debt positions
Equity positions

28

Capital requirements for securitization positions using the Simplified Supervisory 
Formula Approach (SSFA) or applying a specific risk‐weighting factor of 1250% percent

CASSS307

29

Standardized measure of specific risk add‐ons (sum of items 26, 27, and 28)

CASSS311

Item 30 is not applicable to an institution that does not calculate a modeled measure of 
30 Incremental risk capital requirement

31
32
33
34

               ‐

               ‐

CPSSS628

CPSSS311

CPSSN813

CASSN813

35 Surcharge for modeled correlation trading positions (item 34 multiplied by 0.08)
36 Comprehensive risk measure requirement

CASSS336
CASSN814

De minimis positions and other adjustments
37 Capital requirement for all de minimis  exposures
38 Additional capital requirement
39 Sum of items 37 and 38

CASSB825
CASSS344
CASSS345

               ‐

CPSSN825
CPSSS344
CPSSS345

Market risk‐weighted assets
Standardized market risk‐weighted assets: Sum of items 24, 25, 29, 30 (if applicable), 36 (as 
40 appropriate), and 39

CASSS581

               ‐

CPSSS581

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

Risk‐weighted assets before deductions for excess allowance of loan and lease losses 
41 and allocated risk transfer risk reserve (sum of items 22 and 40)

CASSB704

               ‐

CPSSB704

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

42 LESS: Excess allowance for loan and lease losses

CASSA222

CPSSA222

43 LESS: Allocated transfer risk reserve

CASS3128

CPSS3128

44 Total risk‐weighted assets (item 41 minus items 42 and 43)

CASSA223

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

               ‐

               ‐

CPSSS336
CPSSN814

CPSSA223

FR Y‐14A Schedule A.1.c.1 Standardized RWA

Memoranda Items ‐‐ Derivatives
45 Current credit exposure across all derivative contracts covered by the regulatory capital rule

CASS8764

Notional principal amounts of over‐the‐counter derivative contracts (sum of lines 47a 
through 47g)
Interest rate
Foreign exchange rate and gold
Credit (investment grade reference asset)
Credit (non‐investment grade reference asset)
Equity
Precious metals (except gold)
Other

CASSS629

46
47a
47b
47c
47d
47e
47f
47g
48
49a
49b
49c
49d
49e
49f
49g

Notional principal amounts of centrally cleared derivative contracts (sum of lines 49a 
Interest rate
Foreign exchange rate and gold
Credit (investment grade reference asset)
Credit (non‐investment grade reference asset)
Equity
Precious metals (except gold)
Other

CASSS637
CASSS638
CASSS639
CASSS640
CASSS641
CASSS642
CASSS643
CASSS644

CPSS8764
CPSSS629
               ‐

CASSS630
CASSS631
CASSS632
CASSS633
CASSS634
CASSS635
CASSS636

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

CPSSS630
CPSSS631
CPSSS632
CPSSS633
CPSSS634
CPSSS635
CPSSS636
               ‐

CPSSS637
CPSSS638
CPSSS639
CPSSS640
CPSSS641
CPSSS642
CPSSS643
CPSSS644

FR Y‐14A Schedule A.1.c.2 ‐ Advanced RWA

Please note that for purposes of CCAR 2020, BHCs/IHCs are  not  required to complete the following worksheet.
Actual in 
$Millions
as of date

FFIEC 101 reference

Projected in $Millions
PQ 4
PQ 5
PQ 6

PQ 1

PQ 2

PQ 3

PQ 7

PQ 8

PQ 9

              ‐
              ‐

              ‐
              ‐

              ‐
              ‐

              ‐
              ‐

              ‐
              ‐

              ‐
              ‐

              ‐
              ‐

              ‐
              ‐

              ‐
              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

Advanced Approaches Credit Risk (Including CCR and non‐trading credit risk), with 1.06 scaling factor and Operational Risk
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30

31

32
33
34
35
36
37
38
39
40
41
42
43
44

Credit RWA
Wholesale Exposures
Corporate 
Balance Sheet Amount
RWA
Bank 
Balance Sheet Amount
RWA
Sovereign 
Balance Sheet Amount
RWA
IPRE
Balance Sheet Amount
RWA
HVCRE
Balance Sheet Amount
RWA
Counterparty Credit Risk
RWA of eligible margin loans, repostyle transactions and OTC derivatives with crossproduct netting—EAD adjustment method
RWA of eligible margin loans, repostyle transactions and OTC derivatives with crossproduct netting—collateral reflected in LGD
RWA of eligible margin loans, repostyle transactions—no cross‐product netting—EAD adjustment method 
RWA of eligible margin loans, repostyle transactions—no cross‐product netting—collateral reflected in LGD
RWA of OTC derivatives—no cross‐product netting—EAD adjustment method
RWA of OTC derivatives—no crossproduct netting—collateral reflected in LGD
Retail Exposures
Residential mortgage— closed‐end first lien exposures
Balance Sheet Amount
RWA
Residential mortgage— closed‐end junior lien exposures
Balance Sheet Amount
RWA
Residential mortgage—revolving exposures 
Balance Sheet Amount
RWA
Qualifying revolving exposures
Balance Sheet Amount
RWA
Other retail exposures 
Balance Sheet Amount
RWA
Securitization Exposures (72 Federal Register 69288, December 7, 2007)
Balance Sheet Amount

RWA
Securitization Exposures (Revised regulatory capital rule, July 2013)
Subject to supervisory formula approach (SFA)
Balance Sheet Amount
RWA
Subject to simplified supervisory formula approach (SSFA)
Balance Sheet Amount
RWA
Subject to 1,250% risk‐weight
Balance Sheet Amount
RWA
Cleared Transactions (Revised regulatory capital rule, July 2013)
Derivative contracts and netting sets to derivatives
Balance Sheet Amount
RWA
Repo‐style transactions
Balance Sheet Amount
RWA
Default fund contributions

Sum of AABGJ151, AABGJ198

CASAN835
CASAN836

AABBJ124
AABGJ124

CASAN837
CASAN838

CPSAN837
CPSAN838

AABBJ125
AABGJ125

CASAN839
CASAN840

CPSAN839
CPSAN840

AABBJ126
AABGJ126

CASAN841
CASAN842

CPSAN841
CPSAN842

AABBJ127
AABGJ127

CASAN843
CASAN844

CPSAN843
CPSAN844

AABBJ128
AABGJ128

CASAN845
CASAN846
CASAN847
CASAN848
CASAN849
CASAN850
CASAN851
CASAN852
CASAN853
CASAN854

AABGJ129
AABGJ130
AABGJ131
AABGJ132
AABGJ133
AABGJ134

              ‐
              ‐

              ‐

              ‐

CPSAN835
CPSAN836

CPSAN845
CPSAN846
CPSAN847
CPSAN848
CPSAN849
CPSAN850
CPSAN851
CPSAN852
CPSAN853
CPSAN854

AABBJ135
AABGJ135

CASAN855
CASAN856

CPSAN855
CPSAN856

AABBJ136
AABGJ136

CASAN857
CASAN858

CPSAN857
CPSAN858

AABBJ137
AABGJ137

CASAN859
CASAN860

CPSAN859
CPSAN860

AABBJ138
AABGJ138

CASAN861
CASAN862

CPSAN861
CPSAN862

AABBJ139
AABGJ139

CASAN863
CASAN864

CPSAN863
CPSAN864

CASAN865

CPSAN865

Sum of AABBJ140, AABBJ141, 
AABBJ142
Sum of AABGJ140, 
AABGJ141, AABGJ142, 
AABGJ143

CASAN866
CASAN867

              ‐

CPSAN866
CPSAN867

CASAN868
CASAN869

CPSAN868
CPSAN869

CASAN870
CASAN871

CPSAN870
CPSAN871

CASAN872
CASAN873
CASAN874

              ‐

CPSAN872
CPSAN873
CPSAN874

CASAN875
CASAN876

CPSAN875
CPSAN876

CASAN877
CASAN878

CPSAN877
CPSAN878

FR Y‐14A Schedule A.1.c.2 ‐ Advanced RWA

45
46
47

48
49
50
51
52
53
54
55
56
57

Balance Sheet Amount
RWA
Equity Exposures RWA
Other Assets
Balance Sheet Amount
RWA
CVA Capital Charge (risk‐weighted asset equivalent)(Revised regulatory capital rule, July 2013)
Advanced CVA Approach
Unstressed VaR with Multipliers
Stressed VaR with Multipliers
Simple CVA Approach
Assets subject to the general risk‐based capital requirements
Operational RWA
Operational RWA
Total risk‐based capital requirement for operational risk without dependence assumptions

Market Risk 
58 VaR‐based capital requirement
59 Stressed VaR‐based capital requirement
60 Incremental risk capital requirement
61 Comprehensive risk capital requirement (excluding non‐modeled correlation)
62 Non‐modeled Securitization
63
Net Long
64
Net Short
65 Specific risk add‐on (excluding securitization and correlation)
66
Sovereign debt positions
67
Government sponsored entity debt positions
68
Depository institution, foreign bank, and credit union debt positions
69
Public sector entity debt positions
70
Corporate debt positions
71
Equity
72 Capital requirement for de minimis exposures
73 Market risk equivalent assets
74
75

Other RWA
Excess eligible credit reserves not included in tier 2 capital 

76

Total RWA

Sum of AABGJ144, 
AABGJ145,AABGJ146
Sum of AABBJ147, AABBJ148, 
AABBJ149
Sum of AABGJ147, 
AABGJ148, AABGJ149

CASAN879
CASAN880

CPSAN879
CPSAN880

CASAN881

CPSAN881

CASAN882

CPSAN882

AABGJ198

CASAN883
CASAN884
CASAN885
CASAN886
CASAN887
CASAN888
CASAJ198

CPSAN883
CPSAN884
CPSAN885
CPSAN886
CPSAN887
CPSAN888
CPSAJ198

AABGJ154
AASAJ084

CASAJ154
CASAJ084

CPSAJ154
CPSAJ084

bhck1651

CASAN811
CASAN812
CASAN813
CASAN814
CASAN815
CASAN816
CASAN817
CASAN818
CASAN819
CASAN820
CASAN821
CASAN822
CASAN823
CASAN824
CASAN825
CASA1651

CPSAN811
CPSAN812
CPSAN813
CPSAN814
CPSAN815
CPSAN816
CPSAN817
CPSAN818
CPSAN819
CPSAN820
CPSAN821
CPSAN822
CPSAN823
CPSAN824
CPSAN825
CPSA1651

AABGJ152

CASAN826
CASAJ152
CASAA223

              ‐
              ‐

              ‐

              ‐

              ‐

              ‐
              ‐

              ‐
              ‐

              ‐
              ‐

              ‐
              ‐

              ‐
              ‐

              ‐
              ‐

              ‐
              ‐

              ‐
              ‐

              ‐
              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

              ‐

CPSAN826
CPSAJ152
              ‐

CPSAA223

FR Y‐14A Schedule A.1.d. ‐ 1. Capital ‐ CCAR and 2. Capital ‐ DFAST 
Submission Indicator ‐ Indicate if this Capital sub‐schedule pertains
to Capital ‐ CCAR or Capital ‐ DFAST 

CCARP005
Projected in $Millions
Adjusted 
Starting 
1
Value

Item

2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17

18

19
20
21
22
23

Schedule HI‐A—Changes in Bank Holding Company Equity Capital
Total bank holding company equity capital most recently reported for the end of 
previous QUARTER
CASK3217
Effect of changes in accounting principles and corrections of material accounting 
errors
CASKB507
Balance end of previous QUARTER as restated (sum of items 1 and 2)
CASKB508
Net income (loss) attributable to bank holding company
CASK4340
Sale of perpetual preferred stock (excluding treasury stock transactions):
Sale of perpetual preferred stock, gross
CASK3577
Conversion or retirement of perpetual preferred stock
CASK3578
Sale of common stock:
Sale of common stock, gross
CASK3579
Conversion or retirement of common stock
CASK3580
Sale of treasury stock
CASK4782
Purchase of treasury stock
CASK4783
Changes incident to business combinations, net
CASK4356
Cash dividends declared on preferred stock
CASK4598
Cash dividends declared on common stock
CASK4460
Other comprehensive income
CASKB511
Change in the offsetting debit to the liability for Employee Stock Ownership Plan 
(ESOP) debt guaranteed by the bank holding company
CASK4591
Other adjustments to equity capital (not included above)*
CASK3581

PQ 3

PQ 4

PQ 5

PQ 6

PQ 7

PQ 8

PQ 9

CPSK3217

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

CPSKB507
CPSKB508
CPSK4340

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐
            ‐
            ‐

            ‐
            ‐
            ‐

            ‐
            ‐
            ‐

CPSK3577
CPSK3578

            ‐
            ‐

            ‐
            ‐

            ‐
            ‐

CPSK3579
CPSK3580
CPSK4782
CPSK4783
CPSK4356
CPSK4598
CPSK4460
CPSKB511

            ‐
            ‐
            ‐
            ‐
            ‐
            ‐
            ‐
            ‐

            ‐
            ‐
            ‐
            ‐
            ‐
            ‐
            ‐
            ‐

            ‐
            ‐
            ‐
            ‐
            ‐
            ‐
            ‐
            ‐

CPSK4591
CPSK3581

            ‐
            ‐

            ‐
            ‐

            ‐
            ‐

            ‐

            ‐

            ‐

CASK3210             ‐

CPSK3210

Schedule HC‐R Part I.B. per Revised Regulatory Capital Rule (12 CFR 217)
AOCI opt‐out election? (enter "1" for Yes; enter "0" for No)

CASDP838

CPSDP838

CASDP742
CASK3247
CASDB530

CPSDP742
CPSK3247
CPSDB530

CASDP839

CPSDP839

 CASDP840                 ‐     CPSDP840 

Common equity tier 1 capital: adjustments and deductions: where applicable, 
report all line items reflective of transition provisions
24
25
26

Goodwill net of associated deferred tax liabilities (DTLs)
Intangible assets (other than goodwill and mortgage servicing assets (MSAs)), 
net of associated DTLs
Deferred tax assets (DTAs) that arise from net operating loss and tax credit 
carryforwards, net of any related valuation allowances and net of DTLs
If Item 18 is “1” for “Yes”, complete items 27 through 31 only for AOCI related 
adjustments.

PQ 6 ‐ 
PQ 9

PQ 2

Total bank or intermediate B24holding company equity capital end of current 
period (sum of items 3, 4, 5, 6, 7, 8, 9, 11, 14, 15, 16, less items 10, 12, 13)

Common equity tier 1
Common stock and related surplus, net of treasury stock and unearned 
employee stock ownership plan (ESOP) shares
Retained earnings 
Accumulated other comprehensive income (AOCI)
Common equity tier 1 minority interest includable in common equity tier 1 
capital
Common equity tier 1 before adjustments and deductions (sum of items 19 
through 22)

PQ 2 ‐ 
PQ 5

PQ 1

As of Date

1

Sums in $Millions

CASDP841

CPSDP841

CASDP842

CPSDP842

CASDP843

CPSDP843

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

               ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐   

9‐Quarter

FR Y‐14A Schedule A.1.d. ‐ 1. Capital ‐ CCAR and 2. Capital ‐ DFAST 
Projected in $Millions
Adjusted 
Starting 
1
Value

Item
As of Date
27

28

AOCI related adjustments: Net unrealized gains (losses) on available‐for‐sale 
securities (if a gain, report as a positive value; if a loss, report as a negative 
value)
AOCI related adjustments: Net unrealized loss on available‐for‐sale preferred 
stock classified as an equity security under GAAP and available‐for‐sale equity 
exposures (report loss as a positive value)

29

AOCI related adjustments: Accumulated net gains (losses) on cash flow hedges (if 
a gain, report as a positive value; if a loss, report as a negative value)

30

AOCI related adjustments: Amounts recorded in AOCI attributed to defined 
benefit postretirement plans resulting from the initial and subsequent 
application of the relevant GAAP standards that pertain to such plans  (if a gain, 
report as a positive value; if a loss, report as a negative value)

31

AOCI related adjustments: Net unrealized gains (losses) on held‐to‐maturity 
securities that are included in AOCI (if a gain, report as a positive value; if a loss, 
report as a negative value)

CASDP844

CPSDP844

CASDP845

CPSDP845

CASDP846

CPSDP846

CASDP847

CPSDP847

CASDP848

CPSDP848

CASDP849

CPSDP849

CASDQ258

CPSDQ258

CASDP850

CPSDP850

PQ 1

PQ 2

PQ 3

PQ 4

PQ 5

PQ 6

Sums in $Millions

PQ 7

PQ 8

PQ 9

If Item 18 is “0” for “No”, complete item 32 only for AOCI related adjustments.

32

33

34

35
36
37

38

39

40

41
42
43

AOCI related adjustments: Accumulated net gain (loss) on cash flow hedges 
included in AOCI, net of applicable tax effects, that relate to the hedging of items 
that are not recognized at fair value on the balance sheet (if a gain, report as a 
positive value; if a loss, report as a negative value)
Other deductions from (additions to) common equity tier capital 1 before 
threshold‐based deductions: Unrealized net gain (loss) related to changes in the 
fair value of liabilities that are due to changes in own credit risk (if a gain, report 
as a positive value; if a loss, report as a negative value)
Other deductions from (additions to) common equity tier capital 1 before 
threshold‐based deductions: All other deductions from (additions to) common 
equity tier 1 capital before threshold‐based deductions
Non‐significant investments in the capital of unconsolidated financial institutions 
in the form of common stock that exceed the 10 percent threshold for non‐
significant investments
Subtotal (item 23 minus items 24 through 35)
Significant investments in the capital of unconsolidated financial institutions in 
the form of common stock, net of associated DTLs, that exceed the 10 percent 
common equity tier 1 capital deduction threshold (item 71)
MSAs, net of associated DTLs, that exceed the 10 percent common equity tier 1 
capital deduction threshold (item 76)
DTAs arising from temporary differences that could not be realized through net 
operating loss carrybacks, net of related valuation allowances and net of DTLs, 
that exceed the 10 percent common equity tier 1 capital deduction threshold 
(item 79)
Amount of significant investments in the capital of unconsolidated financial 
institutions in the form of common stock; MSAs, net of associated DTLs; and 
DTAs arising from temporary differences that could not be realized through net 
operating loss carrybacks, net of related valuation allowances and net of DTLs; 
that exceeds the 15 percent common equity tier 1 capital deduction threshold 
(item 84 )
Deductions applied to common equity tier 1 capital due to insufficient amount of 
additional tier 1 capital and tier 2 capital to cover deductions
Total adjustments and deductions for common equity tier 1 capital (sum of items 
37 through 41)
Common equity tier 1 capital (item 36 minus 42)

CASDP851
CPSDP851
 CASDP852                 ‐     CPSDP852 

CASKP853

CPSKP853

CASKP854

CPSKP854

CASKP855

CPSKP855

CASKP856

CPSKP856

CASDP857

CPSDP857

 CASDP858                 ‐     CPSDP858 
 CASDP859                 ‐     CPSDP859 

               ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐   

               ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐   
               ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐   

PQ 2 ‐ 
PQ 5

PQ 6 ‐ 
PQ 9

9‐Quarter

FR Y‐14A Schedule A.1.d. ‐ 1. Capital ‐ CCAR and 2. Capital ‐ DFAST 
Projected in $Millions
Adjusted 
Starting 
1
Value

Item
As of Date
44
45

Additional tier 1 capital
Additional tier 1 capital instruments plus related surplus
Non‐qualifying capital instruments subject to phase out from additional tier 1 
capital

CASDP860

Sums in $Millions

PQ 1

PQ 2

PQ 3

PQ 4

PQ 5

PQ 6

PQ 7

PQ 8

PQ 9

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

CPSDP860

CASDP861

CPSDP861

46

Tier 1 minority interest not included in common equity tier 1 capital

CASDP862

CPSDP862

47

Additional tier 1 capital before deductions

CASDP863

CPSDP863

48

Additional tier 1 capital deductions

CASDP864

CPSDP864

49

Additional tier 1 capital

CASDP865

CPSDP865

50

Tier 1 capital
Tier 1 capital (sum of items 43 and 49)

CASD8274             ‐

CPSD8274

 CASDP866 
 CASDP867 
 CASDP868 
 CASD5310 

 CPSDP866 
 CPSDP867 
 CPSDP868 
 CPSD5310 

 CASE5310 

 CPSE5310 

 CASDQ257 
CASDP870             ‐

 CPSDQ257 
CPSDP870

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

 CASEP870 
 CASDP872 
CASD5311             ‐

 CPSEP870 
 CPSDP872 
CPSD5311

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

 CASE5311 

 CPSE5311 

CASD3792             ‐

CPSD3792

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

 CASE3792 

 CPSE3792 

51
52
53
54
55
56
57
58
59
60
61

62
63

Tier 2 capital
Tier 2 capital instruments plus related surplus
Non‐qualifying capital instruments subject to phase out from tier 2 capital
Total capital minority interest that is not included in tier 1 capital
Allowance for loan and lease losses includable in tier 2 capital (2)
(Advanced approaches holding companies that exit parallel run only): eligible 
credit reserves includable in tier 2 capital
Unrealized gains on available‐for‐sale preferred stock classified as an equity 
security under GAAP and available‐for‐sale equity exposures includable in tier 2 
capital
Tier 2 capital before deductions (sum of items 51, 52, 53, 54 and 56)
(Advanced approaches holding companies that exit parallel run only): Tier 2 
capital before deductions
Tier 2 capital deductions
Tier 2 capital (item 57 minus 59)
(Advanced approaches holding companies that exit parallel run only): Tier 2 
capital
Total capital
Total capital, (sum of items 50 and 60)
(Advanced approaches holding companies that exit parallel run only): Total 
capital (sum of items 50 and 61)

PQ 2 ‐ 
PQ 5

PQ 6 ‐ 
PQ 9

9‐Quarter

FR Y‐14A Schedule A.1.d. ‐ 1. Capital ‐ CCAR and 2. Capital ‐ DFAST 
Projected in $Millions
Adjusted 
Starting 
1
Value

Item
As of Date

64

65
66

67
68
69

Threshold Deductions Calculations
Non‐significant investments in the capital of unconsolidated financial institutions 
in the form of common stock, net of associated DTLs
Aggregate Nnon‐significant investments in the capital of unconsolidated 
financial institutions, including in the form of common stock, additional tier 1, 
and tier 2 capital
CASDR643
10 percent common equity tier 1 deduction threshold for non‐significant 
investments in the capital of unconsolidated financial institutions in the form of 
common stock
CASDR646                ‐   
Amount of non‐significant investments that exceed the 10 percent deduction 
threshold for non‐significant investments
CASDR647                ‐   
Significant investments in the capital of unconsolidated financial institutions in 
the form of common stock, net of associated DTLs
Gross significant investments in the capital of unconsolidated financial 
institutions in the form of common stock
CASDQ259
Permitted offsetting short positions in relation to the specific gross holdings 
included above
CASDQ260
Significant investments in the capital of unconsolidated financial institutions in 
the form of common stock net of short positions  (greater of item 67 minus 68 or 
zero)
CASDQ261             ‐

70

10 percent common equity tier 1 deduction threshold (10 percent of item 36)

71

Amount to be deducted from common equity tier 1 due to 10 percent deduction 
threshold (greater of item 69 minus item 70 or zero), prior to transition 
provisions
MSAs, net of associated DTLs
Total mortgage servicing assets classified as intangible

72
73

Associated deferred tax liabilities which would be extinguished if the intangible 
becomes impaired or derecognized under the relevant accounting standards

74

Mortgage servicing assets net of related deferred tax liabilities (item 72 minus 
item 73)

75

10 percent common equity tier 1 deduction threshold (10 percent of item 36)

76

Amount to be deducted from common equity tier 1 due to 10 percent deduction 
threshold (greater of item 74 minus item 75 or zero), prior to transiton provisions

PQ 1

PQ 2

PQ 3

PQ 4

PQ 5

PQ 6

Sums in $Millions

PQ 7

PQ 8

PQ 9

CPSDR643

CPSDR646

               ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐   

CPSDR647

               ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐   

CPSDQ259
CPSDQ260

CPSDQ261

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

CASDQ262             ‐

CPSDQ262

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

CASDP853             ‐

CPSDP853

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

CASDQ263

CPSDQ263

CASDQ264

CPSDQ264

CASDQ265             ‐

CPSDQ265

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

CASDQ262             ‐

CPSDQ262

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

CASDP854             ‐

CPSDP854

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

DTAs arising from temporary differences that could not be realized through net 
operating loss carrybacks, net of related valuation allowances and net of DTLs
77

DTAs arising from temporary differences that could not be realized through net 
operating loss carrybacks, net of related valuation allowances and net of DTLs

78

10 percent common equity tier 1 deduction threshold (10 percent of item 36)

79

Amount to be deducted from common equity tier 1 due to 10 percent deduction 
threshold (greater of item 77 minus item 78 or zero), prior to transition 
provisions

CASDQ296                ‐    CPSDQ296

               ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐   

CASDQ262             ‐

CPSDQ262

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

CASDP855             ‐

CPSDP855

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

PQ 2 ‐ 
PQ 5

PQ 6 ‐ 
PQ 9

9‐Quarter

FR Y‐14A Schedule A.1.d. ‐ 1. Capital ‐ CCAR and 2. Capital ‐ DFAST 
Projected in $Millions
Adjusted 
Starting 
1
Value

Item
As of Date

Sums in $Millions

PQ 1

PQ 2

PQ 3

PQ 4

PQ 5

PQ 6

PQ 7

PQ 8

PQ 9

Aggregate of items subject to the 15% limit (significant investments, mortgage 
servicing assets and deferred tax assets arising from temporary differences)
80
81
82
83
84

85
86
87
88

89
90
91
92
93
94

Sum of items 69, 74, and 77
15 percent common equity tier 1 deduction threshold 
Sum of items 71, 76, and 79
Item 80 minus item 82
Amount to be deducted from common equity tier 1 due to 15 percent deduction 
threshold (greater of item 83 minus item 81 or zero), prior to transition 
provisions
Total Assets for the Leverage Ratio (12 CFR 217)
Average total consolidated assets 
Deductions from common equity tier 1 capital and additional tier 1 capital
Other deductions from (additions to) assets for leverage ratio purposes
Total assets for the leverage ratio (item 85 minus items 86 and 87)
REGULATORY CAPITAL AND RATIOS
Common equity tier 1 (item 43)
Tier 1 capital per revised regulatory capital rule
Total capital per revised regulatory capital rule 
(Advanced approaches holding companies that exit parallel run only): Total 
capital per revised regulatory capital rule (item 63)
Total risk‐weighted assets using standardized approach
(Advanced approaches holding companies that exit parallel run only): total risk‐
weighted assets using advanced approaches rules

95

Total assets for the leverage ratio per revised regulatory capital rule (item 88)

96

Supplementary leverage ratio exposure

CASDQ266
CASDQ267
CASDQ268
CASDQ269

            ‐
            ‐
            ‐
            ‐

CPSDQ266
CPSDQ267
CPSDQ268
CPSDQ269

            ‐
            ‐
            ‐
            ‐

            ‐
            ‐
            ‐
            ‐

            ‐
            ‐
            ‐
            ‐

            ‐
            ‐
            ‐
            ‐

            ‐
            ‐
            ‐
            ‐

            ‐
            ‐
            ‐
            ‐

            ‐
            ‐
            ‐
            ‐

            ‐
            ‐
            ‐
            ‐

            ‐
            ‐
            ‐
            ‐

CASDQ270             ‐

CPSDQ270

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

 CASK3368 
 CASDP875 
 CASDB596 
 CASDA224                 ‐   

 CPSK3368 
 CPSDP875 
 CPSDB596 
 CPSDA224 

               ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐   

 CASDP859                 ‐     CPSDP859 
 CASD8274                 ‐     CPSD8274 
 CASD3792                 ‐     CPSD3792 

               ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐   
               ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐   
               ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐   

 CASE3792 

 CPSE3792 

 CASDA223 

 CPSDA223 

 CASEA223 

 CPSEA223 

 CASKA224                 ‐     CPSKA224 
 CASKHK22 

 CPSKHK22 

               ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐                   ‐   

PQ 2 ‐ 
PQ 5

PQ 6 ‐ 
PQ 9

9‐Quarter

FR Y‐14A Schedule A.1.d. ‐ 1. Capital ‐ CCAR and 2. Capital ‐ DFAST 
Projected in $Millions
Adjusted 
Starting 
1
Value

Item
As of Date
97

PQ 1

PQ 2

PQ 3

PQ 4

PQ 5

PQ 6

PQ 7

PQ 8

PQ 9

 CASDP793  #DIV/0!

 CPSDP793 

#DIV/0!

#DIV/0!

#DIV/0!

#DIV/0!

#DIV/0!

#DIV/0!

#DIV/0!

#DIV/0!

#DIV/0!

 CASEP793 
 CASD7206 

#DIV/0!

 CPSEP793 
 CPSD7206 

#DIV/0!

#DIV/0!

#DIV/0!

#DIV/0!

#DIV/0!

#DIV/0!

#DIV/0!

#DIV/0!

#DIV/0!

 CASE7206 
 CASD7205 

#DIV/0!

 CPSE7206 
 CPSD7205 

#DIV/0!

#DIV/0!

#DIV/0!

#DIV/0!

#DIV/0!

#DIV/0!

#DIV/0!

#DIV/0!

#DIV/0!

 CASE7205 
 CASD7204  #DIV/0!
 CASKHK23 

 CPSE7205 
 CPSD7204 
 CPSKHK23 

#DIV/0!

#DIV/0!

#DIV/0!

#DIV/0!

#DIV/0!

#DIV/0!

#DIV/0!

#DIV/0!

#DIV/0!

Schedule HC‐F—Other Assets
105 Net deferred tax assets

CASK2148

CPSK2148

Schedule HC‐G—Other Liabilities
106 Net deferred tax liabilities

CASK3049

CPSK3049

Issuances associated with the U.S. Department of Treasury Capital Purchase 
Program:
107 Senior perpetual preferred stock or similar items
108 Warrants to purchase common stock or similar items

CASKG234
CASKG235

CPSKG234
CPSKG235

 CASDQ275 
 CASDLC30 
 CASDLC31 
 CASDLC32 

 CPSDQ275 
 CPSDLC30 
 CPSDLC31 
 CPSDLC32 

 CASDR648 

 CPSDR648 

Valuation allowances related to deferred tax assets that arise from net operating 
111
loss and tax credit carryforwards
 CASDR649 

 CPSDR649 

98
99
100
101
102
103
104

Common equity tier 1 ratio (%)
(Advanced approaches holding companies that exit parallel run only): Common 
equity tier 1 ratio (%)
Tier 1 capital ratio (%)
(Advanced approaches holding companies that exit parallel run only): Tier 1 
capital ratio (%)
Total capital ratio (%)
(Advanced approaches holding companies that exit parallel run only): Total 
capital ratio (%)
Tier 1 leverage ratio (%)
Supplementary leverage ratio (%)

Sums in $Millions

Deferred Tax Asset Information
Taxes previously paid that the bank holding company could recover through 
allowed carrybacks if the bank holding company's DTAs on net operating loss, 
tax credits and temporary differences (both deductible and taxable) fully reverse 
at the report date.
109a U.S. Federal Government
109b U.S. State Governments
109c All non‐U.S. tax jursidictions
109

110

Deferred tax assets that arise from net operating loss and tax credit 
carryforwards, net of DTLs, but gross of related valuation allowances

111a U.S. Federal Government
111b U.S. State Governments
111c All non‐U.S. tax jursidictions

 CASDLC33 

 CPSDLC33 

 CASDLC34 

 CPSDLC34 

 CASDLC35 

 CPSDLC35 

112 Deferred tax assets arising from temporary differences, net of DTLs

 CASDR650 

 CPSDR650 

112a U.S. Federal Government

 CASDLC36 

 CPSDLC36 

112b U.S. State Governments

 CASDLC37 

 CPSDLC37 

112c All non‐U.S. tax jursidictions

 CASDLC38 

 CPSDLC38 

113  Valuation allowances related to DTAs arising from temporary differences 

 CASDR651 

 CPSDR651 

113a U.S. Federal Government

 CASDLC39 

 CPSDLC39 

113b U.S. State Governments

 CASDLC40 
 CASDLC41 

 CPSDLC40 
 CPSDLC41 

113c All non‐U.S. tax jursidictions
Supplemental Capital Action Information (report in $Millions unless otherwise 
noted)***
114 Cash dividends declared on common stock

 CASD4460 

 CPSD4460 

115 Common shares outstanding (Millions)
116 Common dividends per share ($)

 CASDQ946 
CASDQ282             ‐

 CPSDQ946 
CPSDQ282

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

PQ 2 ‐ 
PQ 5

PQ 6 ‐ 
PQ 9

9‐Quarter

FR Y‐14A Schedule A.1.d. ‐ 1. Capital ‐ CCAR and 2. Capital ‐ DFAST 
Projected in $Millions
Adjusted 
Starting 
1
Value

Item
As of Date

Sums in $Millions

PQ 1

PQ 2

PQ 3

PQ 4

PQ 5

PQ 6

PQ 7

PQ 8

PQ 9

117 Issuance of common stock for employee compensation
118 Other issuance of common stock
119 Total issuance of common stock

CASDQ283
CASDQ284
CASDQ285             ‐

CPSDQ283
CPSDQ284
CPSDQ285

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

120 Share repurchases to offset issuance for employee compensation
121 Other share repurchase
122 Total share repurchases

CASDQ286
CASDQ287
CASDQ288             ‐

CPSDQ286
CPSDQ287
CPSDQ288

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

Supplemental Information on Trust Preferred Securities Subject to Phase‐Out 
from Tier 1 Capital
123 Outstanding trust preferred securities
124 Trust preferred securities included in Item 49

CASKC699
CASDQ289

CPSKC699
CPSDQ289

Memoranda
*Please break out and explain below other adjustments to equity capital:

CASDQ290

125

**The carryback period is the prior two calendar tax years plus any current taxes paid in the year‐to‐date period.  Please provide disaggregated data for item 109 as follows:
126 Taxes paid during the fiscal year ended two years ago
CASDQ292
127 Taxes paid during the fiscal year ended one year ago
CASDQ293
128 Taxes paid through the as‐of date of the current fiscal year
CASDQ294
***Please reconcile the Supplemental Capital Action and HI‐A projections (i.e., 
allocate the capital actions among the HI‐A buckets):

CASDQ295

129

Footnotes to the Capital Worksheet
(1) Firms should only use this column to report an adjusted starting value for an item subject to adjustment or deduction in capital impacted by the global market shock. 
(2) Institutions that have adopted ASU 2016‐13 should report in item 54 the adjusted allowances for credit losses, as defined in the regulatory capital rule. 

PQ 2 ‐ 
PQ 5

PQ 6 ‐ 
PQ 9

9‐Quarter

FR Y‐14A Schedule A.2.a ‐ Retail Balance and Loss Projections

As‐of 

Item

PQ 1

First Lien Mortgages (in Domestic Offices)
       Balances

CASRP381

1a

         Balances ‐‐ PCD (1)

CASRKU95

CPSRKU95

2

       New originations

CASRP382

CPSRP382

3

       Paydowns

CASRP383

CPSRP383

4

       Asset Purchases

CASRP384

CPSRP384

5

       Asset Sales

CASRP385

CPSRP385

6

       Loan Losses

CASRP386

CPSRP386

6a

         Loan Losses ‐‐ PCD (1)

CASRKU97

CPSRKU97

       Balances

CASRP389

CPSRP389

1

7

Not Applicable

8

Not Applicable

CPSRP381

First Lien HELOANs (in Domestic Offices)
9
9a

         Balances ‐‐ PCD (1)

CASRKV00

CPSRKV00

10

       New originations

CASRP390

CPSRP390

11

       Paydowns

CASRP391

CPSRP391

12

       Asset Purchases

CASRP392

CPSRP392

13

       Asset Sales

CASRP393

CPSRP393

14

       Loan Losses

CASRP394

CPSRP394

14a

         Loan Losses ‐‐ PCD (1)

CASRKV02

CPSRKV02

15

Not Applicable

16

Not Applicable

PQ 2

PQ 3

Projected in $Millions
PQ 4
PQ 5
PQ 6

PQ 7

PQ 8

PQ 9

FR Y‐14A Schedule A.2.a ‐ Retail Balance and Loss Projections

As‐of 

Item

PQ 1

PQ 2

PQ 3

          ‐

          ‐

          ‐

Projected in $Millions
PQ 4
PQ 5
PQ 6

PQ 7

PQ 8

PQ 9

          ‐

          ‐

          ‐

Closed‐End Junior Liens (in Domestic Offices)
17

       Balances

CASRP397

CPSRP397

17a

         Balances ‐‐ PCD (1)

CASRKV05

CPSRKV05

18

       New originations

CASRP398

CPSRP398

19

       Paydowns

CASRP399

CPSRP399

20

       Asset Purchases

CASRP400

CPSRP400

21

       Asset Sales

CASRP401

CPSRP401

22

       Loan Losses

CASRP402

CPSRP402

22a

         Loan Losses ‐‐ PCD (1)

CASRKV07

CPSRKV07

23

Not Applicable

24

Not Applicable
HELOCs (in Domestic Offices)

25
26
26a
27
27a
28

       Balances
      Balance from vintages < PQ 1
              Balances ‐‐ PCD (1)

CASRP405

          ‐

CPSRP405

CASRP406

CPSRP406

CASRKV10

CPSRKV10

Balance from vintage PQ 1 ‐ PQ 5

CPSRP407

              Balances ‐‐ PCD (1)

CPSRLC42

Balance from vintage PQ 6 ‐ PQ 9

CPSRP408

28a

              Balances ‐‐ PCD (1)

29

       Paydowns

CASRP409

CPSRP409

30

       Asset Purchases

CASRP410

CPSRP410

31

       Asset Sales

CASRP411

CPSRP411

32

       Loan Losses

CASRP412

CPSRP412

32a

         Loan Losses ‐‐ PCD (1)

CASRKV12

CPSRKV12

33

Not Applicable

34

Not Applicable

CPSRLC43

          ‐

          ‐

          ‐

FR Y‐14A Schedule A.2.a ‐ Retail Balance and Loss Projections

As‐of 

Item

PQ 1

First Lien Mortgages and HELOANs (International)
35

       Balances

CASRP415

CPSRP415

35a

         Balances ‐‐ PCD (1)

CASRKV15

CPSRKV15

36

       New originations

CASRP416

CPSRP416

37

       Paydowns

CASRP417

CPSRP417

38

       Asset Purchases

CASRP418

CPSRP418

39

       Asset Sales

CASRP419

CPSRP419

40

       Loan Losses

CASRP420

CPSRP420

40a

         Loan Losses ‐‐ PCD (1)

CASRKV17

CPSRKV17

41

Not Applicable

42

Not Applicable
Closed‐End Junior Liens and HELOCs (International)

43

       Balances

CASRP423

CPSRP423

43a

         Balances ‐‐ PCD (1)

CASRKV20

CPSRKV20

44

       New originations

CASRP424

CPSRP424

45

       Paydowns

CASRP425

CPSRP425

46

       Asset Purchases

CASRP426

CPSRP426

47

       Asset Sales

CASRP427

CPSRP427

48

       Loan Losses

CASRP428

CPSRP428

48a

         Loan Losses ‐‐ PCD (1)

CASRKV22

CPSRKV22

49

Not Applicable

50

Not Applicable

PQ 2

PQ 3

Projected in $Millions
PQ 4
PQ 5
PQ 6

PQ 7

PQ 8

PQ 9

FR Y‐14A Schedule A.2.a ‐ Retail Balance and Loss Projections

As‐of 

Item

PQ 1

PQ 2

PQ 3

          ‐

          ‐

          ‐

Projected in $Millions
PQ 4
PQ 5
PQ 6

PQ 7

PQ 8

PQ 9

          ‐

          ‐

          ‐

Corporate Card (Domestic)
51

 Balances 

CASRP431

CPSRP431

52

       Paydowns

CASRP432

CPSRP432

53

       Asset Purchases

CASRP433

CPSRP433

54

       Asset Sales

CASRP434

CPSRP434

55

       Loan Losses

CASRP435

CPSRP435

CASRP436

CPSRP436

Business Card (Domestic)
56

 Balances 

57

       Paydowns

CASRP437

CPSRP437

58

       Asset Purchases

CASRP438

CPSRP438

59

       Asset Sales

CASRP439

CPSRP439

60

       Loan Losses

CASRP440

CPSRP440

Charge Card (Domestic)
61
62

       Balances
      Balance from vintages < PQ 1

CASRP441
CASRP442

          ‐

CPSRP441
CPSRP442

63

Balance from vintage PQ 1 ‐ PQ 5

CPSRP443

64

Balance from vintage PQ 6 ‐ PQ 9

CPSRP444

65

       Paydowns

CASRP445

CPSRP445

66

       Asset Purchases

CASRP446

CPSRP446

67

       Asset Sales

CASRP447

CPSRP447

68

       Loan Losses

CASRP448

CPSRP448

          ‐

          ‐

          ‐

FR Y‐14A Schedule A.2.a ‐ Retail Balance and Loss Projections

As‐of 

Item

PQ 1

PQ 2

PQ 3

          ‐

          ‐

          ‐

Projected in $Millions
PQ 4
PQ 5
PQ 6

PQ 7

PQ 8

PQ 9

          ‐

          ‐

          ‐

Bank Card (Domestic)
69
70
71
72

       Balances
      Balance from vintages < PQ 1

CASRP449
CASRP450

Balance from vintage PQ 1 ‐ PQ 5

          ‐

CPSRP449
CPSRP450
CPSRP451

Balance from vintage PQ 6 ‐ PQ 9

CPSRP452

73

       Paydowns

CASRP453

CPSRP453

74

       Asset Purchases

CASRP454

CPSRP454

75

       Asset Sales

CASRP455

CPSRP455

76

       Loan Losses

CASRP456

CPSRP456

Business and Corporate Card (International)
77

       Balances

CASRP457

CPSRP457

78

       Paydowns

CASRP458

CPSRP458

79

       Asset Purchases

CASRP459

CPSRP459

80

       Asset Sales

CASRP460

CPSRP460

81

       Loan Losses

CASRP461

CPSRP461

Bank and Charge Card (International)
82

       Balances

CASRP462

CPSRP462

83

       Paydowns

CASRP463

CPSRP463

84

       Asset Purchases

CASRP464

CPSRP464

85

       Asset Sales

CASRP465

CPSRP465

86

       Loan Losses

CASRP466

CPSRP466

Auto Loans (Domestic)
87

       Balances

CASRP467

CPSRP467

88

       New originations

CASRP468

CPSRP468

89

       Paydowns

CASRP469

CPSRP469

90

       Asset Purchases

CASRP470

CPSRP470

91

       Asset Sales

CASRP471

CPSRP471

92

       Loan Losses

CASRP472

CPSRP472

          ‐

          ‐

          ‐

FR Y‐14A Schedule A.2.a ‐ Retail Balance and Loss Projections

As‐of 

Item

PQ 1

Auto Loans (International)
93

       Balances

CASRP473

CPSRP473

94

       New originations

CASRP474

CPSRP474

95

       Paydowns

CASRP475

CPSRP475

96

       Asset Purchases

CASRP476

CPSRP476

97

       Asset Sales

CASRP477

CPSRP477

98

       Loan Losses

CASRP478

CPSRP478

Auto Leases (Domestic)
99

       Balances

CASRP479

CPSRP479

100

       New originations

CASRP480

CPSRP480

101

       Paydowns

CASRP481

CPSRP481

102

       Asset Purchases

CASRP482

CPSRP482

103

       Asset Sales

CASRP483

CPSRP483

       Loan Losses

CASRP484

CPSRP484

104

Auto Leases (International)
105

       Balances

CASRP485

CPSRP485

106

       New originations

CASRP486

CPSRP486

107

       Paydowns

CASRP487

CPSRP487

108

       Asset Purchases

CASRP488

CPSRP488

109

       Asset Sales

CASRP489

CPSRP489

110

       Loan Losses

CASRP490

CPSRP490

Student Loan 
111

       Balances

CASRP491

CPSRP491

112

       New originations

CASRP492

CPSRP492

113

       Paydowns

CASRP493

CPSRP493

114

       Asset Purchases

CASRP494

CPSRP494

115

       Asset Sales

CASRP495

CPSRP495

116

       Loan Losses

CASRP496

CPSRP496

PQ 2

PQ 3

Projected in $Millions
PQ 4
PQ 5
PQ 6

PQ 7

PQ 8

PQ 9

FR Y‐14A Schedule A.2.a ‐ Retail Balance and Loss Projections

As‐of 

Item

PQ 1

Small Business Loan ‐ Scored (Domestic)
117

       Balances

CASRP497

CPSRP497

118

       New originations

CASRP498

CPSRP498

119

       Paydowns

CASRP499

CPSRP499

120

       Asset Purchases

CASRP500

CPSRP500

121

       Asset Sales

CASRP501

CPSRP501

       Loan Losses

CASRP502

CPSRP502

122

Small Business Loan ‐ Scored (International)
123

       Balances

CASRP503

CPSRP503

124

       New originations

CASRP504

CPSRP504

125

       Paydowns

CASRP505

CPSRP505

126

       Asset Purchases

CASRP506

CPSRP506

127

       Asset Sales

CASRP507

CPSRP507

       Loan Losses

CASRP508

CPSRP508

128

Other Consumer Loans and Leases (Domestic)
129

       Balances

CASRP509

CPSRP509

130

       New originations

CASRP510

CPSRP510

131

       Paydowns

CASRP511

CPSRP511

132

       Asset Purchases

CASRP512

CPSRP512

133

       Asset Sales

CASRP513

CPSRP513

134

       Loan Losses

CASRP514

CPSRP514

Other Consumer Loans and Leases (International)
135

       Balances

CASRP515

CPSRP515

136

       New originations

CASRP516

CPSRP516

137

       Paydowns

CASRP517

CPSRP517

138

       Asset Purchases

CASRP518

CPSRP518

139

       Asset Sales

CASRP519

CPSRP519

140

       Loan Losses

CASRP520

CPSRP520

(1)

Footnotes to the Retail Balance and Loss Projections Worksheet
This item is only reported by institutions that have adopted ASU 2016‐13.

PQ 2

PQ 3

Projected in $Millions
PQ 4
PQ 5
PQ 6

PQ 7

PQ 8

PQ 9

FR Y‐14A Schedule A.3.b ‐ OTTI Methodology and Assumptions for AFS and HTM Securities by Portfolio
Institutions that have not adopted ASU 2016‐13 
should continue to report sub‐schedules A.3.b and 
A.3.c.  Institutions that have adopted ASU 2016‐13 
should report sub‐schedules A.3.f and A.3.g.
Threshold for 
Determining OTTI

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Aggregate Cumulative 
Lifetime Loss on 
Underlying Collateral
(% Original Balance)

Discount Rate 
Methodology

Please provide the 
name(s) of any vendor(s) 
and any vendor model(s) 
that are used

Were all securities 
reviewed for potential 
OTTI (yes/no) for stress 
testing?

Macroeconomic/financial 
variables used in loss 
estimation

AFS and HTM Securities
CASMN243
CCARP084
CPSMN244
CASMN245
CASMN246
CASMN247
CASMN248
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Common stock (equity)
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestic Non‐Agency RMBS 
(incl HEL ABS)
Foreign RMBS
Municipal Bond
Mutual Fund
Preferred stock (equity)
Sovereign Bond
US Treasuries & Agencies
Other*
*For 'Other' AFS and HTM securities, please provide name of security type in row 20 above (currently labeled "Other").  Please add additional rows if necessary.  If adding additional 
rows, please ensure that grand totals sum appropriately.

FR Y‐14A Schedule A.3.c ‐Projected OTTI for AFS and HTM Securities by Portfolio
Institutions that have not adopted ASU 2016‐13 
should continue to report sub‐schedules A.3.b 
and A.3.c.  Institutions that have adopted ASU 
2016‐13 should report sub‐schedules A.3.f and 
A.3.g.

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21

AFS and HTM Securities
CCARP084
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Common Stock (Equity)
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestic Non‐Agency RMBS
Foreign RMBS
Municipal Bond
Mutual Fund
Preferred Stock (Equity)
Sovereign Bond
US Treasuries & Agencies
Other*
GRAND TOTAL

PQ 1

PQ 2

Actual 
Amortized 
Cost 
Accounting 
Intent (AFS,  (MM/DD/YY
YY)
HTM)

Credit Loss  Non‐ Credit 
Portion
Loss Portion

CCARP092

CPSPN234

0

CASPP087

0

0

Total OTTI

Credit Loss  Non‐ Credit 
Portion
Loss Portion

PQ 3

Total OTTI

Credit Loss  Non‐ Credit 
Portion
Loss Portion

Total OTTI

CPSPN235

 CPSPP091  CPSPN234 CPSPN235  CPSPP091  CPSPN234 CPSPN235  CPSPP091 
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
0                  ‐   
0
0                  ‐   
0
0                  ‐   

*For 'Other' AFS securities, please provide name of security type in row 20 above (currently labeled "Other").  Please add additional rows if necessary.  If adding additional rows, please ensure that grand totals sum 
appropriately.

FR Y‐14A Schedule A.3.c ‐Projected OTTI for AFS and HTM Securities by Portfolio
Institutions that have not adopted ASU 2016‐13 
should continue to report sub‐schedules A.3.b 
and A.3.c.  Institutions that have adopted ASU 
2016‐13 should report sub‐schedules A.3.f and 
A.3.g.

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21

AFS and HTM Securities
CCARP084
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Common Stock (Equity)
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestic Non‐Agency RMBS
Foreign RMBS
Municipal Bond
Mutual Fund
Preferred Stock (Equity)
Sovereign Bond
US Treasuries & Agencies
Other*
GRAND TOTAL

PQ 4

PQ 5

Actual 
Amortized 
Cost 
Accounting 
Intent (AFS,  (MM/DD/YY
YY)
HTM)

Credit Loss  Non‐ Credit 
Portion
Loss Portion

CCARP092

CPSPN234

0

CASPP087

0

*For 'Other' AFS securities, please provide name of security type in row 20 
appropriately.

0

CPSPN235

Total OTTI

Credit Loss  Non‐ Credit 
Portion
Loss Portion

PQ 6

Total OTTI

Credit Loss  Non‐ Credit 
Portion
Loss Portion

Total OTTI

 CPSPP091  CPSPN234 CPSPN235  CPSPP091  CPSPN234 CPSPN235  CPSPP091 
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
0                  ‐   
0
0                  ‐   
0
0                  ‐   

FR Y‐14A Schedule A.3.c ‐Projected OTTI for AFS and HTM Securities by Portfolio
Institutions that have not adopted ASU 2016‐13 
should continue to report sub‐schedules A.3.b 
and A.3.c.  Institutions that have adopted ASU 
2016‐13 should report sub‐schedules A.3.f and 
A.3.g.

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21

AFS and HTM Securities
CCARP084
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Common Stock (Equity)
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestic Non‐Agency RMBS
Foreign RMBS
Municipal Bond
Mutual Fund
Preferred Stock (Equity)
Sovereign Bond
US Treasuries & Agencies
Other*
GRAND TOTAL

PQ 7

PQ 8

Actual 
Amortized 
Cost 
Accounting 
Intent (AFS,  (MM/DD/YY
YY)
HTM)

Credit Loss  Non‐ Credit 
Portion
Loss Portion

CCARP092

CPSPN234

0

CASPP087

0

*For 'Other' AFS securities, please provide name of security type in row 20 
appropriately.

0

CPSPN235

Total OTTI

Credit Loss  Non‐ Credit 
Portion
Loss Portion

PQ 9

Total OTTI

Credit Loss  Non‐ Credit 
Portion
Loss Portion

Total OTTI

 CPSPP091  CPSPN234 CPSPN235  CPSPP091  CPSPN234 CPSPN235  CPSPP091 
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
                 ‐   
0                  ‐   
0
0                  ‐   
0
0                  ‐   

FR Y‐14A Schedule A.3.d ‐ Projected OCI and Fair Value for AFS Securities

Total Actual 
Fair Market 
Value 
MM/DD/YY
CASPP088

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21

Beginning  Fair Value  Projected  Beginning  Fair Value  Projected  Beginning  Fair Value  Projected 
Fair Market  Rate of 
OCI ‐ 
Fair Market  Rate of 
OCI ‐ 
Fair Market  Rate of 
OCI ‐ 
Value PQ 1 Change PQ1
PQ 1
Value PQ 2 Change PQ2
PQ 2
Value PQ 3 Change PQ3
PQ 3
CPSPS677 CPSPS678 CPSPB530 CPSPS677 CPSPS678 CPSPB530 CPSPS677 CPSPS678 CPSPB530

AFS Securities
CCARP084
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Common Stock (Equity)
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestic Non‐Agency RMBS
Foreign RMBS
Municipal Bond
Mutual Fund
Preferred Stock (Equity)
Sovereign Bond
US Treasuries & Agencies
Other*
GRAND TOTAL
                  ‐                      ‐                      ‐                      ‐                      ‐                      ‐                      ‐                      ‐                      ‐                      ‐   
* For 'Other' AFS securities, please provide name of security type in row 20 above (currently labeled "Other").  Please add additional rows if necessary.  If adding additional 
rows, please ensure that grand totals sum appropriately.

FR Y‐14A Schedule A.3.d ‐ Projected OCI and Fair Value for AFS Securities

Projected OCI Based on Macro‐Economic Scenario

Beginning  Fair Value  Projected  Beginning  Fair Value  Projected  Beginning  Fair Value  Projected  Beginning  Fair Value  Projected 
Fair Market  Rate of 
OCI ‐ 
Fair Market  Rate of 
OCI ‐ 
Fair Market  Rate of 
OCI ‐ 
Fair Market  Rate of 
OCI ‐ 
Value PQ 4 Change PQ4
PQ 4
Value PQ 5 Change PQ5
PQ 5
Value PQ 6 Change PQ6
PQ 6
Value PQ 7 Change PQ7
PQ 7
CPSPS677 CPSPS678 CPSPB530 CPSPS677 CPSPS678 CPSPB530 CPSPS677 CPSPS678 CPSPB530 CPSPS677 CPSPS678 CPSPB530

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21

AFS Securities
CCARP084
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Common Stock (Equity)
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestic Non‐Agency RMBS
Foreign RMBS
Municipal Bond
Mutual Fund
Preferred Stock (Equity)
Sovereign Bond
US Treasuries & Agencies
Other*
                  ‐                      ‐                      ‐                      ‐                      ‐                      ‐                      ‐                      ‐                      ‐                      ‐                      ‐                      ‐   
GRAND TOTAL
* For 'Other' AFS securities, please pro
rows, please ensure that grand totals 

FR Y‐14A Schedule A.3.d ‐ Projected OCI and Fair Value for AFS Securities

Beginning  Fair Value  Projected  Beginning  Fair Value  Projected 
Fair Market  Rate of 
OCI ‐ 
Fair Market  Rate of 
OCI ‐ 
Value PQ 8 Change PQ8
PQ 8
Value PQ 9 Change PQ9
PQ 9
CPSPS677 CPSPS678 CPSPB530 CPSPS677 CPSPS678 CPSPB530

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21

Total 
Projected 
OCI in all 
Quarters

Estimated Total Fair 
Market Value after OCI 
Shock applied to all 
Quarters
CPSPP088

AFS Securities
CCARP084
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Common Stock (Equity)
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestic Non‐Agency RMBS
Foreign RMBS
Municipal Bond
Mutual Fund
Preferred Stock (Equity)
Sovereign Bond
US Treasuries & Agencies
Other*
                  ‐                      ‐                      ‐                      ‐                      ‐                      ‐                      ‐                                            ‐   
GRAND TOTAL
* For 'Other' AFS securities, please pro
rows, please ensure that grand totals 

FR Y‐14A Schedule A.3.e ‐ AFS and HTM Fair Market Value Sources by Portfiolio

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

AFS and HTM Securities
CCARP084
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Common Stock (Equity)
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestic Non‐Agency RMBS (incl HEL ABS)
Foreign RMBS
Municipal Bond
Mutual Fund
Preferred Stock (Equity)
Sovereign Bond
US Treasuries & Agencies
Other*

Principal Market Value Source 
Please state whether a vendor or proprietary model is 
used.  If using a 3rd party vendor, please provide the 
name(s) of the 3rd party vendor(s).

CASMN240

In general, how often are securities normally 
marked (e.g., daily, weekly, quarterly, etc.)?
CASMN241

*For 'Other' AFS and HTM securities, please provide name of security type in row 20 above (currently labeled "Other").  Please add additional rows if necessary.  If adding additional 
rows, please ensure that grand totals sum appropriately.

FR Y‐14A Schedule A.3.f ‐ Expected Credit Loss and Provision for Credit Loss ‐‐ HTM securities

HTM Securities

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19

CCARP084
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestric Non‐Agency RMBS
Foreign RMBS
Municipal Bond
Mutual Fund
Sovereign Bond
US Treasuries & Agencies
Other1
Grand Total
Note

1. Please provide name of security type in row 18 above 
(currently labeled 'other').  Please add additional rows if 
necessary.  If adding additional rows, please ensure that 
grand totals sum appropriately.

Actual Amortized 
Cost 
(MM/DD/YYYY)

Total Allowance 
for Credit Loss 
(MM/DD/YYYY)

CASSLC44

CASSLC14

PQ1
Projected 
Provision for 
Amortized Cost
Credit Loss
CPSSLC45
CPSSLC44

FR Y‐14A Schedule A.3.f ‐ Expected Credit Loss and Provision for Credit Loss ‐‐ HTM securities

PQ2
HTM Securities

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19

CCARP084
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestric Non‐Agency RMBS
Foreign RMBS
Municipal Bond
Mutual Fund
Sovereign Bond
US Treasuries & Agencies
Other1
Grand Total
Note

1. Please provide name of security type in row 18 above 
(currently labeled 'other').  Please add additional rows if 
necessary.  If adding additional rows, please ensure that 
grand totals sum appropriately.

Projected 
Provision for 
Amortized Cost
Credit Loss
CPSSLC45
CPSSLC44

PQ3
Projected 
Provision for 
Amortized Cost
Credit Loss
CPSSLC45
CPSSLC44

FR Y‐14A Schedule A.3.f ‐ Expected Credit Loss and Provision for Credit Loss ‐‐ HTM securities

PQ4
HTM Securities

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19

CCARP084
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestric Non‐Agency RMBS
Foreign RMBS
Municipal Bond
Mutual Fund
Sovereign Bond
US Treasuries & Agencies
Other1
Grand Total
Note

1. Please provide name of security type in row 18 above 
(currently labeled 'other').  Please add additional rows if 
necessary.  If adding additional rows, please ensure that 
grand totals sum appropriately.

Projected 
Provision for 
Amortized Cost
Credit Loss
CPSSLC45
CPSSLC44

PQ5
Projected 
Provision for 
Amortized Cost
Credit Loss
CPSSLC45
CPSSLC44

FR Y‐14A Schedule A.3.f ‐ Expected Credit Loss and Provision for Credit Loss ‐‐ HTM securities

PQ6
HTM Securities

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19

CCARP084
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestric Non‐Agency RMBS
Foreign RMBS
Municipal Bond
Mutual Fund
Sovereign Bond
US Treasuries & Agencies
Other1
Grand Total
Note

1. Please provide name of security type in row 18 above 
(currently labeled 'other').  Please add additional rows if 
necessary.  If adding additional rows, please ensure that 
grand totals sum appropriately.

Projected 
Provision for 
Amortized Cost
Credit Loss
CPSSLC45
CPSSLC44

PQ7
Projected 
Provision for 
Amortized Cost
Credit Loss
CPSSLC45
CPSSLC44

FR Y‐14A Schedule A.3.f ‐ Expected Credit Loss and Provision for Credit Loss ‐‐ HTM securities

PQ8
HTM Securities

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19

CCARP084
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestric Non‐Agency RMBS
Foreign RMBS
Municipal Bond
Mutual Fund
Sovereign Bond
US Treasuries & Agencies
Other1
Grand Total
Note

1. Please provide name of security type in row 18 above 
(currently labeled 'other').  Please add additional rows if 
necessary.  If adding additional rows, please ensure that 
grand totals sum appropriately.

Projected 
Provision for 
Amortized Cost
Credit Loss
CPSSLC45
CPSSLC44

PQ9
Projected 
Provision for 
Amortized Cost
Credit Loss
CPSSLC45
CPSSLC44

FR Y‐14A Schedule A.3.g ‐ Expected Credit Loss and Provision for Credit Loss ‐‐ AFS securities

PQ1

AFS Securities

CCARP084
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestric Non‐Agency RMBS
Foreign RMBS
Municipal Bond
Mutual Fund
Sovereign Bond
US Treasuries & Agencies
2
18 Other
19 Grand Total
Note
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17

1. Please do not include Expected lifetime loss for securites 
intended to sell or will be required to sell before the recovery 
of Amortized Cost.

2. Please provide name of security type in row 18 above 
(currently labeled 'other').  Please add additional rows if 
necessary.  If adding additional rows, please ensure that grand 
totals sum appropriately.

Actual Amortized 
Cost 
(MM/DD/YYYY)

CASSLC44

Total Allowance 
for Credit Loss 
(MM/DD/YYYY)

CASSLC14

Projected  Expected credit 
Amortized Cost loss before 
applying the fair 
1
value floor
CPSSLC46
CPSSLC44

Provision for 
Credit Loss
CPSSLC45

FR Y‐14A Schedule A.3.g ‐ Expected Credit Loss and Provision for Credit Loss ‐‐ AFS securities

PQ2

AFS Securities

CCARP084
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestric Non‐Agency RMBS
Foreign RMBS
Municipal Bond
Mutual Fund
Sovereign Bond
US Treasuries & Agencies
2
18 Other
19 Grand Total
Note
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17

1. Please do not include Expected lifetime loss for securites 
intended to sell or will be required to sell before the recovery 
of Amortized Cost.

2. Please provide name of security type in row 18 above 
(currently labeled 'other').  Please add additional rows if 
necessary.  If adding additional rows, please ensure that grand 
totals sum appropriately.

Projected  Expected credit 
Amortized Cost loss before 
applying the fair  Provision for 
1
Credit Loss
value floor
CPSSLC46
CPSSLC45
CPSSLC44

PQ3

Projected  Expected credit 
Amortized Cost loss before 
applying the 
Provision for 
1
fair value floor Credit Loss
CPSSLC46
CPSSLC45
CPSSLC44

FR Y‐14A Schedule A.3.g ‐ Expected Credit Loss and Provision for Credit Loss ‐‐ AFS securities

PQ4

AFS Securities

CCARP084
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestric Non‐Agency RMBS
Foreign RMBS
Municipal Bond
Mutual Fund
Sovereign Bond
US Treasuries & Agencies
2
18 Other
19 Grand Total
Note
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17

1. Please do not include Expected lifetime loss for securites 
intended to sell or will be required to sell before the recovery 
of Amortized Cost.

2. Please provide name of security type in row 18 above 
(currently labeled 'other').  Please add additional rows if 
necessary.  If adding additional rows, please ensure that grand 
totals sum appropriately.

Projected  Expected credit 
Amortized Cost loss before 
applying the fair  Provision for 
1
Credit Loss
value floor
CPSSLC46
CPSSLC45
CPSSLC44

PQ5

Projected 
Amortized Cost

CPSSLC44

Expected credit 
loss before 
applying the 
Provision for 
1
fair value floor Credit Loss
CPSSLC46
CPSSLC45

FR Y‐14A Schedule A.3.g ‐ Expected Credit Loss and Provision for Credit Loss ‐‐ AFS securities

PQ6

AFS Securities

CCARP084
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestric Non‐Agency RMBS
Foreign RMBS
Municipal Bond
Mutual Fund
Sovereign Bond
US Treasuries & Agencies
2
18 Other
19 Grand Total
Note
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17

1. Please do not include Expected lifetime loss for securites 
intended to sell or will be required to sell before the recovery 
of Amortized Cost.

2. Please provide name of security type in row 18 above 
(currently labeled 'other').  Please add additional rows if 
necessary.  If adding additional rows, please ensure that grand 
totals sum appropriately.

Projected  Expected credit 
Amortized Cost loss before 
applying the fair  Provision for 
1
Credit Loss
value floor
CPSSLC46
CPSSLC45
CPSSLC44

PQ7

Projected  Expected credit 
Amortized Cost loss before 
applying the fair  Provision for 
1
value floor
Credit Loss
CPSSLC46
CPSSLC45
CPSSLC44

FR Y‐14A Schedule A.3.g ‐ Expected Credit Loss and Provision for Credit Loss ‐‐ AFS securities

PQ8

AFS Securities

CCARP084
Agency MBS
Auction Rate Securities
CDO
CLO
CMBS
Auto ABS
Credit Card ABS
Student Loan ABS
Other ABS (excl HEL ABS)
Corporate Bond
Covered Bond
Domestric Non‐Agency RMBS
Foreign RMBS
Municipal Bond
Mutual Fund
Sovereign Bond
US Treasuries & Agencies
2
18 Other
19 Grand Total
Note
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17

1. Please do not include Expected lifetime loss for securites 
intended to sell or will be required to sell before the recovery 
of Amortized Cost.

2. Please provide name of security type in row 18 above 
(currently labeled 'other').  Please add additional rows if 
necessary.  If adding additional rows, please ensure that grand 
totals sum appropriately.

Expected 
credit loss 
Projected  before 
Amortized Cost applying the 
fair value 
1
floor
CPSSLC46
CPSSLC44

PQ9

Provision for 
Credit Loss
CPSSLC45

Projected  Expected credit 
Amortized Cost loss before 
applying the fair  Provision for 
1
value floor
Credit Loss
CPSSLC46
CPSSLC45
CPSSLC44

FR Y‐14A Schedule A.4 ‐ Trading

P/L Results in $Millions
(report profits as positive values and losses as negative values)
1 Equity
1A
Delta/Gamma
1B
Vega
1C
Dividends
1D
Correlation
1E
Vanna (dVega / dSpot )
1F
Volgamma (dVega / dVol )
1G
Skew (moneyness)
1H
Higher order
1I
Other (Please describe in documentation)

CPSSLD42
CPSSLD43
CPSSLD44
CPSSLD45
CPSSLD46
CPSSLD47
CPSSLD48
CPSSLD49
CPSSLD50
CPSSLD51

2 FX
2A
Delta/Gamma
2B
Vega
2C
Higher order
2D
Other (Please describe in documentation)

CPSSLD52
CPSSLD53
CPSSLD54
CPSSLD55
CPSSLD56

3 Rates
3A
Delta/Gamma
3B
Vega
3C
Swap Spreads
3D
Basis Spreads
3E
Cross Currency Basis
3F
Inflation
3G
Higher order

CPSSLD57
CPSSLD58
CPSSLD59
CPSSLD60
CPSSLD61
CPSSLD62
CPSSLD63
CPSSLD64

(A)

(B)

(C)  

Trading

CVA Hedges

Total

FR Y‐14A Schedule A.4 ‐ Trading

Other (Please describe in documentation)

CPSSLD65

4 Commodities
4A
Oil Products
4B
Natural Gas
4C
Power
4D
Emissions
4E
Coal
4F
Dry Freight
4G
Structured Products
4H
Precious Metals
4I
Base Metals
4J
Ags & Softs
4K
Indices
4L
Higher order
4M
Other (Please describe in documentation)

CPSSLD66
CPSSLD67
CPSSLD68
CPSSLD69
CPSSLD70
CPSSLD71
CPSSLD72
CPSSLD73
CPSSLD74
CPSSLD75
CPSSLD76
CPSSLD77
CPSSLD78
CPSSLD79

3H

5 Securitized Products
Non‐Agency RMBS (exclude Whole Loans)
5A
5B
Residential Whole Loans
5C
ABS
5D
CMBS (exclude Whole Loans)
5E
CRE Whole Loans
5F
Corporate CDO/CLO
5G
Warehouse
5H
Agencies
5I
Higher order
5J
Other (Please describe in documentation)

CPSSLD80
CPSSLD81
CPSSLD82
CPSSLD83
CPSSLD84
CPSSLD85
CPSSLD86
CPSSLD87
CPSSLD88
CPSSLD89
CPSSLD90

(A)
Trading

(B)
CVA Hedges

(C)  
Total

FR Y‐14A Schedule A.4 ‐ Trading

6

Other Credit

CPSSLD91

7
7A
7B
7C
7D
7E
7F
7G
7H
7I

Corporate Credit (Advanced)
Bonds
Loans
Single‐Name CDS
Loan CDS
Covered Bonds
Indices
Index Tranches
Index Options
Other/Unspecified

CPSSLD92
CPSSLD93
CPSSLD94
CPSSLD95
CPSSLD96
CPSSLD97
CPSSLD98
CPSSLD99
CPSSLE00
CPSSLE01

8
8A
8B
8C
8D
8E
8F
8G
8H
8I

Corporate Credit (Emerging Markets)
Bonds
Loans
Single‐Name CDS
Loan CDS
Covered Bonds
Indices
Index Tranches
Index Options
Other/Unspecified

CPSSLE02
CPSSLE03
CPSSLE04
CPSSLE05
CPSSLE06
CPSSLE07
CPSSLE08
CPSSLE09
CPSSLE10
CPSSLE11

9
9A
9B
9C

Sovereign Credit
Advanced Economies
Emerging Europe
LatAm & Caribbean

CPSSLE12
CPSSLE13
CPSSLE14
CPSSLE15

(A)

(B)

(C)  

Trading

CVA Hedges

Total

FR Y‐14A Schedule A.4 ‐ Trading
9D
9E
9F
9G

Asia ex Japan
Middle East/North Africa
Sub‐Saharan Africa
Supranationals

CPSSLE16
CPSSLE17
CPSSLE18
CPSSLE19

Munis
ARS
Base Correlation
Higher order
Other (Please describe in documentation)

CPSSLE20
CPSSLE21
CPSSLE22
CPSSLE23
CPSSLE24

15 Private Equity
15A
Funded
15B
Unfunded
15C
Other (Please describe in documentation)

CPSSLE25
CPSSLE26
CPSSLE27
CPSSLE28

10
11
12
13
14

16 Other Fair Value Assets
Debt
16A
16B
Equity
16C
Other (Please describe in documentation)

CPSSLE29
CPSSLE30
CPSSLE31
CPSSLE32

17

Cross Asset Terms

CPSSLE33

18

 TOTAL

CPSSLE34

(A)
Trading

(B)
CVA Hedges

(C)  
Total

FR Y‐14A Schedule A.5 ‐ Counterparty Credit Risk

$Millions
Losses should be reported as a positive value.

1 Trading Issuer Default Losses
1a
Trading Issuer Default losses from securitized products
1b
Trading Issuer Default losses from other credit sensitive instruments

CPSSN989
CPSSN990
CPSSN991

                            ‐

2 Counterparty Credit MTM Losses (CVA losses)
2a
Counterparty CVA losses
2b
Offline reserve CVA losses

CPSSN992
CPSSN993
CPSSN994

                            ‐

3 Counterparty Default Losses
3a
Impact of Counterparty Default hedges

CPSSN995
CPSSN996

4 Other Counterparty Losses

CPSSN997

5 Funding Valuation Adjustment (FVA) 

  CPSSJA24

FR Y‐14A Schedule A.6 ‐ Operational Risk Scenario Inputs and Projections

Risk Segment
CPSSN962

Contribution 
($millions)
PQ 1

Total ($millions) $                              ‐
Note: Please add more rows if needed.

PY 1
PQ 2

$                  ‐

PQ 3

$                  ‐

Total
($millions)

PY 2
PQ 4

$                  ‐

PQ 5
CPSNQ945

$                  ‐

PQ 6

$                  ‐

PQ 7

$                  ‐

PQ 8

$                  ‐

PQ 9

$                  ‐

$                  ‐
$                  ‐
$                  ‐
$                  ‐
$                       ‐

FR Y‐14A Schedule A.7.a ‐ PPNR Projections
Please indicate if deposits are 25% or more of total liabilities
Net Interest Income Designation Field ‐ Populated Automatically
Projected in $Millions

FR Y9C Codes
PQ 1

PQ 2

PQ 3

PQ 4

PQ 5

PQ 6

PQ 7

PQ 8

PQ 9

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

Net Interest Income by Business Segment: (17)
1
1A
1B
1C

Retail and Small Business
Domestic (11)
Credit and Charge Cards (10)
Mortgages

1D
1E
1F
1G
2
3
4
5
5A
5B
6
7
8
9
10
11
12

Home Equity
Retail and Small Business Deposits
Other Retail and Small Business Lending
International Retail and Small Business (16)
Commercial Lending
Investment Banking
Merchant Banking / Private Equity
Sales and Trading
Prime Brokerage
Other
Investment Management
Investment Services
Treasury Services
Insurance Services
Retirement / Corporate Benefits Products
Corporate / Other
Optional Immaterial Business Segments (7)

CPSNQ159
CPSNQ160
CPSNQ161
CPSNQ162
CPSNQ163
CPSNQ164
CPSNQ165
CPSNQ166
CPSNQ167
CPSNQ168
CPSNQ169
CPSNQ170
CPSNQ171
CPSNQ172
CPSNQ173
CPSNQ174
CPSNQ175
CPSNQ176
CPSNQ177
CPSNQ178
CPSNQ179

13

Total Net Interest Income (1)

CPSN4074

FR Y‐14A Schedule A.7.a ‐ PPNR Projections
Projected in $Millions

FR Y9C Codes

14
14A
14B
14C
14D
14E
14F
14G
14H
14I
14J
14K

14L
14M
14N
14O
14P
14Q
14R
14S
14T
15
16
16A
16B
16C
16D
17
17A
17B
17C

Non Interest Income by Business Segment: (17)
Retail and Small Business
Domestic
Credit and Charge Cards (10)
Credit and Charge Card Interchange Revenues ‐ Gross 
Other
Mortgages and Home Equity
Production
Gains/(Losses) on Sale (18)
Other
Servicing
Servicing & Ancillary Fees  
MSR Amortization (20)

CPSNQ180
CPSNQ181
CPSNQ182
CPSNQ183
CPSNQ184
CPSNQ185
CPSNQ186
CPSNQ187
CPSNQ188
CPSNQ189
CPSNQ190
CPSNQ191

MSR Value Changes due to Changes in Assumptions/Model Inputs/Other 
Net of Hedge Performance (19)(21)

CPSNQ192

Other

CPSNQ193

Provisions to Repurchase Reserve / Liability for Residential Mortgage 
Representations and Warranties (contra‐revenue) (12)
Retail and Small Business Deposits
Non Sufficient  Funds / Overdraft Fees ‐ Gross
Debit Interchange ‐ Gross
Other (22)
Other Retail and Small Business Lending
International Retail and Small Business (16)
Commercial Lending
Investment Banking
Advisory
Equity Capital Markets
Debt Capital Markets
Syndicated / Corporate Lending
Merchant Banking / Private Equity
Net Investment Mark‐to‐Market 
Management Fees
Other

PQ 1

PQ 2

PQ 3

PQ 4

PQ 5

PQ 6

PQ 7

PQ 8

PQ 9

             ‐
             ‐
             ‐

             ‐
             ‐
             ‐

             ‐
             ‐
             ‐

             ‐
             ‐
             ‐

             ‐
             ‐
             ‐

             ‐
             ‐
             ‐

             ‐
             ‐
             ‐

             ‐
             ‐
             ‐

             ‐
             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

CPSNQ194
CPSNQ195
CPSNQ196
CPSNQ197
CPSNQ198
CPSNQ199
CPSNQ200
CPSNQ201
CPSNQ202
CPSNQ203
CPSNQ204
CPSNQ205
CPSNQ206
CPSNQ207
CPSNQ208
CPSNQ209
CPSNQ210

FR Y‐14A Schedule A.7.a ‐ PPNR Projections
Projected in $Millions

FR Y9C Codes
PQ 1

PQ 2

PQ 3

PQ 4

PQ 5

PQ 6

PQ 7

PQ 8

PQ 9

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

             ‐
             ‐

18
18A
18B
18C
18D
18E
18F
18G
18H
18I
18J
18K
18L
18M
19
19A
19B
20
20A
20B
20C
20D
20E
21
22
23
24
25

Sales and Trading
Equities
Commission and Fees
Other (23)
Fixed Income
Rates
Credit
Other
Commodities
Commission and Fees
Other
Prime Brokerage
Commission and Fees
Other
Investment Management
Asset Management
Wealth Management / Private Banking
Investment Services
Asset Servicing
Securities Lending
Other
Issuer Services
Other
Treasury Services
Insurance Services
Retirement / Corporate Benefits Products
Corporate / Other
Optional Immaterial Business Segments (7)

CPSNQ211
CPSNQ212
CPSNQ213
CPSNQ214
CPSNQ215
CPSNQ216
CPSNQ217
CPSNQ218
CPSNQ219
CPSNQ220
CPSNQ221
CPSNQ222
CPSNQ223
CPSNQ224
CPSNQ225
CPSNQ226
CPSNQ227
CPSNQ228
CPSNQ229
CPSNQ230
CPSNQ231
CPSNQ232
CPSNQ233
CPSNQ234
CPSNQ235
CPSNQ236
CPSNQ237
CPSNQ238

26

Total Non‐Interest Income (2) (26)

CPSN4079

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

27

Total Revenues

CPSNQ239

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

FR Y‐14A Schedule A.7.a ‐ PPNR Projections
Projected in $Millions

FR Y9C Codes

36
37

Non Interest Expense:
Compensation Expense
Salary (14)
Benefits (14)
Commissions (6)
Stock Based Compensation 
Cash Variable Pay
Operational Risk Expense (8)
Provisions to Repurchase Reserve / Liability for Residential Mortgage 
Representations and Warranties (12)
Professional and Outside Services Expenses (13)
Expenses of Premises and Fixed Assets
Amortization Expense and Impairment Losses for Other Intangible Assets
Marketing Expense
Domestic Credit and Charge Card Marketing Expense (10)(15)(17) 
Other
Other Real Estate Owned Expense
Provision for Unfunded Off‐Balance Sheet Credit Exposures (to build/decrease 
item 141 (BHCKB557) in Balance Sheet)
Other Non‐Interest Expense (4)

38

Total Non‐Interest Expense (3)

28
28A
28B
28C
28D
28E
29
30
31
32
33
34
34A
34B
35

39

Projected PPNR (5)

40
41
42

Valuation Adjustment for firm's own debt under fair value option (FVO) (9) (27)
Goodwill Impairment
Loss resulting from trading shock exercise (if applicable) (24) (25)

PQ 1

PQ 2

PQ 3

PQ 4

PQ 5

PQ 6

PQ 7

PQ 8

PQ 9

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

CPSNP630

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

BHCK4074‐
BHCK4079‐
BHCK4093+B CPSNP631
HCKC216‐
Line Item 40

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

CPSNQ240
CPSNQ241
CPSNQ242
CPSNQ243
CPSNQ244
CPSNQ245
CPSNQ246
CPSNQ247
BHCK4217
BHCKC232

CPSNQ248
CPSN4217
CPSNC232
CPSNQ249
CPSNQ250
CPSNQ251
CPSNQ252
CPSNQ253
CPSNQ254

BHCKC216

CPSNQ255
CPSNC216
CPSNQ256

FR Y‐14A Schedule A.7.a ‐ PPNR Projections
Projected in $Millions

FR Y9C Codes
PQ 1

PQ 2

PQ 3

Footnotes to the PPNR Projections Worksheet
(1)
Amount should equal item 49 of the PPNR NII Worksheet, if completed. 
(2)
Excludes Valuation Adjustment for firm's own debt under fair value option (FVO) in item 40. 
(3)
Excludes Goodwill Impairment included in item 41.
(4)
Provide a further break out of significant items included in Other Non‐Interest Expense such that no more than 5% of Non 
Interest Expense are reported without further breakout:
CPSNQ947
CPSNQ949
CPSNQ951
CPSNQ953
CPSNQ955
CPSNQ957
CPSNQ959
CPSNQ961
CPSNQ963
CPSNQ965
CPSNQ967

(5)
(6)
(7)

CPSNQ948
CPSNQ950
CPSNQ952
CPSNQ954
CPSNQ956
CPSNQ958
CPSNQ960
CPSNQ962
CPSNQ964
CPSNQ966
CPSNQ968

By definition, PPNR will calculate as Net Interest Income plus Non‐Interest Income less Non‐Interest Expense, excluding items broken out in items40‐41. 
Report commissions only in "Commissions" line item 28C; do not report commissions in any other compensation line items
See instructions for guidance on related thresholds. List segments included in this line item
CPSNQ969

(8)

All operational loss items, including operational losses that are contra revenue amounts or cannot be separately identified, 
should be reported in the operational risk expense.  Any legal consultation or retainer fees specifically linked to an operational 
risk event should be included in the Operational Risk Expense. Include all Provisions to Litigation Reserves  / Liability for Claims 
related to Sold Residential Mortgages and all Litigation Settlements & Penalties in this line item and not any other items.

(9)

List segments from which item was excluded:
CPSNQ970

(10)
(11)
(12)

Include domestic BHC/IHC/SLHC issued credit and charge cards including  those that result from a partnership agreement.
Applies to line items 1A‐1F; US and Puerto Rico only.  
Provisions to build any non‐litigation reserves/accrued liabilities that have been established for losses related to sold or 
government‐insured residential mortgage loans (first or second lien).  Do not report such provisions in any other items; report 
them only in line items 14N or 30, as applicable.

(13)

Include routine legal expenses (i.e legal expenses not related to operational losses) here.  

(14)
(15)

Do not report stock based and cash variable pay compensation here.
Include both direct and allocated expenses.  Report any expenses that are made to expand the company’s card member and/or merchant base, 
facilitate greater segment penetration, enhance the perception of the company’s credit card brand, and/or increase the utilization of the existing card 
member base across the spectrum of marketing and advertising mediums.

PQ 4

PQ 5

PQ 6

PQ 7

PQ 8

PQ 9

FR Y‐14A Schedule A.7.a ‐ PPNR Projections
Projected in $Millions

FR Y9C Codes
PQ 1

PQ 2

PQ 3

(16)
(17)
(18)

Revenues from regions outside the US and Puerto Rico.
See Instructions for description of standardized Business Segments/Lines. Unless specified otherwise, all numbers are global
Gains/(Losses) from the sale of mortgages and home equity originated through all production channels (retail, broker, correspondent, etc.) with the 
intent to sell.  Such gains/losses should include deferred fees and costs that are reported as adjustments to the carrying balance of the sold loan, fair 
value changes on loan commitments with rate locks that are accounted for as derivatives, fair value changes on mortgage loans held‐for‐sale 
designated for fair value treatment, lower‐of‐cost or market adjustments on mortgage loans held‐for‐sale not designated for fair value treatment, fair 
value changes on derivative instruments used to hedge loan commitments and held‐of‐sale mortgages, and value associated with the initial 
capitalization of the MSR upon sale of the loan.

(19)
(20)
(21)
(22)

Report changes in the MSR value here and not in any other items.  Report changes in the MSR hedges here and not in any other items
Include economic amortization or scheduled and unscheduled payments, net of defaults under both FV and LOCOM accounting methods
Include MSR changes under both FV and LOCOM accounting methods.
Among items included here are debit card contra‐revenues and overdraft waivers, as applicable. 

(23)

Report all Non‐Interest Income for Equities Sales and Trading, excluding Prime Brokerage (to be reported as a separate line item) and excluding 
Commissions and Fees.  This includes trading profits and other non‐interest non‐commission income.

(24)
(25)

Respondents should not report changes in value of the MSR asset or hedges within the trading book
List segments from which item was excluded:
CPSNQ971

(26)
(27)

Exclude result of trading shock exercise (where applicable), as it is reported in item 42.
List FR Y‐9C HI Schedule items in which this item is normally reported although excluded from PPNR for this report
CPSNQ972

PQ 4

PQ 5

PQ 6

PQ 7

PQ 8

PQ 9

FR Y‐14A Schedule A.7.b ‐ PPNR Net Interest Income
Please indicate if deposits are 25% or more of total liabilities
Net Interest Income Designation Field ‐ Populated Automatically

1
2
2A
2B
3
4
5
6
6A
6B
6C

AverageAsset Balances ($Millions) (1)
First Lien Residential Mortgages (in Domestic Offices)
Second / Junior Lien Residential Mortgages (in Domestic Offices)
Closed‐End Junior Liens
Home Equity Lines Of Credit (HELOCs)
C&I Loans (7)
CRE Loans (in Domestic Offices)
Credit Cards
Other Consumer
Auto Loans
Student Loans
Other, incl. loans backed by securities (non‐purpose lending)

CPSNP975
CPSNP976
CPSNP977
CPSNP978
CPSNP979
CPSNP980
CPSNP981
CPSNP982
CPSNP983
CPSNP984

Projected in $Millions
PQ 4
PQ 5
PQ 6

PQ 1

PQ 2

PQ 3

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

PQ 7

PQ 8

PQ 9

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

CPSNP985

7

Real Estate Loans (Not in Domestic Offices)

CPSNP986

7A
7B
8
9
10
11
12
13
14
15
16

Residential Mortgages (First and Second Lien)
Other
Other Loans & Leases (10)
Nonaccrual Loans (5)
Securities (AFS and HTM) ‐ Treasuries and Agency Debentures
Securities (AFS and HTM) ‐ Agency RMBS (both CMOs and pass‐throughs)
Securities (AFS and HTM) ‐ Other
Trading Assets
Deposits with Banks & Other 
Other Interest/Dividend Bearing Assets (2)
Other Assets

CPSNP987
CPSNP988
CPSNP989
CPSNP990
CPSNP991
CPSNP992
CPSNP993
CPSNP994
CPSNP995
CPSNP996
CPSNP997

17

Total Average Asset Balances

CPSNP998

FR Y‐14A Schedule A.7.b ‐ PPNR Net Interest Income

18
19
19A
19B
20
21
22
23
23A
23B
23C
24
24A
24B
25
26
27
28
29
30
31
32

Average Rates Earned (%) (9)
First Lien Residential Mortgages (in Domestic Offices)
Second / Junior Lien Residential Mortgages (in Domestic Offices)
Closed‐End Junior Liens
HELOCs
C&I Loans (7)
CRE Loans (in Domestic Offices)
Credit Cards
Other Consumer
Auto Loans
Student Loans
Other, incl. loans backed by securities (non‐purpose lending
Real Estate Loans (Not in Domestic Offices)
Residential Mortgages (First and Second Lien)
Other
Other Loans & Leases 
Nonaccrual Loans (5)
Securities (AFS and HTM) ‐ Treasuries and Agency Debentures
Securities (AFS and HTM) ‐ Agency RMBS (both CMOs and pass‐throughs)
Securities (AFS and HTM) ‐ Other
Trading Assets
Deposits with Banks & Other 
Other Interest/Dividend Bearing Assets

CPSNP999
               ‐
CPSNQ002
CPSNQ003
CPSNQ004
CPSNQ005
CPSNQ006
               ‐
CPSNQ008
CPSNQ009
CPSNQ010
               ‐
CPSNQ012
CPSNQ013
CPSNQ014
CPSNQ015
CPSNQ016
CPSNQ017
CPSNQ018
CPSNQ019
CPSNQ020
CPSNQ021

33

Total Interest Income 

CPSNQ022

PQ 1

PQ 2

PQ 3

            ‐

            ‐

            ‐

Projected in $Millions
PQ 4
PQ 5
PQ 6

            ‐

            ‐

            ‐

PQ 7

PQ 8

PQ 9

            ‐

            ‐

            ‐

FR Y‐14A Schedule A.7.b ‐ PPNR Net Interest Income

34
34A
34B
34C
34D
34E
35
35A
35B
36
36A
36B
36C
37
38

Average Liability Balances ($Millions)
Deposits‐Domestic (6)
Non‐Interest‐Bearing Demand
Money Market Accounts
Savings
NOW, ATS, and other Transaction Accounts
Time Deposits
Deposits‐Foreign (6)
Foreign Deposits
Foreign Deposits‐Time
Fed Funds, Repos, & Other Short Term Borrowing
Fed Funds
Repos
Other Short Term Borrowing (11)
Trading Liabilities

CPSNQ023
CPSNQ024
CPSNQ025
CPSNQ026
CPSNQ027
CPSNQ028
CPSNQ029
CPSNQ030
CPSNQ031
CPSNQ032
CPSNQ033
CPSNQ034
CPSNQ035
CPSNQ036
CPSNQ037

39
40

Subordinated Notes Payable to Unconsolidated Trusts Issuing Trust Preferred 
Securities (TruPS) and TruPS Issued by Consolidated Special Purpose Entities
Other Interest‐Bearing Liabilities (3)(11)
Other Liabilities (11)

CPSNQ038
CPSNQ039

41

Total Average Liability Balances

CPSNQ040

Projected in $Millions
PQ 4
PQ 5
PQ 6

PQ 1

PQ 2

PQ 3

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

PQ 7

PQ 8

PQ 9

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

FR Y‐14A Schedule A.7.b ‐ PPNR Net Interest Income

PQ 1

PQ 2

PQ 3

Projected in $Millions
PQ 4
PQ 5
PQ 6

PQ 7

PQ 8

PQ 9

47

Average Liability Rates (%) (9)
Deposits‐Domestic (6)
Non‐Interest‐Bearing Demand (8)
Money Market Accounts
Savings
Negotiable Order of Withdrawal (NOW), Automatic Transfer Service (ATS), and 
other Transaction Accounts
Time Deposits
Deposits‐Foreign (6)
Foreign Deposits
Foreign Deposits‐Time
Fed Funds, Repos, & Other Short Term Borrowing
Fed Funds
Repos
Other Short Term Borrowing
Trading Liabilities
Subordinated Notes Payable to Unconsolidated Trusts Issuing TruPS and TruPS 
Issued by Consolidated Special Purpose Entities
Other Interest‐Bearing Liabilities (3)(11)

48

Total Interest Expense 

CPSNQ057

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

49

Total Net Interest Income (4)

CPSS4074

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

            ‐

42
42A
42B
42C
42D
42E
43
43A
43B
44
44A
44B
44C
45
46

0.0%
CPSNQ042
CPSNQ043
CPSNQ044

0.0%

0.0%

0.0%

0.0%

0.0%

0.0%

0.0%

0.0%

0.0%

CPSNQ045
CPSNQ046
0.0%
CPSNQ048
CPSNQ049
0.0%
CPSNQ051
CPSNQ052
CPSNQ053
CPSNQ054
CPSNQ055
CPSNQ056

FR Y‐14A Schedule A.7.b ‐ PPNR Net Interest Income

PQ 1

PQ 2

PQ 3

Projected in $Millions
PQ 4
PQ 5
PQ 6

PQ 7

PQ 8

Footnotes to the Net Interest Income Worksheet
Exclude nonaccrual loans from lines 1‐8, reporting these balances in item 9. Include purchased credit impaired loans. 
(1)
(2)
CPSNQ973
CPSNQ975
CPSNQ977
CPSNQ979
CPSNQ981

Break out and explain nature of significant items included in Other Interest/Dividend Bearing Assets such that no more than 5% of total Average Asset Balances are reported without a further breakout.
CPSNQ974
CPSNQ976
CPSNQ978
CPSNQ980
CPSNQ982

(4)

Break out and explain nature of significant items included in All Other Interest Bearing Liabilities Balances such that no more than 5% of total Liability Balances are reported without a further breakout.
CPSNQ984
CPSNQ986
CPSNQ988
CPSNQ990
CPSNQ992
Amount should equal item 13 of the PPNR Projections Worksheet.

(5)
(6)
(7)
(8)
(9)
(10)
(11)

Institutions are to provide additional details within the supporting documentation; the composition of the non‐accrual loans by key loan type over the reported time periods for each of the scenarios.
A sum of average domestic and foreign deposits should be equal to a sum of average BHDM6631, BHDM6636, BHFN6631, and BHFN6636.
Report C&I Graded, Small Business (Scored/Delinquency Managed), Corporate Card, Business Card
Rates are equal to zero by definition
All rates are annualized.
Include loans secured by farmland here (BHDM1420) and other loans not accounted for in the other categories
Sum of line items 36C and 39 equals sum of BHCK3190, BHCK4062, and interest‐bearing liabilities reported in BHCK2750; item 40 captures non‐interest bearing liabilities in BHCK2750

(3)
CPSNQ983
CPSNQ985
CPSNQ987
CPSNQ989
CPSNQ991

PQ 9

FR Y‐14A Schedule A.7.c ‐ PPNR Metrics

FR Y9C Codes

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34

A. Metrics by Business Segment/Lin e (9)
Retail and Small Business Segment
Domestic (22)
Credit and Charge Cards
Total Open Accounts  –  End of Period
Credit and Charge Card Purchase Volume
Credit and Charge Card Rewards/Partner Sharing Expense (21) (32)
Mortgages and Home Equity
Average Third‐Party Residential Mortgages Serviced (3)
Residential Mortgage Originations Industry Market Size –  Volume (23)
Mortgages and Home Equity Sold during the quarter (24)
Servicing Expenses (8)
Retail and Small Business Deposits
Total Open Checking and Money Market Accounts  –  End of Period (29)
Debit Card Purchase Transactions
International Retail and Small Business (12)
Credit Card Revenues (1)
Investment Banking Segment
Number of Employees (15)
Compensation ‐ Total (8)
Stock Based Compensation and Cash Variable Pay (8)
Advisory
Deal Volume
Industry Market Size ‐ Fees
Industry Market Size ‐ Completed Deal Volume
Backlog (28)
Equity Capital Markets
Deal Volume
Industry Market Size ‐ Fees
Industry Market Size ‐ Volume
Debt Capital Markets
Deal Volume
Industry Market Size ‐ Fees
Industry Market Size ‐ Volume
Syndicated Lending
Deal Volume
Industry Market Size ‐ Fees
Industry Market Size ‐ Volume
Sales and Trading Segment
Number of Employees (15)
Compensation ‐ Total (8)
Stock Based Compensation and Cash Variable Pay (8)
Equities
Average Asset Balance
Fixed Income
Average Asset Balance
Commodities
Average Asset Balance
Prime Brokerage
Average Client Balances (13)
Transaction Volume

PQ 1

Units

#
$Millions
$Millions

CPSNQ058
CPSNQ059
CPSNQ060

$Millions
$Millions

CPSNQ061
CPSNQ062

BHCKF070+BHCKF
071+BHDMF674+ 
BHDMF675
$Millions

$Millions

CPSNQ063
CPSNQ064

#
#

CPSNQ065
CPSNQ066

$Millions

CPSNQ067

#
$Millions
$Millions

CPSNQ068
CPSNQ069
CPSNQ070

$Millions
$Millions
$Millions
$Millions

CPSNQ071
CPSNQ072
CPSNQ073
               ‐

$Millions
$Millions
$Millions

CPSNQ075
CPSNQ076
CPSNQ077

$Millions
$Millions
$Millions

CPSNQ078
CPSNQ079
CPSNQ080

$Millions
$Millions
$Millions

CPSNQ081
CPSNQ082
CPSNQ083

#
$Millions
$Millions

CPSNQ085
CPSNQ087
CPSNQ088

$Millions

CPSNQ089

$Millions

CPSNQ090

$Millions

CPSNQ091

$Millions
$Millions

CPSNQ092
CPSNQ093

PQ 2

PQ 3

PQ 4

Projected
PQ 5

PQ 6

PQ 7

PQ 8

PQ 9

FR Y‐14A Schedule A.7.c ‐ PPNR Metrics

FR Y9C Codes

40

Investment Management Segment
Asset Management
AUM ‐ Total (10)
AUM ‐ Equities
AUM ‐ Fixed Income
AUM ‐ Other
Net Inflows/Outflows
Wealth Management/Private Banking
Fee Earning Client Assets ‐ Total (10)
Fee Earning Client Assets ‐ Equities
Fee Earning Client Assets ‐ Fixed Income
Fee Earning Client Assets ‐ Other
Net Inflows/Outflows
Number of Financial Advisors  (11)
Investment Services Segment 
Asset Servicing
Assets under Custody and Administration

41
42
42A
42B
42C
42D
43
44
45
45A
45B
46
46A
46B
46C
47

B. Firm Wide Metrics: PPNR Projections Worksheet
Number of Employees
Revenues ‐ International
Revenues ‐ APAC (2) (16)
Revenues ‐ EMEA (2) (17)
Revenues ‐ LatAm (2) (18)
Revenues ‐ Canada (2)
Revenues ‐ Domestic 
Severance Costs (14)
Collateral Underlying Operating Leases for Which the Bank is the Lessor (20)
Auto
Other
OREO Balance
Commercial
Residential
Farmland
Non‐Recurring PPNR Items (30)

35
35A
35B
35C
36
37
37A
37B
37C
38
39

48
49

Trading Revenue
Net Gains/(Losses) on Sales of Other Real Estate Owned (19)

BHCK4150

BHCK2150

BHCKA220
BHCK8561

Units

PQ 1

PQ 2

PQ 3

PQ 4

Projected
PQ 5

PQ 6

PQ 7

PQ 8

PQ 9

$Millions
$Millions
$Millions
$Millions
$Millions

CPSNQ094
CPSNQ095
CPSNQ096
CPSNQ097
CPSNQ098

               ‐

              ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

$Millions
$Millions
$Millions
$Millions
$Millions
#

CPSNQ099
CPSNQ100
CPSNQ101
CPSNQ102
CPSNQ103
CPSNQ104

               ‐

              ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

$Millions

CPSNQ105

#
$Millions
$Millions
$Millions
$Millions
$Millions
$Millions
$Millions
$Millions
$Millions
$Millions
$Millions
$Millions
$Millions
$Millions
$Millions

CPSN4150
CPSNQ107
CPSNQ108
CPSNQ109
CPSNQ110
CPSNQ111
CPSNQ112
CPSNQ113
CPSNQ114
CPSNQ115
CPSNQ116
CPSN2150
CPSNQ117
CPSNQ118
CPSNQ119
CPSNQ120

               ‐

              ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

               ‐

              ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

             ‐

               ‐
               ‐
               ‐
               ‐
               ‐
               ‐
               ‐

              ‐
              ‐
              ‐
              ‐
              ‐
              ‐
              ‐

             ‐
             ‐
             ‐
             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐
             ‐
             ‐
             ‐

             ‐
             ‐
             ‐
             ‐
             ‐
             ‐
             ‐

$Millions
$Millions

CPSNA220
CPSN8561

FR Y‐14A Schedule A.7.c ‐ PPNR Metrics

FR Y9C Codes

PQ 1

Units

50
51
52
53

C. Firm Wide Metrics: Net Interest Income Worksheet (Required only for respondents that were required to complete the Net Interest Income Worksheet)
Carrying Value of Purchased Credit Impaired (PCI) Loans (33)
BHCKC780
$Millions
CPSNC780
Net Accretion of discount on PCI Loans included in interest Revenues (34)
$Millions
CPSNQ121
$Millions
CPSNQ122
Loans Held for Sale ‐ First Lien Residential Liens in Domestic Offices (Average Balances)
%
CPSNQ123
Average Rate on Loans Held for Sale‐First Lien Residential Liens in Domestic Offices

54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70

Quarter End Weighted Average Life of Assets (4) (6)
First Lien Residential Mortgages (in Domestic Offices) (31)
Closed‐End Junior Residential Liens (in Domestic Offices)
Home Equity Lines Of Credit (HELOCs)
C&I Loans
CRE Loans (in Domestic Offices)
Credit Cards
Auto Loans
Student Loans
Other, incl. loans backed by securities (non‐purpose lending) (7)
Residential Mortgages (First and Second Lien, Not in Domestic Offices)
Other Real Estate Loans (Not in Domestic Offices)
Other Loans & Leases
Securities (AFS and HTM) ‐ Treasuries and Agency Debentures
Securities (AFS and HTM) ‐ Agency RMBS (both CMOs and pass‐throughs)
Securities (AFS and HTM) ‐ Other
Trading Assets
All Other Earning Assets

71
72
73
74
75
76
77
78

Quarter End Weighted Average Life of Liabilities (4) (6)
Domestic Deposits ‐ Time
Foreign Deposits‐Time
Fed Funds 
Repos
Other Short Term Borrowing
Trading Liabilities
Subordinated Notes Payable to Unconsolidated Trusts Issuing TruPS and TruPS Issued by 
Consolidated Special Purpose Entities
All Other Interest Bearing Liabitilies

months
months
months
months
months
months
months
months
months
months
months
months
months
months
months
months
months

CPSNQ124
CPSNQ125
CPSNQ126
CPSNQ127
CPSNQ128
CPSNQ129
CPSNQ130
CPSNQ131
CPSNQ132
CPSNQ133
CPSNQ134
CPSNQ135
CPSNQ136
CPSNQ137
CPSNQ138
CPSNQ139
CPSNQ140

months
months
months
months
months
months

CPSNQ141
CPSNQ142
CPSNQ143
CPSNQ144
CPSNQ145
CPSNQ146

months
months

CPSNQ147
CPSNQ148

PQ 2

PQ 3

PQ 4

Projected
PQ 5

PQ 6

PQ 7

PQ 8

PQ 9

FR Y‐14A Schedule A.7.c ‐ PPNR Metrics

FR Y9C Codes

PQ 1

Units

PQ 2

For 
For upward  downward 
rate 
rate 
movements movements

Average Domestic Deposit Repricing Beta in a 'Normal Environment' (5)

PQ 3

Assumed 
Floor

 CPSNQ149   CPSNQ933   CPSNQ939 

79

Money Market Accounts  

basis points
 CPSNQ150   CPSNQ934   CPSNQ940 

80

Savings

basis points
 CPSNQ151   CPSNQ935   CPSNQ941 

81

NOW, ATS, and other Transaction Accounts

basis points
 CPSNQ152   CPSNQ936   CPSNQ942 

82

Time Deposits

basis points
 CPSNQ153   CPSNQ937   CPSNQ943 

83

Average  Foreign Deposit Repricing Beta in a 'Normal Environment' (5)
Foreign Deposits

basis points
 CPSNQ154   CPSNQ938   CPSNQ944 

84
85
85A
85B
85C

Foreign Deposits‐Time
New Domestic Business Pricing for Time Deposits (25)
Curve (if multiple terms assumed) (26) 
Index rate  (if single term assumed)  (27)
Spread relative to the Index Rate (27)

basis points
               ‐
CPSNQ156

basis points

CPSNQ157
CPSNQ158

PQ 4

Projected
PQ 5

PQ 6

PQ 7

PQ 8

PQ 9

FR Y‐14A Schedule A.7.c ‐ PPNR Metrics

FR Y9C Codes

Units

PQ 1

PQ 2

PQ 3

Footnotes to the PPNR Metrics Worksheet
Provide metrics data for all quarters, but only if International Retail and Small Business Segment revenues exceeded 5% of Total Retail and Small Business Segment and Total Retail and Small 
Business revenue exceeded 5% of total revenues in any of the last four actual quarters requested in the PPNR schedule.  
Provide regional breakouts for all quarters but only if international revenue exceeded 5% of the total revenue in any of the last four actual quarters requested in the PPNR schedule
Average oustanding principal balance fo residential mortgage loans the BHC/IHC/SLHC services for others
The Weighted Average Life should reflect the current position, the impact of new business activity, as well as the impact of behavioral assumptions such as prepayments or defaults,  based 
on the expected remaining lives, inclusive of behavioral assumptions.  It should reflect the weighted average of time to principal actual repayment (as modeled) for all positions in that 
portfolio, rounded to the nearest monthly term.  For revolving products, the WAL should reflect the underlying repayment behavior assumptions assumed by the institution, which would 
include contractual repayments, any assumed excess payments or prepayments, and defaults.  The WAL for the FR Y‐14Q disclosures should reflect the spot balance sheet position for each 
time period.  For the FR Y‐14A, given that it covers forecasted time periods, the WAL should be forward‐looking which incorporates the changes to the projected WAL, including new 
business activity.

(1)
(2)
(3)
(4)

(5)

A rate movement in an environment where the repricing assumption assumed by each of the major deposit products is not restricted by a cap, floor, or zero.  Beta should be reported as a 
balance‐weighted average of the betas of the line items that contribute to the roll up point requested, with an as‐of date equal to the reporting date.

(6)
(7)
(8)
(9)

Reference PPNR Net Interest Income worksheet for product definitions
Corresponds to line item 7C on the Net Interest Income worksheet
Include both direct and allocated expenses.
"Metrics by Business Segment/Line" correspond to Business Segments/Lines on PPNR Submission worksheet, unless explicitly stated otherwise.   See Instructions for defintions of 
standardized Business Segments/Lines.  Unless specified otherwise, all numbers are global.   Only line items with "Industry Market Size" in the name are industry/market‐wide items; all 
other items are BHC/IHC‐specific.
Assets under Management
Provide a relevant headcount number (e.g. financial advisors, portfolio managers) to facilitate the assessment of revenue productivity in the Wealth Management/Private Banking business 
line.
Regions outside the US and Puerto Rico.
Report the grossed up "interest balances" that result from prime brokerage activities
List items on PPNR Projections worksheet that include this item if any

(10)
(11)
(12)
(13)
(14)
CPSNQ993

Full‐time equivalent employees at end of current period (BHCK4150) for a given segment only
Asia and Pacific region (incl. South Asia, Australia, and New Zealand)
Europe, Middle East, and Africa
Latin America, including Mexico
List Business Segments reported on PPNR Projections Worksheet that include this item if any

(15)
(16)
(17)
(18)
(19)
CPSNQ994
(20)

Refers to the balance sheet carrying amount of any equipment or other asset rented to others under operating leases, net of accumulated depreciation.  The total in 
line item 49 should correspond to the amount provided in Y‐9C Schedule HC‐F Line 6, item 13 in the instructions. The amount included should only reflect collateral 
rented under operating leases and not include collateral subject to capital/ financing type leases.

(21)

Credit cards (including charge cards).  List which line item(s) on PPNR Submission worksheet contain(s) the Cards Rewards/Partner Sharing contra‐revenues and/or 
expenses.
CPSNQ997

(22)
(23)
(24)
(25)

Applies to line items 1‐9; US and Puerto Rico only.
Total domestic mortgages originated during the quarter. 
FR Y‐9C name is "Residential Mortgages Sold During the Quarter"; this metric need not be limited to Mortgages and Home Equity business line.
New business pricing for time deposits refers to the anticipated average rate on newly issued domestic time deposits, including renewals.  Given that time deposits have a stated maturity, all 
time deposits issued for that time period are considered new business. 

PQ 4

Projected
PQ 5

PQ 6

PQ 7

PQ 8

PQ 9

FR Y‐14A Schedule A.7.c ‐ PPNR Metrics

FR Y9C Codes

PQ 1

Units

(27)
(28)

A backlog should be based on probability weighted fees.  The data should be consistent with historical internal reporting, not by market measurement.  The last 
quarter should be the BHC’s/IHC's/SLHC's latest backlog estimate.

(29)

Provide description of the accounts included in this line item (e.g. Negotiable Order of Withdrawal, Interest Bearing Checking, Non Interest Bearing Demand Deposit 
Account, Money Market Savings, etc.)
CPSNQ998

(30)

Please break out and explain nature of non‐recurring items included in PPNR.  Also indicate 
which items on PPRN Projections worksheet include the items broken out in footnote 32: 

(a)

 Revenues (Net Interest Income + Non Interest Income)
CPSNQ999
CPSNR002
CPSNR004
CPSNR006
CPSNR008
CPSNR010
CPSNR012

(b)

$ Milllion
$ Milllion
$ Milllion
$ Milllion
$ Milllion
$ Milllion
$ Milllion

CPSNR001
CPSNR003
CPSNR005
CPSNR007
CPSNR009
CPSNR011
CPSNR013

$ Milllion
$ Milllion
$ Milllion
$ Milllion
$ Milllion
$ Milllion
$ Milllion

CPSNR015
CPSNR017
CPSNR019
CPSNR021
CPSNR023
CPSNR025
CPSNR027

 Non Interest Expenses
CPSNR014
CPSNR016
CPSNR018
CPSNR020
CPSNR022
CPSNR024
CPSNR026

(31)

For WAL, exclude from the reported number Loans Held For Sale

(32)

Note if this item includes any contra‐revenues other than Rewards/Partner Sharing (e g. Marketing Expense Amortization)
CPSNR028

(34)

PQ 3

The term “curve” refers to the reference rate used to price time deposits.  Given that the pricing of time deposits is dependent on the term, the institution should provide the overall curve 
used to price time deposits.  If the institution only assumes a single maturity term for new issuances, complete line 88B and 88C only, otherwise complete line 88A only.
If the institution only assumes a single maturity term for new issuance, then the institution should provide the relative index and spread used to estimate new business pricing in lieu of the 
curve.

(26)

(33)

PQ 2

Institutions that have adopted ASU 2016‐13 should report the carrying value of PCD loans in 
item 50
Institutions that have adopted ASU 2016‐13 should report the net accretion of discount on 
loans included in net interest income as included on the PPNR Submission Worksheet and 
Net Interest Income worksheet.

PQ 4

Projected
PQ 5

PQ 6

PQ 7

PQ 8

PQ 9

FR Y-14A Schedule B - Scenario

Supervisory Baseline Scenario (additional variables used beyond those supplied)
CCSVP006
Variable
Number
CCSVR929

Variable Name
CCSVS019

Variable Definition
CCSVS064

1
2
3
4
5
6
7
8
9
10
Supervisory Adverse Scenario (additional variables used beyond those supplied)
CCSVP006
Variable
Number
CCSVR929

Variable Name
CCSVS019

Variable Definition
CCSVS064

1
2
3
4
5
6
7
8
9
10
Supervisory Severely Adverse Scenario (additional variables used beyond those supplied)
CCSVP006
Variable
Number
CCSVR929

Variable Name
CCSVS019
1
2
3
4
5
6
7
8
9
10

Variable Definition
CCSVS064

FR Y-14A Schedule B - Scenario

BHC Baseline Scenario (variables not included above)
CCSVP006
Variable
Number
CCSVR929

Variable Name
CCSVS019

Variable Definition
CCSVS064

1
2
3
4
5
6
7
8
9
10
BHC Stress Scenario (variables not included above)
CCSVP006
Variable
Number
CCSVR929

Variable Name
CCSVS019

Variable Definition
CCSVS064

1
2
3
4
5
6
7
8
9
10
BHC Additional Scenario #1 (variables not included above)
CCSVP006
Variable
Number
CCSVR929
1
2
3
4
5
6
7
8
9
10

Variable Name
CCSVS019

Variable Definition
CCSVS064

FR Y-14A Schedule B.1 - Supervisory Baseline Scenario

Variable Name
CCSVS019

Actual
As of Date
CCSVS291

PQ 1

PQ 2

PQ 3

PQ 4

Projected
PQ 5
CCSVP009

PQ 6

PQ 7

PQ 8

PQ 9

FR Y-14A Schedule B.2 - Supervisory Adverse Scenario

Variable Name
CCSVS019

Actual
As of Date
CCSVS291

PQ 1

PQ 2

PQ 3

PQ 4

Projected
PQ 5
CCSVP009

PQ 6

PQ 7

PQ 8

PQ 9

FR Y-14A Schedule B.3 - Supervisory Severely Adverse Scenario

Variable Name
CCSVS019

Actual
As of Date
CCSVS291

PQ 1

PQ 2

PQ 3

PQ 4

Projected
PQ 5
CCSVP009

PQ 6

PQ 7

PQ 8

PQ 9

FR Y-14A Schedule B.4 - BHC or IHC Baseline Scenario

Variable Name
CCSVS019

Actual
As of Date
CCSVS291

PQ 1

PQ 2

PQ 3

PQ 4

Projected
PQ 5
CCSVP009

PQ 6

PQ 7

PQ 8

PQ 9

FR Y-14A Schedule B.5 - BHC or IHC Adverse Scenario

Variable Name
CCSVS019

Actual
As of Date
CCSVS291

PQ 1

PQ 2

PQ 3

PQ 4

Projected
PQ 5
CCSVP009

PQ 6

PQ 7

PQ 8

PQ 9

FR Y-14A Schedule B.6 - Additional Scenario

Variable Name
CCSVS019

Actual
As of Date
CCSVS291

PQ 1

PQ 2

PQ 3

PQ 4

Projected
PQ 5
CCSVP009

PQ 6

PQ 7

PQ 8

PQ 9

FR Y-14A Regulatory Capital Instruments Annual Schedule
Institution Name:
RSSD ID:
Date of Data Submission:
As of Date:
Submission Type:

Annual or Adjusted

FR Y-14A Regulatory Capital Instruments: Schedule C

-

Revised regulatory capital treatment
Quarterly Redemption/Repurchase Activity
1
2
3
4
5
6
7
8

Common Stock (CS)
Common Stock (CS) - Employee Stock Compensation
CS Warrants
CS USG Investment
Capital Instrument Issued by Subsidiary
Other Common Equity Tier 1
Non-Cumulative Perpetual Preferred (NCPP)
NCPP Convertible

9

Mandatory Convertible Preferred (MCP)

Additional Tier 1

10
11
12
13
14

MCP USG Preferred
Capital Instrument Issued by Subsidiary
Other Additional Tier 1
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred

Additional Tier 1
Additional Tier 1
Additional Tier 1
Non-qualifying Instrument in Tier 1
Non-qualifying Instrument in Tier 1

15

Mandatory Convertible Preferred (MCP)

Non-qualifying Instrument in Tier 1

16

MCP USG Preferred

Non-qualifying Instrument in Tier 1

17

Cumulative Dated Preferred (TRUPS)

Non-qualifying Instrument in Tier 1

18
19
20
21
22
23
24

USG Preferred TRUPS
Other Non-qualifying Instrument in Tier 1
Subordinated Debt
Capital Instrument Issued by Subsidiary
Other Tier 2
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred

Non-qualifying Instrument in Tier 1
Non-qualifying Instrument in Tier 1
Tier 2
Tier 2
Tier 2
Non-qualifying Instrument in Tier 2
Non-qualifying Instrument in Tier 2

25

Mandatory Convertible Preferred (MCP)

Non-qualifying Instrument in Tier 2

26

MCP USG Preferred

Non-qualifying Instrument in Tier 2

27

Cumulative Dated Preferred (TRUPS)

Non-qualifying Instrument in Tier 2

28
29

USG Preferred TRUPS
Other Non-qualifying Instrument in Tier 2

Non-qualifying Instrument in Tier 2
Non-qualifying Instrument in Tier 2

Common Equity Tier 1
Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Additional Tier 1
Additional Tier 1

Notional Amount
Projected

FR Y-9C, Schedule HC Reference

BHCK 3230 + BHCK 3240 + BHCK A130 BHCK G235
BHCK 3283 + BHCK 3240
BHCK 3230 + BHCK 3240
BHCK 3230 +BHCK G235
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283

Actual As of date

CACIY509
CACIY510
CACIY511
CACIY512
CACIY513
CACIY514
CACIY515
CACIY516

BHCK 3283
BHCK 3283
BHCK G234
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283

CACIY517

BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
BHCA P865
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283

CACIY523

BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283

CACIY533

CACIY518
CACIY519
CACIY520
CACIY521
CACIY522

CACIY524
CACIY525
CACIY526
CACIY527
CACIY528
CACIY529
CACIY530
CACIY531
CACIY532

CACIY534
CACIY535
CACIY536
CACIY537

PQ 1

PQ 2

PQ 3

PQ 4

PQ 5

PQ 6

PQ 7

PQ 8

PQ 9

FR Y‐14A Regulatory Capital Instruments: Schedule C                                                            ‐

                                       Amount Recognized in Regulatory Capital
Projected

Revised regulatory capital treatment

FR Y‐9C, Schedule HC Reference

Common Equity Tier 1
Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Additional Tier 1
Additional Tier 1

BHCK 3230 + BHCK 3240 + BHCK A130 ‐ 
BHCK G235
BHCK 3283 + BHCK 3240
BHCK 3230 + BHCK 3240
BHCK 3230 +BHCK G235
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283

Actual As of date

Quarterly Redemption/Repurchase Activity
1
2
3
4
5
6
7
8

Common Stock (CS)
Common Stock (CS) ‐ Employee Stock Compensation 
CS Warrants
CS USG Investment
Capital Instrument Issued by Subsidiary
Other Common Equity Tier 1
Non‐Cumulative Perpetual Preferred (NCPP)
NCPP Convertible

9

Mandatory Convertible Preferred (MCP)

Additional Tier 1

10
11
12
13
14

MCP USG Preferred
Capital Instrument Issued by Subsidiary
Other Additional Tier 1
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred

Additional Tier 1
Additional Tier 1
Additional Tier 1
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1

15

Mandatory Convertible Preferred (MCP)

Non‐qualifying Instrument in Tier 1

16

MCP USG Preferred

Non‐qualifying Instrument in Tier 1

17

Cumulative Dated Preferred (TRUPS)

Non‐qualifying Instrument in Tier 1

18
19
20
21
22
23
24

USG Preferred TRUPS
Other Non‐qualifying Instrument in Tier 1
Subordinated Debt
Capital Instrument Issued by Subsidiary
Other Tier 2
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred

Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
Tier 2
Tier 2
Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2

25

Mandatory Convertible Preferred (MCP)

Non‐qualifying Instrument in Tier 2

26

MCP USG Preferred

Non‐qualifying Instrument in Tier 2

27

Cumulative Dated Preferred (TRUPS)

Non‐qualifying Instrument in Tier 2

28
29

USG Preferred TRUPS
Other Non‐qualifying Instrument in Tier 2

Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2

CACIY509
CACIY510
CACIY511
CACIY512
CACIY513
CACIY514
CACIY515
CACIY516

BHCK 3283
BHCK 3283
BHCK G234
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283

CACIY517

BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
BHCA P865
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283

CACIY523

BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283

CACIY533

CACIY518
CACIY519
CACIY520
CACIY521
CACIY522

CACIY524
CACIY525
CACIY526
CACIY527
CACIY528
CACIY529
CACIY530
CACIY531
CACIY532

CACIY534
CACIY535
CACIY536
CACIY537

PQ 1

PQ 2

PQ 3

PQ 4

PQ 5

PQ 6

PQ 7

PQ 8

PQ 9

FR Y‐14A Regulatory Capital Instruments: Schedule C                                                            ‐

Revised regulatory capital treatment

FR Y‐9C, Schedule HC Reference

Quarterly Redemption/Repurchase Activity
1
2
3
4
5
6
7
8

Common Stock (CS)
Common Stock (CS) ‐ Employee Stock Compensation 
CS Warrants
CS USG Investment
Capital Instrument Issued by Subsidiary
Other Common Equity Tier 1
Non‐Cumulative Perpetual Preferred (NCPP)
NCPP Convertible

Common Equity Tier 1
Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Additional Tier 1
Additional Tier 1

9

Mandatory Convertible Preferred (MCP)

Additional Tier 1

10
11
12
13
14

MCP USG Preferred
Capital Instrument Issued by Subsidiary
Other Additional Tier 1
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred

Additional Tier 1
Additional Tier 1
Additional Tier 1
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1

15

Mandatory Convertible Preferred (MCP)

Non‐qualifying Instrument in Tier 1

16

MCP USG Preferred

Non‐qualifying Instrument in Tier 1

17

Cumulative Dated Preferred (TRUPS)

Non‐qualifying Instrument in Tier 1

18
19
20
21
22
23
24

USG Preferred TRUPS
Other Non‐qualifying Instrument in Tier 1
Subordinated Debt
Capital Instrument Issued by Subsidiary
Other Tier 2
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred

Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
Tier 2
Tier 2
Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2

25

Mandatory Convertible Preferred (MCP)

Non‐qualifying Instrument in Tier 2

26

MCP USG Preferred

Non‐qualifying Instrument in Tier 2

27

Cumulative Dated Preferred (TRUPS)

Non‐qualifying Instrument in Tier 2

28
29

USG Preferred TRUPS
Other Non‐qualifying Instrument in Tier 2

Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2

BHCK 3230 + BHCK 3240 + BHCK A130 ‐ 
BHCK G235
BHCK 3283 + BHCK 3240
BHCK 3230 + BHCK 3240
BHCK 3230 +BHCK G235
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
BHCA P865
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283

Page Reference in 
the Capital Plan

Comments

CACIY814

CACIQ750

FR Y-14A Regulatory Capital Instruments: Schedule C

-

Revised regulatory capital treatment
Quarterly Issuance Activity
30
31
32
33
34
35
36
37
38

Common Stock (CS)
Common Stock (CS) - Employee Stock Compensation
CS Warrants
CS USG Investment
Capital Instrument Issued by Subsidiary
Other Common Equity Tier 1
Non-Cumulative Perpetual Preferred (NCPP)
NCPP Convertible
Mandatory Convertible Preferred (MCP)

39
40
41
42
43
44

MCP USG Preferred
Capital Instrument Issued by Subsidiary
Other Additional Tier 1
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)

Additional Tier 1
Additional Tier 1
Additional Tier 1
Non-qualifying Instrument in Tier 1
Non-qualifying Instrument in Tier 1
Non-qualifying Instrument in Tier 1

45

MCP USG Preferred

Non-qualifying Instrument in Tier 1

46

Cumulative Dated Preferred (TRUPS)

Non-qualifying Instrument in Tier 1

47
48
49
50
51
52
53
54

USG Preferred TRUPS
Other Non-qualifying Instrument in Tier 1
Subordinated Debt
Capital Instrument Issued by Subsidiary
Other Tier 2
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)

Non-qualifying Instrument in Tier 1
Non-qualifying Instrument in Tier 1
Tier 2
Tier 2
Tier 2
Non-qualifying Instrument in Tier 2
Non-qualifying Instrument in Tier 2
Non-qualifying Instrument in Tier 2

55

MCP USG Preferred

Non-qualifying Instrument in Tier 2

56

Cumulative Dated Preferred (TRUPS)

Non-qualifying Instrument in Tier 2

57
58

USG Preferred TRUPS
Other Non-qualifying Instrument in Tier 2

Non-qualifying Instrument in Tier 2
Non-qualifying Instrument in Tier 2

Common Equity Tier 1
Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1

Notional Amount
Projected

FR Y-9C, Schedule HC Reference

BHCK 3230 + BHCK 3240 + BHCK A130 BHCK G235
BHCK 3283 + BHCK 3240
BHCK 3230 + BHCK 3240
BHCK 3230 +BHCK G235
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
BHCA P865
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283

Actual As of date

CACIY538
CACIY539
CACIY540
CACIY541
CACIY542
CACIY543
CACIY544
CACIY545
CACIY546
CACIY547
CACIY548
CACIY549
CACIY550
CACIY551
CACIY552
CACIY553
CACIY554
CACIY555
CACIY556
CACIY557
CACIY558
CACIY559
CACIY560
CACIY561
CACIY562
CACIY563
CACIY564
CACIY565
CACIY566

PQ 1

PQ 2

PQ 3

PQ 4

PQ 5

PQ 6

PQ 7

PQ 8

PQ 9

FR Y‐14A Regulatory Capital Instruments: Schedule C                                                            ‐

Revised regulatory capital treatment

                                       Amount Recognized in Regulatory Capital
Projected

FR Y‐9C, Schedule HC Reference

Actual As of date

Quarterly Issuance Activity
30
31
32
33
34
35
36
37
38

Common Stock (CS)
Common Stock (CS) ‐ Employee Stock Compensation 
CS Warrants
CS USG Investment
Capital Instrument Issued by Subsidiary
Other Common Equity Tier 1
Non‐Cumulative Perpetual Preferred (NCPP)
NCPP Convertible
Mandatory Convertible Preferred (MCP)

Common Equity Tier 1
Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1

39
40
41
42
43
44

MCP USG Preferred
Capital Instrument Issued by Subsidiary
Other Additional Tier 1
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)

Additional Tier 1
Additional Tier 1
Additional Tier 1
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1

45

MCP USG Preferred

Non‐qualifying Instrument in Tier 1

46

Cumulative Dated Preferred (TRUPS)

Non‐qualifying Instrument in Tier 1

47
48
49
50
51
52
53
54

USG Preferred TRUPS
Other Non‐qualifying Instrument in Tier 1
Subordinated Debt
Capital Instrument Issued by Subsidiary
Other Tier 2
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)

Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
Tier 2
Tier 2
Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2

55

MCP USG Preferred

Non‐qualifying Instrument in Tier 2

56

Cumulative Dated Preferred (TRUPS)

Non‐qualifying Instrument in Tier 2

57
58

USG Preferred TRUPS
Other Non‐qualifying Instrument in Tier 2

Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2

BHCK 3230 + BHCK 3240 + BHCK A130 ‐ 
BHCK G235
BHCK 3283 + BHCK 3240
BHCK 3230 + BHCK 3240
BHCK 3230 +BHCK G235
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
BHCA P865
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283

CACIY538
CACIY539
CACIY540
CACIY541
CACIY542
CACIY543
CACIY544
CACIY545
CACIY546
CACIY547
CACIY548
CACIY549
CACIY550
CACIY551
CACIY552
CACIY553
CACIY554
CACIY555
CACIY556
CACIY557
CACIY558
CACIY559
CACIY560
CACIY561
CACIY562
CACIY563
CACIY564
CACIY565
CACIY566

PQ 1

PQ 2

PQ 3

PQ 4

PQ 5

PQ 6

PQ 7

PQ 8

PQ 9

FR Y‐14A Regulatory Capital Instruments: Schedule C                                                            ‐

Revised regulatory capital treatment

FR Y‐9C, Schedule HC Reference

Quarterly Issuance Activity
30
31
32
33
34
35
36
37
38

Common Stock (CS)
Common Stock (CS) ‐ Employee Stock Compensation 
CS Warrants
CS USG Investment
Capital Instrument Issued by Subsidiary
Other Common Equity Tier 1
Non‐Cumulative Perpetual Preferred (NCPP)
NCPP Convertible
Mandatory Convertible Preferred (MCP)

Common Equity Tier 1
Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1

39
40
41
42
43
44

MCP USG Preferred
Capital Instrument Issued by Subsidiary
Other Additional Tier 1
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)

Additional Tier 1
Additional Tier 1
Additional Tier 1
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1

45

MCP USG Preferred

Non‐qualifying Instrument in Tier 1

46

Cumulative Dated Preferred (TRUPS)

Non‐qualifying Instrument in Tier 1

47
48
49
50
51
52
53
54

USG Preferred TRUPS
Other Non‐qualifying Instrument in Tier 1
Subordinated Debt
Capital Instrument Issued by Subsidiary
Other Tier 2
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)

Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
Tier 2
Tier 2
Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2

55

MCP USG Preferred

Non‐qualifying Instrument in Tier 2

56

Cumulative Dated Preferred (TRUPS)

Non‐qualifying Instrument in Tier 2

57
58

USG Preferred TRUPS
Other Non‐qualifying Instrument in Tier 2

Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2

BHCK 3230 + BHCK 3240 + BHCK A130 ‐ 
BHCK G235
BHCK 3283 + BHCK 3240
BHCK 3230 + BHCK 3240
BHCK 3230 +BHCK G235
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
BHCA P865
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283

Page Reference in 
the Capital Plan

Comments

CACIY814

CACIQ750

FR Y‐14A Regulatory Capital Instruments: Schedule C                                                            ‐

Revised regulatory capital treatment

                                         Notional Amount
Projected

FR Y‐9C, Schedule HC Reference

Actual As of date

Quarterly Activity ‐ Other than issuances or repurchases
59
60
61
62
63
64
65
66
67

Common Stock (CS)
Common Stock (CS) ‐ Employee Stock Compensation 
CS Warrants
CS USG Investment
Capital Instrument Issued by Subsidiary
Other Common Equity Tier 1
Non‐Cumulative Perpetual Preferred (NCPP)
NCPP Convertible
Mandatory Convertible Preferred (MCP)

Common Equity Tier 1
Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1

68
69
70
71
72
73

MCP USG Preferred
Capital Instrument Issued by Subsidiary
Other Additional Tier 1
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)

Additional Tier 1
Additional Tier 1
Additional Tier 1
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1

74

MCP USG Preferred

Non‐qualifying Instrument in Tier 1

75

Cumulative Dated Preferred (TRUPS)

Non‐qualifying Instrument in Tier 1

76
77
78
79
80
81
82
83

USG Preferred TRUPS
Other Non‐qualifying Instrument in Tier 1
Subordinated Debt
Capital Instrument Issued by Subsidiary
Other Tier 2
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)

Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
Tier 2
Tier 2
Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2

84

MCP USG Preferred

Non‐qualifying Instrument in Tier 2

85

Cumulative Dated Preferred (TRUPS)

Non‐qualifying Instrument in Tier 2

86
87

USG Preferred TRUPS
Other Non‐qualifying Instrument in Tier 2

Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2

BHCK 3230 + BHCK 3240 + BHCK A130 ‐ 
BHCK G235
BHCK 3283 + BHCK 3240
BHCK 3230 + BHCK 3240
BHCK 3230 +BHCK G235
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
BHCA P865
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283

CACIY567
CACIY568
CACIY569
CACIY570
CACIY571
CACIY572
CACIY573
CACIY574
CACIY575
CACIY576
CACIY577
CACIY578
CACIY579
CACIY580
CACIY581
CACIY582
CACIY583
CACIY584
CACIY585
CACIY586
CACIY587
CACIY588
CACIY589
CACIY590
CACIY591
CACIY592
CACIY593
CACIY594
CACIY595

PQ 1

PQ 2

PQ 3

PQ 4

PQ 5

PQ 6

PQ 7

PQ 8

PQ 9

FR Y‐14A Regulatory Capital Instruments: Schedule C                                                            ‐

Revised regulatory capital treatment

                                       Amount Recognized in Regulatory Capital
Projected

FR Y‐9C, Schedule HC Reference

Actual As of date

Quarterly Activity ‐ Other than issuances or repurchases
59
60
61
62
63
64
65
66
67

Common Stock (CS)
Common Stock (CS) ‐ Employee Stock Compensation 
CS Warrants
CS USG Investment
Capital Instrument Issued by Subsidiary
Other Common Equity Tier 1
Non‐Cumulative Perpetual Preferred (NCPP)
NCPP Convertible
Mandatory Convertible Preferred (MCP)

Common Equity Tier 1
Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1

68
69
70
71
72
73

MCP USG Preferred
Capital Instrument Issued by Subsidiary
Other Additional Tier 1
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)

Additional Tier 1
Additional Tier 1
Additional Tier 1
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1

74

MCP USG Preferred

Non‐qualifying Instrument in Tier 1

75

Cumulative Dated Preferred (TRUPS)

Non‐qualifying Instrument in Tier 1

76
77
78
79
80
81
82
83

USG Preferred TRUPS
Other Non‐qualifying Instrument in Tier 1
Subordinated Debt
Capital Instrument Issued by Subsidiary
Other Tier 2
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)

Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
Tier 2
Tier 2
Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2

84

MCP USG Preferred

Non‐qualifying Instrument in Tier 2

85

Cumulative Dated Preferred (TRUPS)

Non‐qualifying Instrument in Tier 2

86
87

USG Preferred TRUPS
Other Non‐qualifying Instrument in Tier 2

Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2

BHCK 3230 + BHCK 3240 + BHCK A130 ‐ 
BHCK G235
BHCK 3283 + BHCK 3240
BHCK 3230 + BHCK 3240
BHCK 3230 +BHCK G235
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
BHCA P865
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283

CACIY567
CACIY568
CACIY569
CACIY570
CACIY571
CACIY572
CACIY573
CACIY574
CACIY575
CACIY576
CACIY577
CACIY578
CACIY579
CACIY580
CACIY581
CACIY582
CACIY583
CACIY584
CACIY585
CACIY586
CACIY587
CACIY588
CACIY589
CACIY590
CACIY591
CACIY592
CACIY593
CACIY594
CACIY595

PQ 1

PQ 2

PQ 3

PQ 4

PQ 5

PQ 6

PQ 7

PQ 8

PQ 9

FR Y‐14A Regulatory Capital Instruments: Schedule C                                                            ‐

Revised regulatory capital treatment

FR Y‐9C, Schedule HC Reference

Quarterly Activity ‐ Other than issuances or repurchases
59
60
61
62
63
64
65
66
67

Common Stock (CS)
Common Stock (CS) ‐ Employee Stock Compensation 
CS Warrants
CS USG Investment
Capital Instrument Issued by Subsidiary
Other Common Equity Tier 1
Non‐Cumulative Perpetual Preferred (NCPP)
NCPP Convertible
Mandatory Convertible Preferred (MCP)

Common Equity Tier 1
Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1

68
69
70
71
72
73

MCP USG Preferred
Capital Instrument Issued by Subsidiary
Other Additional Tier 1
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)

Additional Tier 1
Additional Tier 1
Additional Tier 1
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1

74

MCP USG Preferred

Non‐qualifying Instrument in Tier 1

75

Cumulative Dated Preferred (TRUPS)

Non‐qualifying Instrument in Tier 1

76
77
78
79
80
81
82
83

USG Preferred TRUPS
Other Non‐qualifying Instrument in Tier 1
Subordinated Debt
Capital Instrument Issued by Subsidiary
Other Tier 2
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)

Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
Tier 2
Tier 2
Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2

84

MCP USG Preferred

Non‐qualifying Instrument in Tier 2

85

Cumulative Dated Preferred (TRUPS)

Non‐qualifying Instrument in Tier 2

86
87

USG Preferred TRUPS
Other Non‐qualifying Instrument in Tier 2

Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2

BHCK 3230 + BHCK 3240 + BHCK A130 ‐ 
BHCK G235
BHCK 3283 + BHCK 3240
BHCK 3230 + BHCK 3240
BHCK 3230 +BHCK G235
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
BHCA P865
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283

Page Reference in 
the Capital Plan

Comments

CACIY814

CACIQ750

Notional Amount

Revised regulatory capital treatment
Capital Balances
88
89
90
91
92
93
94
95

Common Stock (CS)
CS Warrants
CS USG Investment
Capital Instrument Issued by Subsidiary
Other Common Equity Tier 1
Non-Cumulative Perpetual Preferred (NCPP)
NCPP Convertible
Mandatory Convertible Preferred (MCP)

96 MCP USG Preferred
97
98
99
100
101

Capital Instrument Issued by Subsidiary
Other Additional Tier 1
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)

Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Non-qualifying Instrument in Tier 1
Non-qualifying Instrument in Tier 1
Non-qualifying Instrument in Tier 1

102 MCP USG Preferred

Non-qualifying Instrument in Tier 1

103 Cumulative Dated Preferred (TRUPS)

Non-qualifying Instrument in Tier 1

104 USG Preferred TRUPS

Non-qualifying Instrument in Tier 1

105
106
107
108
109
110
111

Other Non-qualifying Instrument in Tier 1
Subordinated Debt
Capital Instrument Issued by Subsidiary
Other Tier 2
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)

Non-qualifying Instrument in Tier 1
Tier 2
Tier 2
Tier 2
Non-qualifying Instrument in Tier 2
Non-qualifying Instrument in Tier 2
Non-qualifying Instrument in Tier 2

112 MCP USG Preferred

Non-qualifying Instrument in Tier 2

113 Cumulative Dated Preferred (TRUPS)

Non-qualifying Instrument in Tier 2

114 USG Preferred TRUPS

Non-qualifying Instrument in Tier 2

115 Other Non-qualifying Instrument in Tier 2

Non-qualifying Instrument in Tier 2

116 Cash dividends declared on preferred stock
117 Cash dividends declared on common stock
118 Common shares outstanding (Millions)
119 Common dividends per share ($)

FR Y-9C, Schedule HC
Reference

BHCK 3230 + BHCK 3240 +
BHCK A130 - BHCK G235
BHCK 3230 + BHCK 3240
BHCK 3230 +BHCK G235
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
BHCA P865
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283

Actual As of date

PQ 1

PQ 2

PQ 3

CACIY596
CACIY597
CACIY598
CACIY599
CACIY600
CACIY601
CACIY602
CACIY603

Sum (PQ1 Items 1, 2, 30, 31 , 59, 60) + (Actual Item 88)
Sum (PQ1 Items 3, 32, 61) + (Actual Item 89)
Sum (PQ1 Items 4, 33, 62) + (Actual Item 90)
Sum (PQ1 Items 5, 34, 63) + (Actual Item 91)
Sum (PQ1 Items 6, 35, 64) + (Actual Item 92)
Sum (PQ1 Items 7, 36, 65) + (Actual Item 93)
Sum (PQ1 Items 8, 37, 66) + (Actual Item 94)
Sum (PQ1 Items 9, 38, 67) + (Actual Item 95)

Sum (PQ2 Items 1, 2, 30, 31 , 59, 60) + (PQ1 Item 88)
Sum (PQ2 Items 3, 32, 61) + (PQ1 Item 89)
Sum (PQ2 Items 4, 33, 62) + (PQ1 Item 90)
Sum (PQ2 Items 5, 34, 63) + (PQ1 Item 91)
Sum (PQ2 Items 6, 35, 64) + (PQ1 Item 92)
Sum (PQ2 Items 7, 36, 65) + (PQ1 Item 93)
Sum (PQ2 Items 8, 37, 66) + (PQ1 Item 94)
Sum (PQ2 Items 9, 38, 67) + (PQ1 Item 95)

Sum (PQ3 Items 1, 2, 30, 31 , 59, 60) + (PQ2 Item 88)
Sum (PQ3 Items 3, 32, 61) + (PQ2 Item 89)
Sum (PQ3 Items 4, 33, 62) + (PQ2 Item 90)
Sum (PQ3 Items 5, 34, 63) + (PQ2 Item 91)
Sum (PQ3 Items 6, 35, 64) + (PQ2 Item 92)
Sum (PQ3 Items 7, 36, 65) + (PQ2 Item 93)
Sum (PQ3 Items 8, 37, 66) + (PQ2 Item 94)
Sum (PQ3 Items 9, 38, 67) + (PQ2 Item 95)

CACIY604

Sum (PQ1 Items 10, 39, 68) + (Actual Item 96)

Sum (PQ2 Items 10, 39, 68) + (PQ1 Item 96)

Sum (PQ3 Items 10, 39, 68) + (PQ2 Item 96)

CACIY605
CACIY606
CACIY607
CACIY608
CACIY609

Sum (PQ1 Items 11, 40, 69) + (Actual Item 97)
Sum (PQ1 Items 12, 41, 70) + (Actual Item 98)
Sum (PQ1 Items 13, 42, 71) + (Actual Item 99)
Sum (PQ1 Items 14, 43, 72) + (Actual Item 100)
Sum (PQ1 Items 15, 44, 73) + (Actual Item 101)

Sum (PQ2 Items 11, 40, 69) + (PQ1 Item 97)
Sum (PQ2 Items 12, 41, 70) + (PQ1 Item 98)
Sum (PQ2 Items 13, 42, 71) + (PQ1 Item 99)
Sum (PQ2 Items 14, 43, 72) + (PQ1 Item 100)
Sum (PQ2 Items 15, 44, 73) + (PQ1 Item 101)

Sum (PQ3 Items 11, 40, 69) + (PQ2 Item 97)
Sum (PQ3 Items 12, 41, 70) + (PQ2 Item 98)
Sum (PQ3 Items 13, 42, 71) + (PQ2 Item 99)
Sum (PQ3 Items 14, 43, 72) + (PQ2 Item 100)
Sum (PQ3 Items 15, 44, 73) + (PQ2 Item 101)

CACIY610

Sum (PQ1 Items 16, 45, 74) + (Actual Item 102)

Sum (PQ2 Items 16, 45, 74) + (PQ1 Item 102)

Sum (PQ3 Items 16, 45, 74) + (PQ2 Item 102)

CACIY611

Sum (PQ1 Items 17, 46, 75) + (Actual Item 103)

Sum (PQ2 Items 17, 46, 75) + (PQ1 Item 103)

Sum (PQ3 Items 17, 46, 75) + (PQ2 Item 103)

CACIY612

Sum (PQ1 Items 18, 47, 76) + (Actual Item 104)

Sum (PQ2 Items 18, 47, 76) + (PQ1 Item 104)

Sum (PQ3 Items 18, 47, 76) + (PQ2 Item 104)

CACIY613
CACIY614
CACIY615
CACIY616
CACIY617
CACIY618
CACIY619

Sum (PQ1 Items 19, 48, 77) + (Actual Item 105)
Sum (PQ1 Items 20, 49, 78) + (Actual Item 106)
Sum (PQ1 Items 21, 50, 79) + (Actual Item 107)
Sum (PQ1 Items 22, 51, 80) + (Actual Item 108)
Sum (PQ1 Items 23, 52, 81) + (Actual Item 109)
Sum (PQ1 Items 24, 53, 82) + (Actual Item 110)
Sum (PQ1 Items 25, 54, 83) + (Actual Item 111)

Sum (PQ2 Items 19, 48, 77) + (PQ1 Item 105)
Sum (PQ2 Items 20, 49, 78) + (PQ1 Item 106)
Sum (PQ2 Items 21, 50, 79) + (PQ1 Item 107)
Sum (PQ2 Items 22, 51, 80) + (PQ1 Item 108)
Sum (PQ2 Items 23, 52, 81) + (PQ1 Item 109)
Sum (PQ2 Items 24, 53, 82) + (PQ1 Item 110)
Sum (PQ2 Items 25, 54, 83) + (PQ1 Item 111)

Sum (PQ3 Items 19, 48, 77) + (PQ2 Item 105)
Sum (PQ3 Items 20, 49, 78) + (PQ2 Item 106)
Sum (PQ3 Items 21, 50, 79) + (PQ2 Item 107)
Sum (PQ3 Items 22, 51, 80) + (PQ2 Item 108)
Sum (PQ3 Items 23, 52, 81) + (PQ2 Item 109)
Sum (PQ3 Items 24, 53, 82) + (PQ2 Item 110)
Sum (PQ3 Items 25, 54, 83) + (PQ2 Item 111)

CACIY620

Sum (PQ1 Items 26, 55, 84) + (Actual Item 112)

Sum (PQ2 Items 26, 55, 84) + (PQ1 Item 112)

Sum (PQ3 Items 26, 55, 84) + (PQ2 Item 112)

CACIY621

Sum (PQ1 Items 27, 56, 85) + (Actual Item 113)

Sum (PQ2 Items 27, 56, 85) + (PQ1 Item 113)

Sum (PQ3 Items 27, 56, 85) + (PQ2 Item 113)

CACIY622

Sum (PQ1 Items 28, 57, 86) + (Actual Item 114)

Sum (PQ2 Items 28, 57, 86) + (PQ1 Item 114)

Sum (PQ3 Items 28, 57, 86) + (PQ2 Item 114)

CACIY623

Sum (PQ1 Items 29, 58, 87) + (Actual Item 115)

Sum (PQ2 Items 29, 58, 87) + (PQ1 Item 115)

Sum (PQ3 Items 29, 58, 87) + (PQ2 Item 115)

Notional Amount
Projected

Revised regulatory capital treatment
Capital Balances
88
89
90
91
92
93
94
95

Common Stock (CS)
CS Warrants
CS USG Investment
Capital Instrument Issued by Subsidiary
Other Common Equity Tier 1
Non-Cumulative Perpetual Preferred (NCPP)
NCPP Convertible
Mandatory Convertible Preferred (MCP)

96 MCP USG Preferred
97
98
99
100
101

Capital Instrument Issued by Subsidiary
Other Additional Tier 1
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)

Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Non-qualifying Instrument in Tier 1
Non-qualifying Instrument in Tier 1
Non-qualifying Instrument in Tier 1

102 MCP USG Preferred

Non-qualifying Instrument in Tier 1

103 Cumulative Dated Preferred (TRUPS)

Non-qualifying Instrument in Tier 1

104 USG Preferred TRUPS

Non-qualifying Instrument in Tier 1

105
106
107
108
109
110
111

Other Non-qualifying Instrument in Tier 1
Subordinated Debt
Capital Instrument Issued by Subsidiary
Other Tier 2
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)

Non-qualifying Instrument in Tier 1
Tier 2
Tier 2
Tier 2
Non-qualifying Instrument in Tier 2
Non-qualifying Instrument in Tier 2
Non-qualifying Instrument in Tier 2

112 MCP USG Preferred

Non-qualifying Instrument in Tier 2

113 Cumulative Dated Preferred (TRUPS)

Non-qualifying Instrument in Tier 2

114 USG Preferred TRUPS

Non-qualifying Instrument in Tier 2

115 Other Non-qualifying Instrument in Tier 2

Non-qualifying Instrument in Tier 2

116 Cash dividends declared on preferred stock
117 Cash dividends declared on common stock
118 Common shares outstanding (Millions)
119 Common dividends per share ($)

FR Y-9C, Schedule HC
Reference

BHCK 3230 + BHCK 3240 +
BHCK A130 - BHCK G235
BHCK 3230 + BHCK 3240
BHCK 3230 +BHCK G235
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
BHCA P865
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283

PQ 4

PQ 5

PQ 6

Sum (PQ4 Items 1, 2, 30, 31 , 59, 60) + (PQ3 Item 88)
Sum (PQ4 Items 3, 32, 61) + (PQ3 Item 89)
Sum (PQ4 Items 4, 33, 62) + (PQ3 Item 90)
Sum (PQ4 Items 5, 34, 63) + (PQ3 Item 91)
Sum (PQ4 Items 6, 35, 64) + (PQ3 Item 92)
Sum (PQ4 Items 7, 36, 65) + (PQ3 Item 93)
Sum (PQ4 Items 8, 37, 66) + (PQ3 Item 94)
Sum (PQ4 Items 9, 38, 67) + (PQ3 Item 95)

Sum (PQ5 Items 1, 2, 30, 31 , 59, 60) + (PQ4 Item 88)
Sum (PQ5 Items 3, 32, 61) + (PQ4 Item 89)
Sum (PQ5 Items 4, 33, 62) + (PQ4 Item 90)
Sum (PQ5 Items 5, 34, 63) + (PQ4 Item 91)
Sum (PQ5 Items 6, 35, 64) + (PQ4 Item 92)
Sum (PQ5 Items 7, 36, 65) + (PQ4 Item 93)
Sum (PQ5 Items 8, 37, 66) + (PQ4 Item 94)
Sum (PQ5 Items 9, 38, 67) + (PQ4 Item 95)

Sum (PQ6 Items 1, 2, 30, 31 , 59, 60) + (PQ5 Item 88)
Sum (PQ6 Items 3, 32, 61) + (PQ5 Item 89)
Sum (PQ6 Items 4, 33, 62) + (PQ5 Item 90)
Sum (PQ6 Items 5, 34, 63) + (PQ5 Item 91)
Sum (PQ6 Items 6, 35, 64) + (PQ5 Item 92)
Sum (PQ6 Items 7, 36, 65) + (PQ5 Item 93)
Sum (PQ6 Items 8, 37, 66) + (PQ5 Item 94)
Sum (PQ6 Items 9, 38, 67) + (PQ5 Item 95)

Sum (PQ4 Items 10, 39, 68) + (PQ3 Item 96)

Sum (PQ5 Items 10, 39, 68) + (PQ4 Item 96)

Sum (PQ6 Items 10, 39, 68) + (PQ5 Item 96)

Sum (PQ4 Items 11, 40, 69) + (PQ3 Item 97)
Sum (PQ4 Items 12, 41, 70) + (PQ3 Item 98)
Sum (PQ4 Items 13, 42, 71) + (PQ3 Item 99)
Sum (PQ4 Items 14, 43, 72) + (PQ3 Item 100)
Sum (PQ4 Items 15, 44, 73) + (PQ3 Item 101)

Sum (PQ5 Items 11, 40, 69) + (PQ4 Item 97)
Sum (PQ5 Items 12, 41, 70) + (PQ4 Item 98)
Sum (PQ5 Items 13, 42, 71) + (PQ4 Item 99)
Sum (PQ5 Items 14, 43, 72) + (PQ4 Item 100)
Sum (PQ5 Items 15, 44, 73) + (PQ4 Item 101)

Sum (PQ6 Items 11, 40, 69) + (PQ5 Item 97)
Sum (PQ6 Items 12, 41, 70) + (PQ5 Item 98)
Sum (PQ6 Items 13, 42, 71) + (PQ5 Item 99)
Sum (PQ6 Items 14, 43, 72) + (PQ5 Item 100)
Sum (PQ6 Items 15, 44, 73) + (PQ5 Item 101)

Sum (PQ4 Items 16, 45, 74) + (PQ3 Item 102)

Sum (PQ5 Items 16, 45, 74) + (PQ4 Item 102)

Sum (PQ6 Items 16, 45, 74) + (PQ5 Item 102)

Sum (PQ4 Items 17, 46, 75) + (PQ3 Item 103)

Sum (PQ5 Items 17, 46, 75) + (PQ4 Item 103)

Sum (PQ6 Items 17, 46, 75) + (PQ5 Item 103)

Sum (PQ4 Items 18, 47, 76) + (PQ3 Item 104)

Sum (PQ5 Items 18, 47, 76) + (PQ4 Item 104)

Sum (PQ6 Items 18, 47, 76) + (PQ5 Item 104)

Sum (PQ4 Items 19, 48, 77) + (PQ3 Item 105)
Sum (PQ4 Items 20, 49, 78) + (PQ3 Item 106)
Sum (PQ4 Items 21, 50, 79) + (PQ3 Item 107)
Sum (PQ4 Items 22, 51, 80) + (PQ3 Item 108)
Sum (PQ4 Items 23, 52, 81) + (PQ3 Item 109)
Sum (PQ4 Items 24, 53, 82) + (PQ3 Item 110)
Sum (PQ4 Items 25, 54, 83) + (PQ3 Item 111)

Sum (PQ5 Items 19, 48, 77) + (PQ4 Item 105)
Sum (PQ5 Items 20, 49, 78) + (PQ4 Item 106)
Sum (PQ5 Items 21, 50, 79) + (PQ4 Item 107)
Sum (PQ5 Items 22, 51, 80) + (PQ4 Item 108)
Sum (PQ5 Items 23, 52, 81) + (PQ4 Item 109)
Sum (PQ5 Items 24, 53, 82) + (PQ4 Item 110)
Sum (PQ5 Items 25, 54, 83) + (PQ4 Item 111)

Sum (PQ6 Items 19, 48, 77) + (PQ5 Item 105)
Sum (PQ6 Items 20, 49, 78) + (PQ5 Item 106)
Sum (PQ6 Items 21, 50, 79) + (PQ5 Item 107)
Sum (PQ6 Items 22, 51, 80) + (PQ5 Item 108)
Sum (PQ6 Items 23, 52, 81) + (PQ5 Item 109)
Sum (PQ6 Items 24, 53, 82) + (PQ5 Item 110)
Sum (PQ6 Items 25, 54, 83) + (PQ5 Item 111)

Sum (PQ4 Items 26, 55, 84) + (PQ3 Item 112)

Sum (PQ5 Items 26, 55, 84) + (PQ4 Item 112)

Sum (PQ6 Items 26, 55, 84) + (PQ5 Item 112)

Sum (PQ4 Items 27, 56, 85) + (PQ3 Item 113)

Sum (PQ5 Items 27, 56, 85) + (PQ4 Item 113)

Sum (PQ6 Items 27, 56, 85) + (PQ5 Item 113)

Sum (PQ4 Items 28, 57, 86) + (PQ3 Item 114)

Sum (PQ5 Items 28, 57, 86) + (PQ4 Item 114)

Sum (PQ6 Items 28, 57, 86) + (PQ5 Item 114)

Sum (PQ4 Items 29, 58, 87) + (PQ3 Item 115)

Sum (PQ5 Items 29, 58, 87) + (PQ4 Item 115)

Sum (PQ6 Items 29, 58, 87) + (PQ5 Item 115)

Notional Amount

Revised regulatory capital treatment
Capital Balances
88
89
90
91
92
93
94
95

Common Stock (CS)
CS Warrants
CS USG Investment
Capital Instrument Issued by Subsidiary
Other Common Equity Tier 1
Non-Cumulative Perpetual Preferred (NCPP)
NCPP Convertible
Mandatory Convertible Preferred (MCP)

96 MCP USG Preferred
97
98
99
100
101

Capital Instrument Issued by Subsidiary
Other Additional Tier 1
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)

Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Non-qualifying Instrument in Tier 1
Non-qualifying Instrument in Tier 1
Non-qualifying Instrument in Tier 1

102 MCP USG Preferred

Non-qualifying Instrument in Tier 1

103 Cumulative Dated Preferred (TRUPS)

Non-qualifying Instrument in Tier 1

104 USG Preferred TRUPS

Non-qualifying Instrument in Tier 1

105
106
107
108
109
110
111

Other Non-qualifying Instrument in Tier 1
Subordinated Debt
Capital Instrument Issued by Subsidiary
Other Tier 2
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)

Non-qualifying Instrument in Tier 1
Tier 2
Tier 2
Tier 2
Non-qualifying Instrument in Tier 2
Non-qualifying Instrument in Tier 2
Non-qualifying Instrument in Tier 2

112 MCP USG Preferred

Non-qualifying Instrument in Tier 2

113 Cumulative Dated Preferred (TRUPS)

Non-qualifying Instrument in Tier 2

114 USG Preferred TRUPS

Non-qualifying Instrument in Tier 2

115 Other Non-qualifying Instrument in Tier 2

Non-qualifying Instrument in Tier 2

116 Cash dividends declared on preferred stock
117 Cash dividends declared on common stock
118 Common shares outstanding (Millions)
119 Common dividends per share ($)

FR Y-9C, Schedule HC
Reference

BHCK 3230 + BHCK 3240 +
BHCK A130 - BHCK G235
BHCK 3230 + BHCK 3240
BHCK 3230 +BHCK G235
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
BHCA P865
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283

PQ 7

PQ 8

PQ 9

Sum (PQ7 Items 1, 2, 30, 31 , 59, 60) + (PQ6 Item 88)
Sum (PQ7 Items 3, 32, 61) + (PQ6 Item 89)
Sum (PQ7 Items 4, 33, 62) + (PQ6 Item 90)
Sum (PQ7 Items 5, 34, 63) + (PQ6 Item 91)
Sum (PQ7 Items 6, 35, 64) + (PQ6 Item 92)
Sum (PQ7 Items 7, 36, 65) + (PQ6 Item 93)
Sum (PQ7 Items 8, 37, 66) + (PQ6 Item 94)
Sum (PQ7 Items 9, 38, 67) + (PQ6 Item 95)

Sum (PQ8 Items 1, 2, 30, 31 , 59, 60) + (PQ7 Item 88)
Sum (PQ8 Items 3, 32, 61) + (PQ7 Item 89)
Sum (PQ8 Items 4, 33, 62) + (PQ7 Item 90)
Sum (PQ8 Items 5, 34, 63) + (PQ7 Item 91)
Sum (PQ8 Items 6, 35, 64) + (PQ7 Item 92)
Sum (PQ8 Items 7, 36, 65) + (PQ7 Item 93)
Sum (PQ8 Items 8, 37, 66) + (PQ7 Item 94)
Sum (PQ8 Items 9, 38, 67) + (PQ7 Item 95)

Sum (PQ9 Items 1, 2, 30, 31 , 59, 60) + (PQ8 Item 88)
Sum (PQ9 Items 3, 32, 61) + (PQ8 Item 89)
Sum (PQ9 Items 4, 33, 62) + (PQ8 Item 90)
Sum (PQ9 Items 5, 34, 63) + (PQ8 Item 91)
Sum (PQ9 Items 6, 35, 64) + (PQ8 Item 92)
Sum (PQ9 Items 7, 36, 65) + (PQ8 Item 93)
Sum (PQ9 Items 8, 37, 66) + (PQ8 Item 94)
Sum (PQ9 Items 9, 38, 67) + (PQ8 Item 95)

Sum (PQ7 Items 10, 39, 68) + (PQ6 Item 96)

Sum (PQ8 Items 10, 39, 68) + (PQ7 Item 96)

Sum (PQ9 Items 10, 39, 68) + (PQ8 Item 96)

Sum (PQ7 Items 11, 40, 69) + (PQ6 Item 97)
Sum (PQ7 Items 12, 41, 70) + (PQ6 Item 98)
Sum (PQ7 Items 13, 42, 71) + (PQ6 Item 99)
Sum (PQ7 Items 14, 43, 72) + (PQ6 Item 100)
Sum (PQ7 Items 15, 44, 73) + (PQ6 Item 101)

Sum (PQ8 Items 11, 40, 69) + (PQ7 Item 97)
Sum (PQ8 Items 12, 41, 70) + (PQ7 Item 98)
Sum (PQ8 Items 13, 42, 71) + (PQ7 Item 99)
Sum (PQ8 Items 14, 43, 72) + (PQ7 Item 100)
Sum (PQ8 Items 15, 44, 73) + (PQ7 Item 101)

Sum (PQ9 Items 11, 40, 69) + (PQ8 Item 97)
Sum (PQ9 Items 12, 41, 70) + (PQ8 Item 98)
Sum (PQ9 Items 13, 42, 71) + (PQ8 Item 99)
Sum (PQ9 Items 14, 43, 72) + (PQ8 Item 100)
Sum (PQ9 Items 15, 44, 73) + (PQ8 Item 101)

Sum (PQ7 Items 16, 45, 74) + (PQ6 Item 102)

Sum (PQ8 Items 16, 45, 74) + (PQ7 Item 102)

Sum (PQ9 Items 16, 45, 74) + (PQ8 Item 102)

Sum (PQ7 Items 17, 46, 75) + (PQ6 Item 103)

Sum (PQ8 Items 17, 46, 75) + (PQ7 Item 103)

Sum (PQ9 Items 17, 46, 75) + (PQ8 Item 103)

Sum (PQ7 Items 18, 47, 76) + (PQ6 Item 104)

Sum (PQ8 Items 18, 47, 76) + (PQ7 Item 104)

Sum (PQ9 Items 18, 47, 76) + (PQ8 Item 104)

Sum (PQ7 Items 19, 48, 77) + (PQ6 Item 105)
Sum (PQ7 Items 20, 49, 78) + (PQ6 Item 106)
Sum (PQ7 Items 21, 50, 79) + (PQ6 Item 107)
Sum (PQ7 Items 22, 51, 80) + (PQ6 Item 108)
Sum (PQ7 Items 23, 52, 81) + (PQ6 Item 109)
Sum (PQ7 Items 24, 53, 82) + (PQ6 Item 110)
Sum (PQ7 Items 25, 54, 83) + (PQ6 Item 111)

Sum (PQ8 Items 19, 48, 77) + (PQ7 Item 105)
Sum (PQ8 Items 20, 49, 78) + (PQ7 Item 106)
Sum (PQ8 Items 21, 50, 79) + (PQ7 Item 107)
Sum (PQ8 Items 22, 51, 80) + (PQ7 Item 108)
Sum (PQ8 Items 23, 52, 81) + (PQ7 Item 109)
Sum (PQ8 Items 24, 53, 82) + (PQ7 Item 110)
Sum (PQ8 Items 25, 54, 83) + (PQ7 Item 111)

Sum (PQ9 Items 19, 48, 77) + (PQ8 Item 105)
Sum (PQ9 Items 20, 49, 78) + (PQ8 Item 106)
Sum (PQ9 Items 21, 50, 79) + (PQ8 Item 107)
Sum (PQ9 Items 22, 51, 80) + (PQ8 Item 108)
Sum (PQ9 Items 23, 52, 81) + (PQ8 Item 109)
Sum (PQ9 Items 24, 53, 82) + (PQ8 Item 110)
Sum (PQ9 Items 25, 54, 83) + (PQ8 Item 111)

Sum (PQ7 Items 26, 55, 84) + (PQ6 Item 112)

Sum (PQ8 Items 26, 55, 84) + (PQ7 Item 112)

Sum (PQ9 Items 26, 55, 84) + (PQ8 Item 112)

Sum (PQ7 Items 27, 56, 85) + (PQ6 Item 113)

Sum (PQ8 Items 27, 56, 85) + (PQ7 Item 113)

Sum (PQ9 Items 27, 56, 85) + (PQ8 Item 113)

Sum (PQ7 Items 28, 57, 86) + (PQ6 Item 114)

Sum (PQ8 Items 28, 57, 86) + (PQ7 Item 114)

Sum (PQ9 Items 28, 57, 86) + (PQ8 Item 114)

Sum (PQ7 Items 29, 58, 87) + (PQ6 Item 115)

Sum (PQ8 Items 29, 58, 87) + (PQ7 Item 115)

Sum (PQ9 Items 29, 58, 87) + (PQ8 Item 115)

Amount Recognized in Regulatory Capital

Revised regulatory capital treatment
Capital Balances
88
89
90
91
92
93
94
95

Common Stock (CS)
CS Warrants
CS USG Investment
Capital Instrument Issued by Subsidiary
Other Common Equity Tier 1
Non-Cumulative Perpetual Preferred (NCPP)
NCPP Convertible
Mandatory Convertible Preferred (MCP)

96 MCP USG Preferred
97
98
99
100
101

Capital Instrument Issued by Subsidiary
Other Additional Tier 1
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)

Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Non-qualifying Instrument in Tier 1
Non-qualifying Instrument in Tier 1
Non-qualifying Instrument in Tier 1

102 MCP USG Preferred

Non-qualifying Instrument in Tier 1

103 Cumulative Dated Preferred (TRUPS)

Non-qualifying Instrument in Tier 1

104 USG Preferred TRUPS

Non-qualifying Instrument in Tier 1

105
106
107
108
109
110
111

Other Non-qualifying Instrument in Tier 1
Subordinated Debt
Capital Instrument Issued by Subsidiary
Other Tier 2
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)

Non-qualifying Instrument in Tier 1
Tier 2
Tier 2
Tier 2
Non-qualifying Instrument in Tier 2
Non-qualifying Instrument in Tier 2
Non-qualifying Instrument in Tier 2

112 MCP USG Preferred

Non-qualifying Instrument in Tier 2

113 Cumulative Dated Preferred (TRUPS)

Non-qualifying Instrument in Tier 2

114 USG Preferred TRUPS

Non-qualifying Instrument in Tier 2

115 Other Non-qualifying Instrument in Tier 2

Non-qualifying Instrument in Tier 2

116 Cash dividends declared on preferred stock
117 Cash dividends declared on common stock
118 Common shares outstanding (Millions)
119 Common dividends per share ($)

FR Y-9C, Schedule HC
Reference

BHCK 3230 + BHCK 3240 +
BHCK A130 - BHCK G235
BHCK 3230 + BHCK 3240
BHCK 3230 +BHCK G235
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
BHCA P865
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283

Actual As of date

PQ 1

PQ 2

PQ 3

CACIY596
CACIY597
CACIY598
CACIY599
CACIY600
CACIY601
CACIY602
CACIY603

Sum (PQ1 Items 1, 2, 30, 31 , 59, 60) + (Actual Item 88)
Sum (PQ1 Items 3, 32, 61) + (Actual Item 89)
Sum (PQ1 Items 4, 33, 62) + (Actual Item 90)
Sum (PQ1 Items 5, 34, 63) + (Actual Item 91)
Sum (PQ1 Items 6, 35, 64) + (Actual Item 92)
Sum (PQ1 Items 7, 36, 65) + (Actual Item 93)
Sum (PQ1 Items 8, 37, 66) + (Actual Item 94)
Sum (PQ1 Items 9, 38, 67) + (Actual Item 95)

Sum (PQ2 Items 1, 2, 30, 31 , 59, 60) + (PQ1 Item 88)
Sum (PQ2 Items 3, 32, 61) + (PQ1 Item 89)
Sum (PQ2 Items 4, 33, 62) + (PQ1 Item 90)
Sum (PQ2 Items 5, 34, 63) + (PQ1 Item 91)
Sum (PQ2 Items 6, 35, 64) + (PQ1 Item 92)
Sum (PQ2 Items 7, 36, 65) + (PQ1 Item 93)
Sum (PQ2 Items 8, 37, 66) + (PQ1 Item 94)
Sum (PQ2 Items 9, 38, 67) + (PQ1 Item 95)

Sum (PQ3 Items 1, 2, 30, 31 , 59, 60) + (PQ2 Item 88)
Sum (PQ3 Items 3, 32, 61) + (PQ2 Item 89)
Sum (PQ3 Items 4, 33, 62) + (PQ2 Item 90)
Sum (PQ3 Items 5, 34, 63) + (PQ2 Item 91)
Sum (PQ3 Items 6, 35, 64) + (PQ2 Item 92)
Sum (PQ3 Items 7, 36, 65) + (PQ2 Item 93)
Sum (PQ3 Items 8, 37, 66) + (PQ2 Item 94)
Sum (PQ3 Items 9, 38, 67) + (PQ2 Item 95)

CACIY604

Sum (PQ1 Items 10, 39, 68) + (Actual Item 96)

Sum (PQ2 Items 10, 39, 68) + (PQ1 Item 96)

Sum (PQ3 Items 10, 39, 68) + (PQ2 Item 96)

CACIY605
CACIY606
CACIY607
CACIY608
CACIY609

Sum (PQ1 Items 11, 40, 69) + (Actual Item 97)
Sum (PQ1 Items 12, 41, 70) + (Actual Item 98)
Sum (PQ1 Items 13, 42, 71) + (Actual Item 99)
Sum (PQ1 Items 14, 43, 72) + (Actual Item 100)
Sum (PQ1 Items 15, 44, 73) + (Actual Item 101)

Sum (PQ2 Items 11, 40, 69) + (PQ1 Item 97)
Sum (PQ2 Items 12, 41, 70) + (PQ1 Item 98)
Sum (PQ2 Items 13, 42, 71) + (PQ1 Item 99)
Sum (PQ2 Items 14, 43, 72) + (PQ1 Item 100)
Sum (PQ2 Items 15, 44, 73) + (PQ1 Item 101)

Sum (PQ3 Items 11, 40, 69) + (PQ2 Item 97)
Sum (PQ3 Items 12, 41, 70) + (PQ2 Item 98)
Sum (PQ3 Items 13, 42, 71) + (PQ2 Item 99)
Sum (PQ3 Items 14, 43, 72) + (PQ2 Item 100)
Sum (PQ3 Items 15, 44, 73) + (PQ2 Item 101)

CACIY610

Sum (PQ1 Items 16, 45, 74) + (Actual Item 102)

Sum (PQ2 Items 16, 45, 74) + (PQ1 Item 102)

Sum (PQ3 Items 16, 45, 74) + (PQ2 Item 102)

CACIY611

Sum (PQ1 Items 17, 46, 75) + (Actual Item 103)

Sum (PQ2 Items 17, 46, 75) + (PQ1 Item 103)

Sum (PQ3 Items 17, 46, 75) + (PQ2 Item 103)

CACIY612

Sum (PQ1 Items 18, 47, 76) + (Actual Item 104)

Sum (PQ2 Items 18, 47, 76) + (PQ1 Item 104)

Sum (PQ3 Items 18, 47, 76) + (PQ2 Item 104)

CACIY613
CACIY614
CACIY615
CACIY616
CACIY617
CACIY618
CACIY619

Sum (PQ1 Items 19, 48, 77) + (Actual Item 105)
Sum (PQ1 Items 20, 49, 78) + (Actual Item 106)
Sum (PQ1 Items 21, 50, 79) + (Actual Item 107)
Sum (PQ1 Items 22, 51, 80) + (Actual Item 108)
Sum (PQ1 Items 23, 52, 81) + (Actual Item 109)
Sum (PQ1 Items 24, 53, 82) + (Actual Item 110)
Sum (PQ1 Items 25, 54, 83) + (Actual Item 111)

Sum (PQ2 Items 19, 48, 77) + (PQ1 Item 105)
Sum (PQ2 Items 20, 49, 78) + (PQ1 Item 106)
Sum (PQ2 Items 21, 50, 79) + (PQ1 Item 107)
Sum (PQ2 Items 22, 51, 80) + (PQ1 Item 108)
Sum (PQ2 Items 23, 52, 81) + (PQ1 Item 109)
Sum (PQ2 Items 24, 53, 82) + (PQ1 Item 110)
Sum (PQ2 Items 25, 54, 83) + (PQ1 Item 111)

Sum (PQ3 Items 19, 48, 77) + (PQ2 Item 105)
Sum (PQ3 Items 20, 49, 78) + (PQ2 Item 106)
Sum (PQ3 Items 21, 50, 79) + (PQ2 Item 107)
Sum (PQ3 Items 22, 51, 80) + (PQ2 Item 108)
Sum (PQ3 Items 23, 52, 81) + (PQ2 Item 109)
Sum (PQ3 Items 24, 53, 82) + (PQ2 Item 110)
Sum (PQ3 Items 25, 54, 83) + (PQ2 Item 111)

CACIY620

Sum (PQ1 Items 26, 55, 84) + (Actual Item 112)

Sum (PQ2 Items 26, 55, 84) + (PQ1 Item 112)

Sum (PQ3 Items 26, 55, 84) + (PQ2 Item 112)

CACIY621

Sum (PQ1 Items 27, 56, 85) + (Actual Item 113)

Sum (PQ2 Items 27, 56, 85) + (PQ1 Item 113)

Sum (PQ3 Items 27, 56, 85) + (PQ2 Item 113)

CACIY622

Sum (PQ1 Items 28, 57, 86) + (Actual Item 114)

Sum (PQ2 Items 28, 57, 86) + (PQ1 Item 114)

Sum (PQ3 Items 28, 57, 86) + (PQ2 Item 114)

CACIY623

Sum (PQ1 Items 29, 58, 87) + (Actual Item 115)

Sum (PQ2 Items 29, 58, 87) + (PQ1 Item 115)

Sum (PQ3 Items 29, 58, 87) + (PQ2 Item 115)

Amount Recognized in Regulatory Capital
Projected

Revised regulatory capital treatment
Capital Balances
88
89
90
91
92
93
94
95

Common Stock (CS)
CS Warrants
CS USG Investment
Capital Instrument Issued by Subsidiary
Other Common Equity Tier 1
Non-Cumulative Perpetual Preferred (NCPP)
NCPP Convertible
Mandatory Convertible Preferred (MCP)

96 MCP USG Preferred
97
98
99
100
101

Capital Instrument Issued by Subsidiary
Other Additional Tier 1
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)

Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Non-qualifying Instrument in Tier 1
Non-qualifying Instrument in Tier 1
Non-qualifying Instrument in Tier 1

102 MCP USG Preferred

Non-qualifying Instrument in Tier 1

103 Cumulative Dated Preferred (TRUPS)

Non-qualifying Instrument in Tier 1

104 USG Preferred TRUPS

Non-qualifying Instrument in Tier 1

105
106
107
108
109
110
111

Other Non-qualifying Instrument in Tier 1
Subordinated Debt
Capital Instrument Issued by Subsidiary
Other Tier 2
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)

Non-qualifying Instrument in Tier 1
Tier 2
Tier 2
Tier 2
Non-qualifying Instrument in Tier 2
Non-qualifying Instrument in Tier 2
Non-qualifying Instrument in Tier 2

112 MCP USG Preferred

Non-qualifying Instrument in Tier 2

113 Cumulative Dated Preferred (TRUPS)

Non-qualifying Instrument in Tier 2

114 USG Preferred TRUPS

Non-qualifying Instrument in Tier 2

115 Other Non-qualifying Instrument in Tier 2

Non-qualifying Instrument in Tier 2

116 Cash dividends declared on preferred stock
117 Cash dividends declared on common stock
118 Common shares outstanding (Millions)
119 Common dividends per share ($)

FR Y-9C, Schedule HC
Reference

BHCK 3230 + BHCK 3240 +
BHCK A130 - BHCK G235
BHCK 3230 + BHCK 3240
BHCK 3230 +BHCK G235
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
BHCA P865
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283

PQ 4

PQ 5

PQ 6

Sum (PQ4 Items 1, 2, 30, 31 , 59, 60) + (PQ3 Item 88)
Sum (PQ4 Items 3, 32, 61) + (PQ3 Item 89)
Sum (PQ4 Items 4, 33, 62) + (PQ3 Item 90)
Sum (PQ4 Items 5, 34, 63) + (PQ3 Item 91)
Sum (PQ4 Items 6, 35, 64) + (PQ3 Item 92)
Sum (PQ4 Items 7, 36, 65) + (PQ3 Item 93)
Sum (PQ4 Items 8, 37, 66) + (PQ3 Item 94)
Sum (PQ4 Items 9, 38, 67) + (PQ3 Item 95)

Sum (PQ5 Items 1, 2, 30, 31 , 59, 60) + (PQ4 Item 88)
Sum (PQ5 Items 3, 32, 61) + (PQ4 Item 89)
Sum (PQ5 Items 4, 33, 62) + (PQ4 Item 90)
Sum (PQ5 Items 5, 34, 63) + (PQ4 Item 91)
Sum (PQ5 Items 6, 35, 64) + (PQ4 Item 92)
Sum (PQ5 Items 7, 36, 65) + (PQ4 Item 93)
Sum (PQ5 Items 8, 37, 66) + (PQ4 Item 94)
Sum (PQ5 Items 9, 38, 67) + (PQ4 Item 95)

Sum (PQ6 Items 1, 2, 30, 31 , 59, 60) + (PQ5 Item 88)
Sum (PQ6 Items 3, 32, 61) + (PQ5 Item 89)
Sum (PQ6 Items 4, 33, 62) + (PQ5 Item 90)
Sum (PQ6 Items 5, 34, 63) + (PQ5 Item 91)
Sum (PQ6 Items 6, 35, 64) + (PQ5 Item 92)
Sum (PQ6 Items 7, 36, 65) + (PQ5 Item 93)
Sum (PQ6 Items 8, 37, 66) + (PQ5 Item 94)
Sum (PQ6 Items 9, 38, 67) + (PQ5 Item 95)

Sum (PQ4 Items 10, 39, 68) + (PQ3 Item 96)

Sum (PQ5 Items 10, 39, 68) + (PQ4 Item 96)

Sum (PQ6 Items 10, 39, 68) + (PQ5 Item 96)

Sum (PQ4 Items 11, 40, 69) + (PQ3 Item 97)
Sum (PQ4 Items 12, 41, 70) + (PQ3 Item 98)
Sum (PQ4 Items 13, 42, 71) + (PQ3 Item 99)
Sum (PQ4 Items 14, 43, 72) + (PQ3 Item 100)
Sum (PQ4 Items 15, 44, 73) + (PQ3 Item 101)

Sum (PQ5 Items 11, 40, 69) + (PQ4 Item 97)
Sum (PQ5 Items 12, 41, 70) + (PQ4 Item 98)
Sum (PQ5 Items 13, 42, 71) + (PQ4 Item 99)
Sum (PQ5 Items 14, 43, 72) + (PQ4 Item 100)
Sum (PQ5 Items 15, 44, 73) + (PQ4 Item 101)

Sum (PQ6 Items 11, 40, 69) + (PQ5 Item 97)
Sum (PQ6 Items 12, 41, 70) + (PQ5 Item 98)
Sum (PQ6 Items 13, 42, 71) + (PQ5 Item 99)
Sum (PQ6 Items 14, 43, 72) + (PQ5 Item 100)
Sum (PQ6 Items 15, 44, 73) + (PQ5 Item 101)

Sum (PQ4 Items 16, 45, 74) + (PQ3 Item 102)

Sum (PQ5 Items 16, 45, 74) + (PQ4 Item 102)

Sum (PQ6 Items 16, 45, 74) + (PQ5 Item 102)

Sum (PQ4 Items 17, 46, 75) + (PQ3 Item 103)

Sum (PQ5 Items 17, 46, 75) + (PQ4 Item 103)

Sum (PQ6 Items 17, 46, 75) + (PQ5 Item 103)

Sum (PQ4 Items 18, 47, 76) + (PQ3 Item 104)

Sum (PQ5 Items 18, 47, 76) + (PQ4 Item 104)

Sum (PQ6 Items 18, 47, 76) + (PQ5 Item 104)

Sum (PQ4 Items 19, 48, 77) + (PQ3 Item 105)
Sum (PQ4 Items 20, 49, 78) + (PQ3 Item 106)
Sum (PQ4 Items 21, 50, 79) + (PQ3 Item 107)
Sum (PQ4 Items 22, 51, 80) + (PQ3 Item 108)
Sum (PQ4 Items 23, 52, 81) + (PQ3 Item 109)
Sum (PQ4 Items 24, 53, 82) + (PQ3 Item 110)
Sum (PQ4 Items 25, 54, 83) + (PQ3 Item 111)

Sum (PQ5 Items 19, 48, 77) + (PQ4 Item 105)
Sum (PQ5 Items 20, 49, 78) + (PQ4 Item 106)
Sum (PQ5 Items 21, 50, 79) + (PQ4 Item 107)
Sum (PQ5 Items 22, 51, 80) + (PQ4 Item 108)
Sum (PQ5 Items 23, 52, 81) + (PQ4 Item 109)
Sum (PQ5 Items 24, 53, 82) + (PQ4 Item 110)
Sum (PQ5 Items 25, 54, 83) + (PQ4 Item 111)

Sum (PQ6 Items 19, 48, 77) + (PQ5 Item 105)
Sum (PQ6 Items 20, 49, 78) + (PQ5 Item 106)
Sum (PQ6 Items 21, 50, 79) + (PQ5 Item 107)
Sum (PQ6 Items 22, 51, 80) + (PQ5 Item 108)
Sum (PQ6 Items 23, 52, 81) + (PQ5 Item 109)
Sum (PQ6 Items 24, 53, 82) + (PQ5 Item 110)
Sum (PQ6 Items 25, 54, 83) + (PQ5 Item 111)

Sum (PQ4 Items 26, 55, 84) + (PQ3 Item 112)

Sum (PQ5 Items 26, 55, 84) + (PQ4 Item 112)

Sum (PQ6 Items 26, 55, 84) + (PQ5 Item 112)

Sum (PQ4 Items 27, 56, 85) + (PQ3 Item 113)

Sum (PQ5 Items 27, 56, 85) + (PQ4 Item 113)

Sum (PQ6 Items 27, 56, 85) + (PQ5 Item 113)

Sum (PQ4 Items 28, 57, 86) + (PQ3 Item 114)

Sum (PQ5 Items 28, 57, 86) + (PQ4 Item 114)

Sum (PQ6 Items 28, 57, 86) + (PQ5 Item 114)

Sum (PQ4 Items 29, 58, 87) + (PQ3 Item 115)

Sum (PQ5 Items 29, 58, 87) + (PQ4 Item 115)

Sum (PQ6 Items 29, 58, 87) + (PQ5 Item 115)

Amount Recognized in Regulatory Capital

Revised regulatory capital treatment

FR Y‐9C, Schedule HC 
Reference

PQ 7

PQ 8

PQ 9

Capital Balances
88
89
90
91
92
93
94
95

Common Stock (CS)
CS Warrants
CS USG Investment
Capital Instrument Issued by Subsidiary
Other Common Equity Tier 1
Non‐Cumulative Perpetual Preferred (NCPP)
NCPP Convertible
Mandatory Convertible Preferred (MCP)

96 MCP USG Preferred
97
98
99
100
101

Capital Instrument Issued by Subsidiary
Other Additional Tier 1
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)

Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Common Equity Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Additional Tier 1
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1
Non‐qualifying Instrument in Tier 1

102 MCP USG Preferred

Non‐qualifying Instrument in Tier 1

103 Cumulative Dated Preferred (TRUPS)

Non‐qualifying Instrument in Tier 1

104 USG Preferred TRUPS

Non‐qualifying Instrument in Tier 1

105
106
107
108
109
110
111

Non‐qualifying Instrument in Tier 1
Tier 2
Tier 2
Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2
Non‐qualifying Instrument in Tier 2

Other Non‐qualifying Instrument in Tier 1
Subordinated Debt
Capital Instrument Issued by Subsidiary
Other Tier 2
Cumulative Perpetual Preferred (CPP)
CPP TARP Preferred
Mandatory Convertible Preferred (MCP)

112 MCP USG Preferred

Non‐qualifying Instrument in Tier 2

113 Cumulative Dated Preferred (TRUPS)

Non‐qualifying Instrument in Tier 2

114 USG Preferred TRUPS

Non‐qualifying Instrument in Tier 2

115 Other Non‐qualifying Instrument in Tier 2

Non‐qualifying Instrument in Tier 2

116  Cash dividends declared on preferred stock 
117  Cash dividends declared on common stock 
118  Common shares outstanding (Millions) 
119  Common dividends per share ($) 

BHCK 3230 + BHCK 3240 + 
BHCK A130 ‐ BHCK G235
BHCK 3230 + BHCK 3240
BHCK 3230 +BHCK G235
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283
BHCA P865
BHCK P839
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK 3283
BHCK G234
BHCK 3283
BHCK 3000
BHCK 3283
BHCK G234
BHCK 3283

Sum (PQ7 Items 1,  2, 30,  31 , 59, 60) + (PQ6 Item 88) 
Sum (PQ7 Items 3, 32, 61) + (PQ6 Item 89) 
Sum (PQ7 Items 4, 33, 62) + (PQ6 Item 90) 
Sum (PQ7 Items 5, 34, 63) + (PQ6 Item 91) 
Sum (PQ7 Items 6, 35, 64) + (PQ6 Item 92) 
Sum (PQ7 Items 7, 36, 65) + (PQ6 Item 93) 
Sum (PQ7 Items 8, 37, 66) + (PQ6 Item 94) 
Sum (PQ7 Items 9, 38, 67) + (PQ6 Item 95) 

Sum (PQ8 Items 1,  2, 30,  31 , 59, 60) + (PQ7 Item 88)  Sum (PQ9 Items 1,  2, 30,  31 , 59, 60) + (PQ8 Item 88) 
Sum (PQ8 Items 3, 32, 61) + (PQ7 Item 89) 
Sum (PQ9 Items 3, 32, 61) + (PQ8 Item 89) 
Sum (PQ8 Items 4, 33, 62) + (PQ7 Item 90) 
Sum (PQ9 Items 4, 33, 62) + (PQ8 Item 90) 
Sum (PQ8 Items 5, 34, 63) + (PQ7 Item 91) 
Sum (PQ9 Items 5, 34, 63) + (PQ8 Item 91) 
Sum (PQ8 Items 6, 35, 64) + (PQ7 Item 92) 
Sum (PQ9 Items 6, 35, 64) + (PQ8 Item 92) 
Sum (PQ8 Items 7, 36, 65) + (PQ7 Item 93) 
Sum (PQ9 Items 7, 36, 65) + (PQ8 Item 93) 
Sum (PQ8 Items 8, 37, 66) + (PQ7 Item 94) 
Sum (PQ9 Items 8, 37, 66) + (PQ8 Item 94) 
Sum (PQ8 Items 9, 38, 67) + (PQ7 Item 95) 
Sum (PQ9 Items 9, 38, 67) + (PQ8 Item 95) 

Sum (PQ7 Items 10, 39, 68) + (PQ6 Item 96) 

Sum (PQ8 Items 10, 39, 68) + (PQ7 Item 96) 

Sum (PQ9 Items 10, 39, 68) + (PQ8 Item 96) 

Sum (PQ7 Items 11, 40, 69) + (PQ6 Item 97) 
Sum (PQ7 Items 12, 41, 70) + (PQ6 Item 98) 
Sum (PQ7 Items 13, 42, 71) + (PQ6 Item 99) 
Sum (PQ7 Items 14, 43, 72) + (PQ6 Item 100) 
Sum (PQ7 Items 15, 44, 73) + (PQ6 Item 101) 

Sum (PQ8 Items 11, 40, 69) + (PQ7 Item 97) 
Sum (PQ8 Items 12, 41, 70) + (PQ7 Item 98) 
Sum (PQ8 Items 13, 42, 71) + (PQ7 Item 99) 
Sum (PQ8 Items 14, 43, 72) + (PQ7 Item 100) 
Sum (PQ8 Items 15, 44, 73) + (PQ7 Item 101) 

Sum (PQ9 Items 11, 40, 69) + (PQ8 Item 97) 
Sum (PQ9 Items 12, 41, 70) + (PQ8 Item 98) 
Sum (PQ9 Items 13, 42, 71) + (PQ8 Item 99) 
Sum (PQ9 Items 14, 43, 72) + (PQ8 Item 100) 
Sum (PQ9 Items 15, 44, 73) + (PQ8 Item 101) 

Sum (PQ7 Items 16, 45, 74) + (PQ6 Item 102) 

Sum (PQ8 Items 16, 45, 74) + (PQ7 Item 102) 

Sum (PQ9 Items 16, 45, 74) + (PQ8 Item 102) 

Sum (PQ7 Items 17, 46, 75) + (PQ6 Item 103) 

Sum (PQ8 Items 17, 46, 75) + (PQ7 Item 103) 

Sum (PQ9 Items 17, 46, 75) + (PQ8 Item 103) 

Sum (PQ7 Items 18, 47, 76) + (PQ6 Item 104) 

Sum (PQ8 Items 18, 47, 76) + (PQ7 Item 104) 

Sum (PQ9 Items 18, 47, 76) + (PQ8 Item 104) 

Sum (PQ7 Items 19, 48, 77) + (PQ6 Item 105) 
Sum (PQ7 Items 20, 49, 78) + (PQ6 Item 106) 
Sum (PQ7 Items 21, 50, 79) + (PQ6 Item 107) 
Sum (PQ7 Items 22, 51, 80) + (PQ6 Item 108) 
Sum (PQ7 Items 23, 52, 81) + (PQ6 Item 109) 
Sum (PQ7 Items 24, 53, 82) + (PQ6 Item 110) 
Sum (PQ7 Items 25, 54, 83) + (PQ6 Item 111) 

Sum (PQ8 Items 19, 48, 77) + (PQ7 Item 105) 
Sum (PQ8 Items 20, 49, 78) + (PQ7 Item 106) 
Sum (PQ8 Items 21, 50, 79) + (PQ7 Item 107) 
Sum (PQ8 Items 22, 51, 80) + (PQ7 Item 108) 
Sum (PQ8 Items 23, 52, 81) + (PQ7 Item 109) 
Sum (PQ8 Items 24, 53, 82) + (PQ7 Item 110) 
Sum (PQ8 Items 25, 54, 83) + (PQ7 Item 111) 

Sum (PQ9 Items 19, 48, 77) + (PQ8 Item 105) 
Sum (PQ9 Items 20, 49, 78) + (PQ8 Item 106) 
Sum (PQ9 Items 21, 50, 79) + (PQ8 Item 107) 
Sum (PQ9 Items 22, 51, 80) + (PQ8 Item 108) 
Sum (PQ9 Items 23, 52, 81) + (PQ8 Item 109) 
Sum (PQ9 Items 24, 53, 82) + (PQ8 Item 110) 
Sum (PQ9 Items 25, 54, 83) + (PQ8 Item 111) 

Sum (PQ7 Items 26, 55, 84) + (PQ6 Item 112) 

Sum (PQ8 Items 26, 55, 84) + (PQ7 Item 112) 

Sum (PQ9 Items 26, 55, 84) + (PQ8 Item 112) 

Sum (PQ7 Items 27, 56, 85) + (PQ6 Item 113) 

Sum (PQ8 Items 27, 56, 85) + (PQ7 Item 113) 

Sum (PQ9 Items 27, 56, 85) + (PQ8 Item 113) 

Sum (PQ7 Items 28, 57, 86) + (PQ6 Item 114) 

Sum (PQ8 Items 28, 57, 86) + (PQ7 Item 114) 

Sum (PQ9 Items 28, 57, 86) + (PQ8 Item 114) 

Sum (PQ7 Items 29, 58, 87) + (PQ6 Item 115) 

Sum (PQ8 Items 29, 58, 87) + (PQ7 Item 115) 

Sum (PQ9 Items 29, 58, 87) + (PQ8 Item 115) 

Page Reference in the 
Capital Plan

Comments

CACIY814

CACIQ750

FR Y-14A Schedule E - Operational Risk

Institution Name:
RSSD ID:
Source:
Submission Date (MM/DD/YYYY):

BHC or IHC

FR Y-14A Schedule E.1 - Legal Reserves Reporting

Annual Reporting of Legal Reserves

a. For each year in the chart below, report the total dollar value of the institution’s legal reserve balance, representing the total legal reserve balance that was included on the institution’s financial statements for the as-of quarter. The BHC’s
or IHC's initial submission should contain annual legal reserve balances from Q4 of the as-of reporting quarter as well as Q4 from the prior four years.

Total Legal Reserve Balance
Year

Total Legal Reserves:

$ Balance (Millions)

As-of Q4

CAORW923

Q4 - HY1

CAORW924

Q4 - HY2

CAORW925

Q4 - HY3

CAORW926

Q4 - HY4

CAORW927

*HY = Historical Year

b. Legal Reserves Pertaining to Repurchase Litigation (Voluntary): For the as-of quarter, on a voluntary basis, report the total dollar value of the institution’s legal reserves pertaining to repurchase litigation which was
included on the institution’s financial statements as part of the total legal reserve for the as-of quarter. Also please report the subset of this amount which is related only to contractual Representation and Warranty
(R&W) claims (excluding any amounts set aside for damages, penalties, etc).

Total Repurchase Litigation Reserve Balance
As of Quarter
Voluntary Reporting of Legal Reserves Pertaining to Repurchase Litigation:

Q4

$ Balance (Millions)
CAORW928

Repurchase Litigation Reserve
Balance related only to
contractual R&W claims
$ Balance (Millions)
CAORW929

FR Y-14A Schedule E.2 - Material Operational Risk Identification

Material Operational Risk Identification

List all material operational risks identified within the firm, the risk segments in which each risk appears and the loss projection amount for each risk/risk segment combination. Add additional rows when necessary.

Material Operational Risks
Material Operational Risks included in the firm's loss projections:

…
Material Operational Risks excluded from the firm's loss projections:

…

Risk Name

Risk Segment

BHC Baseline Projection Amount - BHC Stress Projection Amount 9 Quarter Loss Projection
9 Quarter Loss Projection

FR Y-14A Schedule E.3 - Operational Risk Scenarios
Operational Risk Scenarios
Firm name:
Operational Risk Scenario Name

What percentage of the operational loss estimates were generated using scenarios?
Total number of operational risk scenarios used in loss projections

Operational Risk BHC
Baseline 9 Quarter
Projection
0
0
0
0
0
0

Operational Risk BHC
Stress 9 Quarter
Projection
0
0
0
0
0
0

%
0

%
0

Methodology for Applying Operational Risk
Scenario Results

FR Y‐14A Schedule F.2 ‐ Pro Forma Combining Balance Sheet Mergers and Material Acquisitions 
Amounts in Millions
Purchase 
Accounting 
Pre‐Acquisition Book Value 
Adjustments
on as‐of date

Fair Value 
Adjustments

4
5

SECURITIES
Held to Maturity (HTM) (1)
Available for Sale (AFS)
Total Securities
Of which:
Securitizations (investment grade)
Securitizations (non‐investment grade)

6

Total Loans and Leases
Real Estate Loans (in Domestic Offices)

CBPLP643

CBPMP643

CBPNP643

7

First Lien Mortgages

CBPL5367

CBPM5367

CBPN5367

8

First Lien Mortgages

CBPLP644

CBPMP644

CBPNP644

9

First Lien HELOAN

CBPLP645

CBPMP645

CBPNP645

10

Second / Junior Lien Mortgages

CBPLP646

CBPMP646

CBPNP646

11

Closed‐End Junior Liens

CBPL5368

CBPM5368

CBPN5368

12

HELOCs

CBPL1797

CBPM1797

CBPN1797

13

CRE Loans

CBPLP647

CBPMP647

CBPNP647

14

Construction

CBPLP648

CBPMP648

CBPNP648

15

Multifamily

CBPL1460

CBPM1460

CBPN1460

16

Nonfarm, Non‐residential

CBPLP649

CBPMP649

CBPNP649

17

Owner‐Occupied

CBPLF160

CBPMF160

CBPNF160

18

Non‐Owner‐Occupied

CBPLF161

CBPMF161

CBPNF161

19

Loans Secured by Farmland

CBPL1420

CBPM1420

CBPN1420

20

Real Estate Loans (Not in Domestic Offices)

CBPLP650

CBPMP650

CBPNP650

21

First Lien Mortgages

CBPLP651

CBPMP651

CBPNP651

22

Second / Junior Lien Mortgages

CBPLP652

CBPMP652

CBPNP652

CRE Loans

CBPLP653

CBPMP653

CBPNP653

24

Construction

CBPLP654

CBPMP654

CBPNP654

25

Multifamily

CBPLP655

CBPMP655

CBPNP655

26

Nonfarm, Non‐residential

CBPLP656

CBPMP656

CBPNP656

27

Owner‐Occupied

CBPLP657

CBPMP657

CBPNP657

28

Non‐Owner‐Occupied

CBPLP658

CBPMP658

CBPNP658

29
30

Loans Secured by Farmland

CBPLP659

CBPMP659

CBPNP659

C&I Loans

31

C&I Graded

CBPLP660
CBPLP661

CBPMP660
CBPMP661

CBPNP660
CBPNP661

32

Small Business (Scored/Delinquency Managed)

CBPLP662

CBPMP662

CBPNP662

33

Corporate Card

CBPLP663

CBPMP663

CBPNP663

34

Business Card

CBPLP664

CBPMP664

CBPNP664

1
2
3

23

CBPL1754
CBPL1773
CBPLP640

CBPM1754
CBPM1773
CBPMP640

CBPN1754
CBPN1773
CBPNP640

CBPLP641
CBPLP642

CBPMP641
CBPMP642

CBPNP641
CBPNP642

FR Y‐14A Schedule F.2 ‐ Pro Forma Combining Balance Sheet Mergers and Material Acquisitions 
Amounts in Millions
Purchase 
Accounting 
Pre‐Acquisition Book Value 
Adjustments
on as‐of date

Fair Value 
Adjustments

35

Credit Cards

CBPLP665

CBPMP665

CBPNP665

36

Charge Card

CBPLP666

CBPMP666

CBPNP666

37

Bank Card

CBPLP667

CBPMP667

CBPNP667

Other Consumer
Auto Loans
Student Loans
Other loans backed by securities (non‐purpose lending)
Other 
Other Loans and Leases
Loans to Foreign Governments
Agricultural Loans
Loans for purchasing or carrying securities (secured or 
unsecured)
Loans to Depositories and Other Financial Institutions
All Other Loans and Leases
All Other Loans (exclude consumer loans)
All Other Leases
Total Loans and Leases

CBPLP668

CBPMP668

CBPNP668

CBPLK137
CBPLP669
CBPLP670
CBPLP671
CBPLP672
CBPL2081
CBPL1590
CBPL1545

CBPMK137
CBPMP669
CBPMP670
CBPMP671
CBPMP672
CBPM2081
CBPM1590
CBPM1545

CBPNK137
CBPNP669
CBPNP670
CBPNP671
CBPNP672
CBPN2081
CBPN1590
CBPN1545

CBPLP673
CBPLP674
CBPLJ451
CBPLF163
CBPLP675

CBPMP673
CBPMP674
CBPMJ451
CBPMF163
CBPMP675

CBPNP673
CBPNP674
CBPNJ451
CBPNF163
CBPNP675

38
39
40
41
42
43
44
45
46
47
48
49
50
51

FR Y‐14A Schedule F.2 ‐ Pro Forma Combining Balance Sheet Mergers and Material Acquisitions 
Amounts in Millions
Purchase 
Accounting 
Pre‐Acquisition Book Value 
Adjustments
on as‐of date

52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85

LOANS HELD FOR INVESTMENT AT AMORTIZED COST
Real Estate Loans (in Domestic Offices)
First Lien Mortgages
First Lien Mortgages
First Lien HELOAN
Second / Junior Lien Mortgages
Closed‐End Junior Liens
HELOCs
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential
Owner‐Occupied
Non‐Owner‐Occupied
Loans Secured by Farmland
Real Estate Loans (Not in Domestic Offices)
First Lien Mortgages
Second / Junior Lien Mortgages
CRE Loans
Construction
Multifamily
Nonfarm, Non‐residential
Owner‐Occupied
Non‐Owner‐Occupied
Loans Secured by Farmland
C&I Loans
C&I Graded
Small Business (Scored/Delinquency Managed)
Business and Corporate Card
Credit Cards
Other Consumer
Auto Loans
Student Loans
Other loans backed by securities (non‐purpose lending)
Other 

CBPLP676
CBPLP677
CBPLP381
CBPLP389
CBPLP678
CBPLP397
CBPLP405
CBPLP679
CBPLP680
CBPLP681
CBPLP682
CBPLP683
CBPLP684
CBPLP685
CBPLP686
CBPLP415
CBPLP423
CBPLP687
CBPLP688
CBPLP689
CBPLP690
CBPLP691
CBPLP692
CBPLP693
CBPLP694
CBPLP695
CBPLP696
CBPLP697
CBPLP698
CBPLP699
CBPLP700
CBPLP491
CBPLP701
CBPLP702

CBPMP676
CBPMP677
CBPMP381
CBPMP389
CBPMP678
CBPMP397
CBPMP405
CBPMP679
CBPMP680
CBPMP681
CBPMP682
CBPMP683
CBPMP684
CBPMP685
CBPMP686
CBPMP415
CBPMP423
CBPMP687
CBPMP688
CBPMP689
CBPMP690
CBPMP691
CBPMP692
CBPMP693
CBPMP694
CBPMP695
CBPMP696
CBPMP697
CBPMP698
CBPMP699
CBPMP700
CBPMP491
CBPMP701
CBPMP702

Fair Value 
Adjustments

CBPNP676
CBPNP677
CBPNP381
CBPNP389
CBPNP678
CBPNP397
CBPNP405
CBPNP679
CBPNP680
CBPNP681
CBPNP682
CBPNP683
CBPNP684
CBPNP685
CBPNP686
CBPNP415
CBPNP423
CBPNP687
CBPNP688
CBPNP689
CBPNP690
CBPNP691
CBPNP692
CBPNP693
CBPNP694
CBPNP695
CBPNP696
CBPNP697
CBPNP698
CBPNP699
CBPNP700
CBPNP491
CBPNP701
CBPNP702

FR Y‐14A Schedule F.2 ‐ Pro Forma Combining Balance Sheet Mergers and Material Acquisitions 
Amounts in Millions
Purchase 
Accounting 
Pre‐Acquisition Book Value 
Adjustments
on as‐of date
86 Other Loans and Leases
87 Loans to Foreign Governments
88 Agricultural Loans
Loans for purchasing or carrying securities (secured or 
89 unsecured)
90 Loans to Depositories and Other Financial Institutions
91 All Other Loans and Leases
92 All Other Loans (exclude consumer loans)
93 All Other Leases
94 Total Loans and Leases

95
96
97
98
99
100
101
102
103
104
105
106
107
108

Loans Held for Sale and Loans Accounted for under the Fair 
Value Option
Real Estate Loans (in Domestic Offices)
First Lien Mortgages
Second / Junior Lien Mortgages
CRE Loans
Loans Secured by Farmland
Real Estate Loans (Not in Domestic Offices)
Residential Mortgages
CRE Loans
Loans Secured by Farmland
C&I Loans
Credit Cards
Other Consumer
Other Loans and Leases
Total Loans Held for Sale and Loans Accounted for under the 
Fair Value Option

109 Unearned Income on Loans
110 Allowance for Loan and Lease Losses (2)
Loans and Leases (Held for Investment and Held for Sale), Net 
111 of Unearned Income and Allowance for Loan and Lease Losses 
(3)

Fair Value 
Adjustments

CBPLP703
CBPLP704
CBPLP705
CBPLP706

CBPMP703
CBPMP704
CBPMP705
CBPMP706

CBPNP703
CBPNP704
CBPNP705
CBPNP706

CBPLP707
CBPLP708
CBPLP709
CBPLP710
CBPLP711

CBPMP707
CBPMP708
CBPMP709
CBPMP710
CBPMP711

CBPNP707
CBPNP708
CBPNP709
CBPNP710
CBPNP711

CBPLP712
CBPLP713
CBPLP714
CBPLP715
CBPLP716
CBPLP717
CBPLP718
CBPLP719
CBPLP720
CBPLP721
CBPLP722
CBPLP723
CBPLP724
CBPLP725

CBPMP712
CBPMP713
CBPMP714
CBPMP715
CBPMP716
CBPMP717
CBPMP718
CBPMP719
CBPMP720
CBPMP721
CBPMP722
CBPMP723
CBPMP724
CBPMP725

CBPNP712
CBPNP713
CBPNP714
CBPNP715
CBPNP716
CBPNP717
CBPNP718
CBPNP719
CBPNP720
CBPNP721
CBPNP722
CBPNP723
CBPNP724
CBPNP725

CBPL2123
CBPL3123
CBPLP726

CBPM2123
CBPM3123
CBPMP726

CBPN2123
CBPN3123
CBPNP726

FR Y‐14A Schedule F.2 ‐ Pro Forma Combining Balance Sheet Mergers and Material Acquisitions 
Amounts in Millions
Purchase 
Accounting 
Pre‐Acquisition Book Value 
Adjustments
on as‐of date
TRADING
112 Trading Assets

113
114
115
116
117

118
119
120
121
122
123
124
125
126
127
128
129
130

INTANGIBLES
Goodwill
Mortgage Servicing Rights
Not applicable
All Other Identifiable Intangible Assets
Total Intangible Assets
OTHER
Cash and cash equivalent
Federal funds sold
Securities purchased under agreements to resell (4)
Premises and Fixed Assets
OREO
Commercial
Residential
Farmland
Collateral Underlying Operating Leases for Which the Bank is 
the Lessor (5)
Autos
Other
Other Assets (6)
Total Other

131 TOTAL ASSETS

Fair Value 
Adjustments

CBPL3545

CBPM3545

CBPN3545

CBPL3163
CBPL3164

CBPM3163
CBPM3164

CBPN3163
CBPN3164

CBPL5507
CBPLP727

CBPM5507
CBPMP727

CBPN5507
CBPNP727

CBPLP728
CBPLB987
CBPLB989
CBPL2145
CBPL2150
CBPLP729
CBPLP730
CBPLP731
CBPLP732

CBPMP728
CBPMB987
CBPMB989
CBPM2145
CBPM2150
CBPMP729
CBPMP730
CBPMP731
CBPMP732

CBPNP728
CBPNB987
CBPNB989
CBPN2145
CBPN2150
CBPNP729
CBPNP730
CBPNP731
CBPNP732

CBPLP733
CBPLP734
CBPLP735
CBPLP736

CBPMP733
CBPMP734
CBPMP735
CBPMP736

CBPNP733
CBPNP734
CBPNP735
CBPNP736

CBPL2170

CBPM2170

CBPN2170

FR Y‐14A Schedule F.2 ‐ Pro Forma Combining Balance Sheet Mergers and Material Acquisitions 
Amounts in Millions
Purchase 
Accounting 
Pre‐Acquisition Book Value 
Adjustments
on as‐of date
132 Deposits in domestic offices
Deposits in foreign offices, Edge and Agreement subsidiaries, 
133 and IBFs
134 Deposits
Federal funds purchased and securities sold under agreements 
135 to repurchase
136 Trading Liabilities
137 Other Borrowed Money
138 Subordinated Notes and Debentures
Subordinated Notes Payable to Unconsolidated Trusts Issuing 
TruPS and TruPS Issued by Consolidated Special Purpose 
139 Entities
140 Other Liabilities
Memo: Allowance for off‐balance sheet credit exposures 
141
142 Total Liabilities
143
144
145
146
147
148
149

Perpetual Preferred Stock and Related Surplus
Common Stock (Par Value)
Surplus (Exclude All Surplus Related to Preferred Stock)
Retained Earnings
Accumulated Other Comprehensive Income (AOCI)
Other Equity Capital Components
Total BHC Equity Capital

Noncontrolling (Minority) Interests in Consolidated 
150 Subsidiaries
151 Total Equity Capital

(1)
(2)
(3)
(4)
(5)
(6)

Fair Value 
Adjustments

CBPLP737
CBPLP738

CBPMP737
CBPMP738

CBPNP737
CBPNP738

CBPLP739
CBPLP740

CBPMP739
CBPMP740

CBPNP739
CBPNP740

CBPL3548
CBPL3190
CBPL4062
CBPLC699

CBPM3548
CBPM3190
CBPM4062
CBPMC699

CBPN3548
CBPN3190
CBPN4062
CBPNC699

CBPL2750
CBPLB557

CBPM2750
CBPMB557

CBPN2750
CBPNB557

CBPL2948

CBPM2948

CBPN2948

CBPL3283
CBPL3230
CBPL3240
CBPL3247
CBPLB530
CBPLA130
CBPL3210

CBPM3283
CBPM3230
CBPM3240
CBPM3247
CBPMB530
CBPMA130
CBPM3210

CBPN3283
CBPN3230
CBPN3240
CBPN3247
CBPNB530
CBPNA130
CBPN3210

CBPL3000

CBPM3000

CBPN3000

CBPLG105

CBPMG105

CBPNG105

Footnotes to the Balance Sheet Worksheet
Institutions that have adopted ASU 2016‐13 should report item 1 net of any applicable allowance for credit losses.
For institutions that adopted ASU 2016‐13, this item will represent the allowance for credit losses on loans and leases.
For institutions that adopted ASU 2016‐13, this item will be net of unearned income and allowance for credit losses on loans and leases.
Institutions that adopted ASU 2016‐13 should report item 120 net of any applicable allowance for credit losses.
Refers to the balance sheet carrying amount of any equipment or other asset rented to others under operating leases, net of accumulated depreciation.  
Institutions that adopted ASU 2016‐13, should report item 129 net of any applicable allowance for credit losses.

Collection of Supplemental CECL Information
Effect of Changes in Accounting Principles 

Item
First quarter of CECL adoption
1
Institutions applying CECL transition provisions
2
Institutions applying CECL transition provisions: Retained 
2a Earnings
Institutions applying CECL transition provisions: DTAs from 
2b temporary differences
Institutions applying CECL transition provisions: credit loss 
2c allowances eligible for inclusion in regulatory capital  

2d

3
4

5
6

Institutions applying CECL transition provisions: average 
total consolidated assets  

Institutions applying CECL transition provisions: total 
2e leverage exposure  
Adoption of Current Expected Credit Loss Methodology – 
ASC Topic 326 
Allowances for credit losses recognized upon the acquisition 
of purchased credit‐deteriorated assets
Effect of adoption of current expected credit losses 
methodology on allowances for credit losses on loans and 
leases held for investment and held‐to‐maturity debt 
securities 
Total allowance for credit losses
Allowance for credit losses on loans and leases held for 
6a investment
6b Allowance for credit losses on held‐to‐maturity securities
6c Allowance for credit losses on available‐for‐sale securities

MDRM
CASTLC05
CASTLC06
CASTLC07
CASTLC08
CASTLC09

CASTLC10
CASTLC11
CASTJJ26
CASTLC12

CASTLC13
CASTLC14
CASTLC15
CASTLC16
CASTLC17

Actual in 
$Millions as 
of date


File Typeapplication/pdf
File Modified2020-06-10
File Created2020-06-10

© 2024 OMB.report | Privacy Policy